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P R E F A C E 
During the last decades man has become more and more conscious that the 
use of his power to alter the appearance of his planet and to control life 
processes on it, has conjured up a number of unforeseen reactions which 
have become a substantial threat to various forms of life and, finally, to 
himself also. 
As successful consequences of mankind's management in developed and 
thriving countries the increasing human population with a longer expectation 
of life, the expanded production of food by improved agriculture and 
cattle-breeding, and the effective preservation and distribution of nutritives 
by the food-processing industry and transport facilities can be mentioned. 
However, the advances in science and technology do not produce merely 
beneficial effects. For instance, beside social and psychological problems 
with which man is confronted as a consequence of overpopulation and 
urbanization, detrimental effects of several factors on the various parts of the 
biosphere (air, soil, water, and biological objects) become manifest. 
These factors may be divided in 4 categories: 
mechanical factors, for instance, changes in nature by projects with refer-
ence to traffic, water-engineering, agriculture, and recreation, by dust 
formation, and accumulation of waste products such as rubbish, plastics, 
wrecks of cars, and refrigerators; 
physical factors, for instance, noise, radioactive radiation, and thermal 
pollution of surface water; 
chemical factors, for instance, stench, improper sewage disposal, combustion 
products of industrial furnaces, domestic incinerators, and internal-combus-
tion engines, and extensive application of detergents and biocides; 
biological factors, for instance, the introduction of foreign plant and animal 
species into certain areas, and the creation of monocultures. 
These factors may be a source of hazard for public health. It will be obvious, 
therefore, that man ought to be concerned about the safety of the biosphere, 
the environment of living organisms. The awakening to a collective respons-
ibility in order to maintain a habitable milieu has to result in actual practice 
of environmental hygiene. The intervention in natural processes in the future 
should be based on an orderly, well-considered development and application 
of the requisite knowledge. In this connection, the present study has to be 
considered as an approach from the viewpoint of pharmacology to one of the 
categories of the environmental problem outlined above: the pollution of 
the biosphere with chemical substances. 
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CHAPTER I 
I N T R O D U C T I O N 
I, 1. ENVIRONMENTAL PHARMACOLOGY 
The biosphere into which man introduces increasingly — both in quantity 
and variety — chemical substances, has a finite ability to dilute out the 
concentrations of the compounds to negligible levels. This may be elucidated 
by figure 1, in which the biosphere is divided schematically in 4 compart-
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FIGURE 1. Schematic representation of some aspects of the fate of chemical pollutants 
in the biosphere. 
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ments, viz. air, soil, water, and biological objects, forming together a closed 
system. After being introduced into one of the compartments a chemical 
compound can move to other parts of the biosphere. The actual fate of a 
compound is determined by its physicochemical properties — especially 
in relation to its distribution over the various compartments — and by the 
processes occurring in the various compartments, especially the processes 
leading to elimination of the substance. Important routes for elimination of 
chemicals are: 
physicochemical disintegration, for instance, the decay of radioactive com-
pounds, and the photochemical decomposition of certain compounds; 
sequestration, processes in which compounds precipitate in the biosphere 
by being bound to other substances; 
biotransformation, processes in which compounds are converted by enzymatic 
reactions. 
In view of the fact that some of the chemical pollutants are eliminated at 
very low rates, the biosphere is becoming loaded with persistent and po-
tentially harmful materials. Due to their stability and relatively high lipid-
solubility, certain compounds will accumulate in the various forms of life, 
the biomasses. The environmental fate of DDT-like compounds exemplifies 
this (figure 2). It is well-known that a long-term exposure, even to low 
concentrations of these compounds, via long-term accumulation, can lead 
to dramatic effects on a certain link of a food chain (cf. Dustman and 
Stickel, 1969). 
Relevant information on the interaction between biological systems and alien 
chemical compounds and the effects of this interaction, can be obtained 
from pharmacology. Modern pharmacology is a multidisciplinary science 
which is neither restricted to drugs with a therapeutic or toxic action, nor 
to man as a biological object. It includes all living organisms and the 
multitude of chemical compounds in their environment. The chemical 
substances dealt with in pharmacology are commonly indicated by the 
terms drug, pharmacon, or xenobiotic. At the present time the word drug 
is mainly used to indicate the substances which are employed as therapeutics, 
whereas nowadays in the public conception the significance of the term has 
gradually shifted to the group of psychoactive compounds. The word 
pharmacon is used in a broader sense, indicating any bioactive nonnutrient 
agent, independent of whether it has a therapeutic (medicaments) or toxic 
(pesticides) action. According to this definition, substances which can be 
considered as normal food components do not belong to the class of 
pharmaca. The word xenobiotic is the most general term: it refers to the 
substances grouped together with the only criterion that they are alien to 
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living organisms (foreign to the body). Bioactive properties are of secondary 
importance. The indication alien to living organisms does not strictly mean 
foreign to all organisms, since various substances which are synthesized in 
certain plant species can be considered to be xenobiotics for animals. More-
FIGURE 2. Schematic representation of the accumulation of DDT and its degradation 
product DDE (ppm) along food chains. The surface of the squares represents the size 
of the biomasses involved; the degree of shadowing represents ihe concentration of 
DDT and its product (Modified after Woodwell, 1967). 
over, foreign to the body is not identical with unjit /or consumption, since 
various xenobiotics — for instance certain detergents — can be used as food 
by various microorganisms. In view of the fact that in most of the literature 
no distinction is made between the terms drug, pharmacon, and xenobiotic, 
in this report, too, no distinction will be made between them. When the terms 
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drug or pharmacon are used they are meant to indicate xenobiotic substances 
as defined above. 
It seems adequate to speak of environmental pharmacology with regard to 
that branch of pharmacology which deals with the exposure of biological 
objects to chemicals that are contaminants of their environment viz. food, 
air, soil, and water. In this field of study several aspects can be recognized, 
as for instance the problems relating to the flows of xenobiotics in nature, 
to and through the various compartments including the different forms of life, 
the biomasses. The study of these problems, dealing with the time-relationship 
in the distribution of the substances over the various compartments of the 
biosphere, can be described as environmental pharmacokinetics (Ariens, 
1969a and 1969b). Further, factors which control the concentrations of 
foreign compounds in nature, for instance, the degradation of the substances 
can be mentioned. In a number of cases the degradation of xenobiotics is 
performed by the biomasses themselves. This phenomenon is indicated with 
the terms biological self-clearance or biological self-purification. 
Studies in the field of environmental pharmacology do not only deal with 
individual organisms but also with populations in relation to their environ-
ment, and consequently depend upon ecological knowledge. On the other 
hand, a rational approach to environmental pharmacology implies a study of 
the mode of action on, and the fate of foreign chemicals in, particular 
organisms and species, as for instance differences in the capability of metabol-
izing xenobiotics in different species. Pharmacological studies borrow freely 
from the knowledge of several of the basic sciences, such as biology, chemistry, 
and physics, and in a more specialized sense from biochemistry, physiology, 
and cytology. It will be clear that environmental pharmacology, too, is based 
upon these sciences and upon the specialized fields of general ecology, 
hydrobiology, geochemistry, meteorology, and climatology. 
In conclusion, the fact that all forms of life are exposed to chemicals that 
are foreign to them, the fact that the number and variety of chemicals 
continuously increase, the fact that such chemicals can, potentially, produce 
harmful effects on individual organisms and consequently on whole popula-
tions, and the requirement of the contribution by a great variety of sciences 
in order to rationally approach the problem outlined, indicate the vast scope 
of study of environmental pharmacology. 
In the study described here an effort has been made to investigate some 
particular aspects of environmental pharmacology. Firstly, attention is 
directed to factors playing a role in the disposal of xenobiotics from several 
vertebrates, especially aquatic species. Emphasis is put upon the differences 
in the capacity of different species to metabolize xenobiotics. 
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Secondly, attention is paid to some general phenomena which can be observed 
in the environmental pharmacokinetics of chemical pollutants. Emphasis 
is put upon the factors which determine the level of accumulation of pol-
lutants in ecosystems. 
I, 2. BIOTRANSFORMATION OF XENOBIOTICS IN HIGHER ORGANISMS 
In studies dealing with the action of drugs in organisms knowledge of the 
factors which control the concentrations of these compounds in the com-
partment in which the sites of action {receptors) are located — which can 
be defined as the concentrations in the biophase — is indispensable (figure 3). 
The concentration of a drug in the biophase is determined mainly by the 
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Figure 3. Schematic representation of the sequence of events occurring between the 
exposure to a drug and its effect. The biophase is the compartment in which the sites 
of action (receptors) are located. 
relative rates of absorption, distribution — including factors such as trans-
port across membranes and protein binding — and the rate of elimination. 
The rate of elimination of most drugs from the organism is controlled by the 
speed at which they are metabolized and excreted. It is known that the usual 
result of the metabolism of drugs in vivo is the formation of derivatives 
which are less active pharmacologically than the parent molecules. In general 
it may be stated that, due to the lipoidal character of most cellular and 
subcellular barriers across which drugs must pass in order to gain access to 
their sites of action, penetration is dependent upon the lipid-solubility of the 
drugs. Therefore, the observed reduction of drug activity is, at least in part, 
due to a decrease in the concentration of the relatively lipophilic drugs by 
enzymatic conversion to more hydrophilic metabolites which are less capable 
of crossing biological membranes to reach their sites of action. 
A general trend of the processes involved in the metabolism of xenobiotics 
in vertebrate animals is the conversion to more polar, more water-soluble, 
substances. As a result, the distribution of the hydrophilic products in the 
body is more restricted to the extracellular fluid as compared with the lipo-
philic parent compounds. In this way the substances are put to a higher con-
centration at disposal of the excretory mechanisms. Moreover, the less the 
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degree of lipophility of a compound, the more rapidly it can be excreted by 
the kidney. 
It should be emphasized that drug metabolism is not strictly identical with 
detoxication, since some chemical compounds are transformed in the or-
ganism to pharmacologically more active — in certain cases toxic — 
substances (Axelrod, 1965). Xenobiotics can be transformed in the animal 
body by a wide variety of metabolic changes. According to whether the 
products of the metabolic conversions are less active or more active than the 
parent compounds, the terms bioinactivation or bioactivation are applied. 
The formation of active or inactive metabolites will usually depend on the 
chemical structure of the parent compound as well as on the type of chemical 
reaction. 
The biotransformation of xenobiotics can be broadly classified into oxida-
tions, reductions, hydrolyses and syntheses. The literature in this field is 
extensive (Brodie et al., 1958; Williams, 1959; Shideman and Mannering, 
1963; Ariens and Simonis, 1964; Remmer, 1965; Uehleke, 1965; Gillette, 
1966; Dutton, 1966). Interest, however, has been so far nearly exclusively 
devoted to certain aspects of drug metabolism in mammals. Examples are: 
the mechanisms of various biotransformation reactions and the enzymes 
involved, and the influence on drug-metabolizing enzymatic activity of a 
number of factors which include genetic properties, age, hormonal changes 
in the body, and of environmental factors such as temperature, stress, diet 
and the administration of certain xenobiotics. In these studies it is common 
practice to investigate the various aspects of drug metabolism in small 
experimental animals, such as rat, mouse, rabbit, and guinea pig. Studies 
of drug metabolism in other vertebrates such as birds and reptiles are much 
less frequent, and for aquatic species and invertebrates other than insects, 
little or no information is available (cf. Smith, 1964; Symposium Comparative 
Patterns of Drug Metabolism, 1967). If one considers the connection and 
interdependency of the various forms of life, and the important role of drug 
metabolism with regard to the biological activity of xenobiotics and their 
fate in biological objects — especially in relation to the level of accumulation 
— it will be clear that knowledge of the quantitative and qualitative differ-
ences in the drug-metabolizing capacities of many more animal and plant 
species is essential for understanding the selective influence of drugs and 
poisons on organisms and therefore on populations. From a more practical 
point of view it will be obvious that a rational development and application 
of selective therapeutics and pesticides and prevention of persistent environ-
mental pollution will only be possible with knowledge of the differences 
in the patterns of drug metabolism in various organisms. 
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I, 2.1. Metabolism of xenobiotics in aquatic animals 
Up to a short time ago it was a general idea that aquatic vertebrates (fishes, 
tadpoles of frogs and toads, and certain frogs), in contrast to terrestrial 
animals, were not provided with special mechanisms for detoxication of 
lipid-soluble substances, such as oxidative biotransformation or conjugation 
with glucuronic acid for instance (Brodie et al., 1958; Brodie and Maickel, 
1962). Lipid-soluble compounds would present no problem for water-
dwelling animals since, because of the lipoidal character of gills and/or 
skin, they would readily diffuse from the body into a large volume of water: 
a continuous exchange (counter-current system) between gill and the infinite 
volume of environmental water. However, it has been totally overlooked in 
this theory, that not only mammals but fishes, too, will profit by the metabolic 
conversion of xenobiotics: the products are preferentially kept in the extra-
cellular phase, which favours excretion. 
On the other hand, lipophilic substances will easily penetrate, and possibly 
accumulate, in aquatic animals. This, at least in part, may explain the 
extreme sensitivity of amphibia and fishes to contamination of the surround-
ing water with lipophilic pesticides and other poisons. It is a well-known fact 
that lipid-soluble compounds from food or water strongly accumulate in 
aquatic animals (Allison et al., 1964; Levy and Miller, 1965; Cope, 1966; 
Ferguson et al., 1966; Holden, 1966; Mount and Fumichi, 1966; Koeman 
et al., 1969a). This may result in the appearance of tumors and other diseases 
(Ashley et al., 1964; Stanton, 1965; Sinhuber et al., 1968), and often more 
dramatically in mortality on a large scale (Thiodan contamination of the 
Rhine, june 1969). Aquatic life finds itself in a vulnerable position because 
it is becoming increasingly exposed to industrial wastes, chemicals and pesti-
cides in streams, rivers, lakes, and oceans, which communicate together over 
the earth and through which a distribution of especially the highly persistent 
chemicals can take place in an almost unlimited way. Not only are 
chlorinated hydrocarbon pesticide residues found in fish living in streams 
remote from the place of application, but they have also been found in 
penguins and seals from the Ross Sea area of Antarctica (Sladen et al., 
1966). 
The aquatic populations consist of innumerable species of organisms. 
Fish alone comprise more than half the vertebrate animal species on earth. 
They frequently represent links in various food chains and are also of great 
concern to man as important sources of protein for food. From studies on 
the disposition of xenobiotic compounds in various aquatic species more 
basic knowledge of comparative physiology and pharmacology can be 
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obtained. These studies may also shed further light on the evolution of 
enzymes that metabolize drugs, on drug-metabolizing pathways and drug 
excretion in lower species. 
If one considers the preceding remarks it will be obvious that many reasons 
indicate the necessity of a study of the disposition of xenobiotics from 
aquatic animals. 
I, 3. ENVIRONMENTAL PHARMACOKINETICS 
Up to the present, the study of pharmacokinetics has been restricted to 
individuals, man or animals, as objects of study. It has been attempted in 
these investigations to understand aspects related to the distribution of drugs 
over the various compartments of the body and to describe these events 
mathematically. Attention is directed to plasma and tissue concentrations, 
levels of accumulation, and the half-life time of drugs. In relation to these 
aspects the rates of uptake, degradation and excretion of the compounds 
play a decisive role. With respect to the fate of drugs in individuals and that 
of chemical pollutants in the biosphere, which can also be considered as a 
multicompartment system, to a certain degree a parallelism can be observed. 
In this connection it is worthwhile to investigate whether the knowledge 
obtained in the study of individual pharmacokinetics can be used in order 
to understand the processes which determine the fate of chemicals in the 
biosphere. 
I, 4. THE AIM OF THIS INVESTIGATION 
In the foregoing discussion the motives starting research from the viewpoint 
of pharmacology with reference to the contamination of the environment 
with xenobiotics, have been outlined. In the present study the problem was 
attacked from two different approaches. 
In the first part of this study the metabolic conversion of xenobiotics in 
some freshwater fishes took the central position. Comparatively, the study 
has also been extended to certain homeothermic animal species. As a general 
parameter for the drug-metabolizing capacity of the animal species studied 
it was decided to take the enzymatic drug-metabolizing capacity of the 
liver, since this organ appeared to play the principal role in drug metabolism 
(see chapters II, 3 and VI, 2). The measurements were performed in vitro. 
Further the question was put whether the enzymatic drug-metabolizing 
capacity of fish is influenced by the same factors which affect hepatic drug 
metabolism in mammals, as for instance age, sex, and the administration 
of other xenobiotics. Enhancement of drug metabolism under the charge 
20 
of xenobiotics will be important for fishes in giving them a certain degree 
of protection against water pollution: enhancement of processes involved 
in drug elimination counteracts the accumulation of xenobiotics. 
The purpose of the second part of the study was to demonstrate the utility 
of mathematical models which describe aspects of distribution of xenobiotics 
over the various compartments of ecosystems. Emphasis was put upon the 
shifts in concentration, the rates of elimination, and the levels of accumula-
tion. The mathematical models were tested in the laboratory with an exper-
imental system consisting of a relatively simple ecosystem: activated sludge 
from a sewage purification station. 
The structure of this thesis can be outlined as follows: 
Chapter II, an introduction to certain aspects of the biotransformation of 
xenobiotics in vertebrates, such as the enzymatic reactions involved and 
their specificity; a discussion of the factors which can affect the metabolism of 
xenobiotics, and of the comparative studies on drug metabolism in different 
animal species. 
Chapter III, a description of the materials, animals, and methods used in 
this study on comparative drug metabolism. 
Chapter IV, a description of the experiments performed in order to develop 
methods for the in vitro assay of the enzymes that catalyze the oxidative 
N-demethylation, the aromatic hydroxylation, and the transfer of glucuronic 
acid, the final step in glucuronidation. Emphasis is put on the differences 
in the nature of enzymes of different species, which necessitate adapted con-
ditions for correct in vitro assays. 
Chapter V, a start to a characterization of the mechanism of oxidative 
N-demethylation of aminopyrine in vitro. 
Chapter VI, a comparison of the drug-metabolizing enzymatic activities of 
different species, in particular in species of fish. 
Chapter VII, a report of the study of the influence of external factors on 
the level of hepatic drug metabolism in fish. Attention is directed to the 
influence of seasonal changes, of different ambient temperature, of alterations 
of the aquatic environment, and of treatment with xenobiotic agents. 
Chapter VIII, a discussion of the fate of chemical pollutants in the biosphere. 
Some mathematical models are presented for a description of the kinetics of 
elimination and of accumulation of pollutants in ecosystems. An effort is 
made to fit some experimental data by the mathematical models described. 
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CHAPTER II 
SOME A S P E C T S O F THE E N Z Y M A T I C C O N V E R S I O N 
O F X E N O B I O T I C C H E M I C A L S IN V E R T E B R A T E S 
R E V I E W O F T H E L I T E R A T U R E 
II, 1. INTRODUCTION 
The pharmacological effect produced by a drug depends on a number of 
events and factors of which the most important ones are schematically re-
presented in figure 3 (chapter I, 2). In this scheme the concentration of the 
drug in the biophase is indicated as a factor influencing the intensity of drug 
action. The concentration in the biophase depends on the dose administered, 
the route of administration, and on several other processes indicated with 
the term drug transference (Ariëns, 1964). In this connection the absorption, 
distribution, metabolism, and elimination of the drug can be mentioned. 
In this chapter attention will be focused on one important factor, the 
metabolic conversion of xenobiotics. Of the processes involved attention will 
be particularly focused on some catabolic reactions leading to the elimination 
of the drug and these will be reviewed. Anabolic processes in which assimila-
tion — incorporation of xenobiotics into body constituents — takes place, 
will not be discussed extensively. Such an assimilation only occurs when the 
enzymes involved in intermediary anabolism cannot distinguish the xenobiotic 
compounds from the endogenous substrates, because of a close resemblance 
in physicochemical properties. In that case the drug may substitute for the 
natural metabolite both in a morphological as well as in a functional sense, 
or lethal synthesis may occur. Such a drug is indicated with the term 
parametabolite. When the drug substitutes for the natural metabolite only 
in a morphological sense with, as a result, a blockage of the normal biological 
process, it is called an antimetabolite. With respect to the fate of anti- and 
parametabolites in the body, reference may be made to the review of Ariëns 
and Simonis (1964). The following discussion will be restricted to the 
enzymatic conversion of xenobiotics with physicochemical properties rather 
different from the natural body constituents. 
Most of the xenobiotic substances, when taken up into the body, undergo 
chemical transformation before they are eliminated into air, bile or urine. 
Due to the biochemical changes the products may differ not only chemically 
but, dependent on the events and factors outlined above, also pharmacolo-
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gically from the administered compounds. The products may be less active 
than the parent compound or inactive; they can be equally active or more 
active. The bioactivity of the products usually does not primarily depend 
on the type of metabolic conversion involved but on their chemical structure 
and properties. From the viewpoint of detoxication generally, the metabolism 
of drugs in the body still will be of advantage for the organism since the 
products are less lipid-soluble in character than the parent drugs. The profits 
of a decrease in the lipid-solubility of xenobiotics for the organism can be 
explained by a teleologica! consideration of phenomena involved in distribu-
tion and excretion. The decrease in the lipophility of xenobiotic compounds 
as a result of the drug-metabolizing reactions causes a change in the distribu-
tion of the products over the various compartments of the body: hydrophilic 
substances are more restricted to the extracellular phase and can be offered 
so in a higher concentration to excretory mechanisms. The hydrophilization 
may also cause a decrease in the extent and firmness with which the sub-
stances are reversibly bound to proteins or other body constituents, or stored 
in adipose tissue. Thus again a substantial reduction of the volume of distribu-
tion occurs, whereas a decrease in the binding of drugs to blood proteins is 
directly in favour of excretory mechanisms based on ultrafiltration. Another 
important factor is that the kidney is poorly equiped to excrete lipid-soluble 
substances. Due to the lipoidal properties of the boundary between the renal 
tubuli and the blood capillaries — which consists of highly packed epithelial 
cells — lipid-soluble compounds would diffuse back into the plasma from the 
tubular compartment. Therefore, the reduction in the lipophilic character of 
the xenobiotics by the metabolic reactions results in a reduction of the back-
resorption from the renal tubuli and therefore in a better fixation of the 
ultrafiltrated substances in the urine. 
The phenomena described here can be considered as a serious objection 
against the hypothesis that aquatic animals would have no need for drug-
metabolizing processes (Brodie et al., 1958; Brodie and Maickel, 1962). 
Many xenobiotics would persist for too long a time in the body with as a 
result of prolonged exposure, accumulation, if the organisms did not have 
the ability to convert them into more polar derivatives. Since the products 
are kept in the extracellular phase, they can be excreted more rapidly by the 
kidney and/or gills. 
II, 2. THE GENERAL PATTERN OF THE METABOLISM OF XENOBIOTICS 
The general pattern of the metabolic conversion of xenobiotics can be seen 
in the scheme in figure 4. 
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From the viewpoint of toxicity, the oxidative, reductive, and hydrolytic 
reactions can lead to less active (detoxication) or more active (toxication) 
products, which generally have a more hydrophilic character and can possibly 
be eliminated by the kidney or gill. Furthermore, the oxidative, reductive, 
and hydrolytic reactions lead to the introduction of groups into the xenobiotic, 
which are suitable for conjugation of the compound with physiologically 
occurring substances. The products of the conjugative reactions are always 
nontoxic and can be easily excreted by kidney or bile. 
bound xenobiotics 
free xenobiotice 
^ ^ 
oxidation 
reduction ^шшшш^. conjugation 
hydrolysis 
I 1 
rrorff polar producto 
FIGURE 4. Schematic representation of the metabolism of xenobiotics. Lipophilic 
xenobiotics are transformed by enzymatic reactions into more water-soluble products. 
The predominant pathways in the conversion of xenobiotics are the oxidative 
reactions. They include aromatic hydroxylation, O-, N-, and 5-dealkylation, 
oxidation of alkyl chains, 5-oxidation, oxidative deamination, aromatization, 
and epoxidation. Oxidation of xenobiotics will take the central position in 
this discussion. 
For some xenobiotics the organism makes use of reductive reactions, such 
as the reduction of keto and nitro groups, and the reductive splitting of the 
azo-configuration, e.g. the conversion of prontosil (4'-sulfamyl-2, 4-diamino-
azobenzene) into sulfanilamide (p-aminobenzenesulfonamide). 
Enzymatic hydrolysis takes place in the case of some esters, and amides. 
The conjugation of xenobiotics includes the synthesis of glucuronides, ethereal 
sulfates, mercapturic acids, amino acid conjugates, and acetylated aromatic 
amines. The methylation of nitrogen in heterocyclic rings, for instance in 
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nicotinamide, and of phenolic OH-groups in catecholamines also belong to 
synthetic reactions. 
A detailed survey of the reactions involved in the metabolism and detoxica-
tion of xenobiotics has been given by Williams (1959). 
II, 3. LOCALIZATION OF THE ENZYME SYSTEMS INVOLVED IN THE 
CONVERSION OF XENOBIOTICS 
In the metabolism of xenobiotics the liver plays the principal role. However, 
minor amounts of the drug-metabolizing enzymes have also been found in 
other tissues, such as kidney (Gelboin and Blackburn, 1964; Kato, 1966; 
Uehleke and Greim, 1968), lung, (Gelboin and Blackburn, 1964; Kato, 1966; 
Uehleke, 1968), gastrointestinal tract (Uehleke, 1968; Wattenberg et al., 
1962), placenta (Dixon and Willson, 1968; van Petten et al., 1968), adrenal 
(Kupfer et al., 1969), heart (Kato, 1966), spleen (Heinzc and Kicse, 1968), 
pancreas (Hcinze and Kiese, 1968), brain (Kato, 1966; Uehleke, 1968), 
testis and thyroid (Wattenberg and Leong, 1962) and muscle (Kato, 1966). 
Biotransformation of xenobiotics in nonhepatic tissues cannot be neglected, 
since compounds that did not yet reach, or that escaped the metabolic 
conversion by the liver can be altered near a possible site of action. For 
instance, the drug-metabolizing enzymes present in the gastrointestinal tract, 
lung, or skin may be of particular importance with regard to the direct contact 
of animals with foreign chemicals in the environment. Generally, the forma-
tion of toxic or nontoxic metabolites within the cells of nonhepatic tissue may 
be of importance with respect to, for instance, general and local toxicity, 
allergy, and chemical carcinogenesis. 
As far as the intracellular localization of the drug-metabolizing enzyme 
systems is concerned extensive studies have been carried out with liver tissue. 
Almost all drug-metabolizing enzymes appear to be bound to the membranes 
of the endoplasmic reticulum. When the liver is homogenized, the disintegrated 
membranes of the endoplasmic reticulum form small vesicles. They can be 
isolated by centrifugation of the 9000 g supernatant of the homogenate at 
105000 g. The sediment thus obtained is generally described as the microsomal 
fraction. This fraction also contains ribosomes which are either attached to 
a portion of membrane or exist freely. From a morphological point of view 
the subcellular fraction, which was indicated for the first time with the term 
microsomes by Claude (1943), must be regarded as an artefact. The com-
position of the microsomal fraction is closely related to the isolation procedure 
and varies according to the tissue of origin (Dallner and Ernster, 1968). 
Under the electron microscope that part of the membranes which carries 
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ribosomes, the so-called rough endoplasmic reticulum, can be distinguished 
from the membranes without ribosomes, the smooth endoplasmic reticulum. 
Microsomes therefore can be divided in two subfractions. The enzymes which 
oxidize xenobiotics are present in both subfractions. There are indications that 
they are more abundantly present in the subfraction containing the smooth 
membranes than in that containing the rough membranes (Gillette, 1966; 
Remmer, 1965; Holtzman et al, 1968). Studies of Dallman et al. (1969) 
also suggest a nonrandom distribution of the enzymes in the membranes of 
the endoplasmic reticulum. NADPH-cytochrome с reductase and cytochrome 
P-450, involved in most of the drug-metabolizing reactions, are localized 
in a microsomal subfraction different from that containing NADH-ferri-
cyanide reductase, NADH-cytochrome с reductase, and cytochrome b 5, which 
mainly function in intermediary reactions. In order to study the properties 
of the drug-metabolizing enzymes, in the past many attempts have been made 
to solubilize the enzymes. Separation of the protein fraction from the lipid 
part of the microsomal membranes has been performed, for instance, by 
treatment with phospholipase (Lumper et al., 1969) and with deoxycholate 
(Gillette et al., 1957; Ernster et al., 1962). After solubilization, differences 
in the properties of the enzymes have been observed. Mostly, reduction or 
complete disappearance of enzymatic activity occurred for the structurally 
bound enzymes, e.g. the oxidative drug-metabolizing enzymes. Other micro­
somal enzymes which can be more easily solubilized, such as the enzymes 
involved in hydrolytic and conjugative reactions show after solubilization a 
similar or increased activity (Krisch, 1963; Henderson, 1970). From the 
alterations in the properties of drug-metabolizing enzymes when forced out 
of their natural relation with lipids, it appears to be essential for them to 
exist and to operate in special structures. 
Since the mechanism of the drug-metabolizing reactions is rather complex, 
a spatial organization of the various components involved in the microsomal 
reactions is quite conceivable. Any change in the microenvironment of the 
enzyme proteins consequently may lead to a change in their activity. 
II, 4. SPECIFICITY OF THE DRUG-METABOLIZING ENZYMES 
It has already been mentioned that foreign organic compounds may be 
metabolized in animal species if the substances are sufficiently like the natural 
metabolites to fit into the normal metabolic system. The metabolism of many 
foreign compounds probably occurs in this manner. 
In the case of the microsomal metabolism of substances which the body has 
never "seen" before, questions arise about the specificity of the enzyme 
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systems. The enzymes of intermediary metabolism have a high specificity 
towards natural substrates so that they can achieve an effective organization 
of the cellular biochemical processes. In contrast, an attack on the xeno-
biotics, which may enter the organism in a great variety, requires a rather 
low discrimination by the enzymes in their acceptance of substrates. There­
fore, the metabolic attack on xenobiotics by means of the already mentioned 
kind of reactions depends largely on the recognition of the presence of a 
vulnerable site in the molecule. The nature of the rest of the compound will 
have consequences almost solely for the processes of distribution, and to 
some degree, for the affinity between enzyme and substrate. 
Gaudette and Brodie (1959) and McMahon (1961) presented experimental 
evidence that an important requirement for the substrate is that it be lipid-
soluble. This proposal was particularly attractive in view of the lipoidal 
character of the membranes of the endoplasmic reticulum. It provided an 
explanation of why the oxidative enzymes have a predilection for foreign 
lipophilic compounds, while naturally occurring hydrophilic substances (e.g. 
sugars, amino acids) are not attacked. Dealkylation of normally occurring 
substrates such as sarcosine and dimethylglycine, and hydroxylation of L-
tryptophan, L-phenylalanine, kynurenin, and phenylacetic acid, all poorly 
lipid-soluble substances, are not catalyzed by the microsomal enzymes, but by 
quite different selective enzyme systems in other parts of the cell, e.g. in 
mitochondria (Mackenzie et al., 1953). Although there is little doubt that 
lipid-solubility is an important factor in controlling the rate of drug-metabol­
izing reactions, other physicochemical factors, such as the sterical structure 
and the charge distribution over the molecule, most certainly are also 
involved. 
It can be asked whether the metabolism of xenobiotics is a special function 
rather than an involvement of the enzymes of physiological lipophilic sub­
strates. It has been shown that many of the normal lipophilic body constituents 
are metabolized by NADPH-dependent enzymes in liver microsomes. For 
instance, it is probable that the enzyme systems which metabolize steroid 
hormones, e.g. estrogens, androgens, and glucocorticoids, convert barbiturates 
and other xenobiotics as well (Kuntzman et al., 1964 and 1966; Conney et 
al., 1965). Further the possible participation of the microsomal oxidative 
enzymes in ω-oxidation of fatty acids (Wada et ed., 1968a), in the formation 
of unsaturated fatty acids (Marsh and James, 1962) and bile acids (Wada 
et al., 1968b) can also be mentioned. The enzyme system, involved in the 
formation of glucuronides seems to be also involved in the normal formation 
of bilirubine glucuronide (Schmid et ed., 1957). 
Brodie and Maickel (1962) suggest that the properties of the drug-metabolizing 
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enzyme systems in microsomes fit those postulated for systems evolved to 
dispose of naturally occurring lipid-soluble, unwanted substances in the food, 
e.g. alkaloids, steroids, and terpenes. The data showing similarities between 
the microsomal metabolism of xenobiotics and of normal body substrates 
suggest that both enzyme systems if not identical, may have evolved from the 
same origin. It is not excluded that organisms, during their contact with 
foreign substances, have used certain enzyme systems of intermediary meta-
bolism as the basis for the development of a more extended capacity to 
metabolize xenobiotics. 
II, 5. MECHANISM OF THE ENZYMATIC OXIDATION OF XENOBIOTICS 
The microsomal enzyme systems for the oxidative biotransformation of 
xenobiotics were first extensively described by Brodie and collaborators 
(1958) and by Axelrod (1960). It has been shown by Mason (1957) that 
this type of enzymatic reaction requires both NADPH and free oxygen. He 
introduced the term mixed function oxidase for the enzyme system involved. 
As far as the mechanism of the reaction is concerned, at the present time 
most of the oxidative drug-metabolizing NADPH-dependent reactions are 
considered to belong to the general category of hydroxylations (table 1). 
TABLE 1 - Hydroxylation mechanisms in drug metabolism 
aliphatic hydroxylation R-CH., -* R-CH2OH 
aromatic hydroxylation R-CuHj -»- R-CeH4OH 
H 
oxidative dealkylation R-X-CH„-R' -»- [R-X-C(OH)(H)-R'] -»- R-XH + 0=C-R' 
(X = O, S, or NH) 
oxidative deamination R-CH(NH,)-R' -> [R-C(OH)(NHä)-R'] -»• R-CO-R' + NH3 
i-oxidation R-S-R' ->- [R-SOH-R']+ -»- R-SO-R' + H+ 
N-oxidation (CH3),N -»• [(CHs),NOH]+ -»- (CH^NO + H+ 
Since the introduction of the concept by Fish et al. (1956) that ЛГ-dealkylation 
proceeds via intermediate N-oxides, several studies have been performed 
that argue for (Pettit and Ziegler, 1963; Ziegler and Pettit, 1964; Smuckler 
et al., 1967; Dehner et al., 1968) or against it (McMahon and Sullivan, 1964). 
The arguments have been reviewed by McMahon (1966) and Gillette (1966), 
and recently by Bickel (1969). A final answer concerning the role of TV-oxides 
as intermediary metabolites in N-dealkylation has, however, as yet not 
been given. 
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The oxidative reactions require the mediation of an electron-transporting 
chain which consists of NADPH-cytochrome с reductase (an FAD-containing 
flavoprotein), a non-heme iron-protein and cytochrome P-450 (Omura et al., 
1965; Orrenius, 1965). The sequence of the different steps is schematically 
represented in figure 5. Gillette and Gram (1969) propose the following 
scheme for the mechanism of the mixed function oxidase reaction. The 
substrate first forms a complex with the oxidized form of a microsomal 
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FIGURE 5. Sequence of steps in the oxidation of xenobiotics. 
hemoprotein, the cytochrome P-450. This complex then is reduced through 
other microsomal components by NADPH. The reduced cytochrome P-450-
substrate complex rapidly combines with molecular oxygen to form an 0 2-
cytochrome P-450-substrate complex, which quickly decomposes to form the 
oxidized substrate and the oxidized form of the cytochrome. The reduction 
of the oxidized cytochrome P-450-substrate complex is suggested as the 
rate-limiting step. 
At present, the full identity of the non-heme iron-protein is not known. 
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Cytochrome P-450 is a specific cytochrome which is also called reticulo-
chrome or СО-cytochrome. After its first description in 1958 (Garfinkel, 
1958; Klingenberg, 1958), it was not until 1963 that the function of cyto­
chrome P-450 in the oxygen activation and the associate reactions of micro­
somal electron transport became known (Estabrook et al., 1963; Cooper et 
al., 1965). Thereupon the cytochrome P-450 has been extensively investigated, 
especially its spectral properties (Omura and Sato, 1964a and 1964b; Omura 
et al., 1965; Gillette, 1966; Remmer et al, 1968a). The cytochrome P-450 
can be distinguished from another microsomal pigment, the cytochrome b5, 
since the spectral properties of the two cytochromes react in a different way 
to the presence of carbon monoxide. The presence of the cytochrome P-450 
may be detected only in an atmosphere of carbon monoxide. In that case 
the reduced form of the pigment combines readily with CO to form a complex 
having an absorption maximum at 450 nm. As a result of the binding to 
carbon monoxide an inhibition of many drug-metabolizing reactions of 
various animal species have been observed (Gillette, 1966). Light, especially 
monochromatic light having a wavelength of 450 nm, can split the CO-
cytochrome P-450-complex resulting in an abolishment of the inhibition. 
More recent studies have been directed to the interaction between xenobiotics 
and the microsomal cytochrome P-450. It has been shown that the spectral 
properties of the microsomal suspensions can be altered by the addition of 
various drugs (Narasimhulu, 1963; Narasimhulu et al., 1965; Remmer et al., 
1966; Imai and Sato, 1966). Two distinct types of spectral changes have 
been observed. A type I spectral change with an absorption minimum at 
about 420 nm and a maximum at about 390 nm caused by, for instance, 
barbiturates, cyclohexane, isooctane, aminopyrine, DDT, chlorpromazine, 
and SKF 525A, and a type 11 spectral change with a maximum at about 
430 nm and a minimum at about 390 nm caused by, for instance, aniline, 
acetanilide, and metyrapone (Imai and Sato, 1967; Schenkman et al., 1967b; 
Schenkman and Sato, 1968; Remmer et ed., 1968b; Leibman et al, 1969). 
It is suggested that the difference in the two types of absorption spectra is 
caused by a difference in the nature of the complexes formed. A definite 
answer to the questions about the enzyme-substrate interaction requires 
further characterization of the structure of the hemoprotein involved. In the 
centre of interest is the question whether a single species of cytochrome P-450 
exists in two or more functionally different, but interconvertible, forms 
capable of interacting with two different types of substrates (Hildebrandt et al, 
1968 and 1969; Leibman et al, 1969; Schenkman and Sato, 1968; Schenk­
man et al, 1969), or whether two or more hemoprotein species of cytochrome 
P-450 are present in microsomes (Alvares et al, 1968a; Conney et al, 1969; 
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Mannering et al, 1969; Kuntzman et al, 1968 and 1969). Up to now, 
however, this question is still a matter of debate. 
II, 6. REDUCTION, HYDROLYSIS, AND CONJUGATION REACTIONS IN THE 
METABOLISM OF XENOBIOTICS 
A wide variety of xenobiotic substances used as food-additives, medicaments, 
and pesticides contain groups which can be biochemically reduced in the 
organism. As such can be mentioned the azo group in prontosil, azobenzene, 
and dimethylazobenzene which can be cleaved (thus forming primary aromatic 
amines), and the nitro group in chloramphenicol, p-nitrobenzoic acid, and 
nitrobenzene. The enzyme systems involved in reduction appear to occur 
mainly in the liver. Minor amounts are also observed in a variety of other 
tissues including kidney and lung (Fouts et al, 1957; Fouts and Brodie, 
1957). Intracellularly, the enzyme systems are mainly located in the endo­
plasmic reticulum, but are also found in the soluble fraction of the cell 
(Fouts and Brodie, 1957; Kato and Oshima, 1968; Umar and Mitchard, 
1968). The studies of Kato et al (1969) revealed different properties of the 
differently located reductase systems. For instance, the microsomal reductases 
are NADPH-dependent, whereas for the reductases found in the super­
natant NADPH can be replaced by NADH. Reduction proceeds at a maximal 
rate under anaerobic conditions. The properties of the microsomal reduction 
mechanism resemble in some aspects those of the oxidative reactions since 
for the concomitant electron transport both types of reaction appear to make 
use of the same system (Gillette and Gram, 1969). NADPH acts as hydrogen 
donor. The reaction requires the mediation of NADPH-cytochrome с 
reductase (Hernandez et al, 1965), and of cytochrome P-450. For details 
about the role of cytochrome P-450 in the reduction of p-nitrobenzoate by 
liver microsomes may be referred to the papers of Gillette et al. (1968) and 
Sasame and Gillette (1969). 
In contrast to the oxidative and reductive drug-metabolizing enzymes, which 
only are located intracellularly, a considerable number of hydrolytic enzymes 
has been shown to be present both intracellularly as well as in blood plasma. 
Lee and Livett (1967) showed that various local anaesthetics containing an 
ester link are hydrolysed by esterases occurring in the liver. As examples 
of plasma esterases, aromatic esterases hydrolysing phenyl and p-nitrophenyl 
esters, aliphatic esterases hydrolysing aliphatic esters (e.g. tributyrin) and 
choline esterases (i.e. acetylcholine esterase and pseudocholine esterase) hy­
drolysing preferentially choline esters can be mentioned. 
In conjugation, within the liver cells products suitable for excretion in urine 
31 
or bile are synthesized by the coupling of xenobiotics or waste products from 
intermediary metabolism with normal body substances indicated by the term 
conjugating agents. In order to be conjugated the unwanted molecule must 
possess one or more polar groups. Not only xenobiotics, which often have 
first to be modified by the previously discussed oxidative, reductive and/or 
hydrolytic reactions, but also products from normal carbohydrate, protein, 
and lipid metabolism are removed from the body in this way. Glucuronide 
formation may occur with compounds bearing OH-, COOH-, NH2- and 
SH-groups. Conjugation with amino acids can take place in the case of 
aromatic and aliphatic carboxy-acids. Acetylation occurs with drugs contain-
ing hydroxyl or sulfhydryl groups, but more frequently with xenobiotics 
bearing amino groups. Phenolic hydroxyl groups may be conjugated with 
sulfuric acid. Methylation may occur with OH-, SH-, NH2- and NH-groups. 
In view of the above mentioned possibilities, it will be clear that a drug, 
dependent on its structure, can be attacked at different points and by differ-
ent types of reaction. In any case of conjugation it is a requirement that the 
drug or the conjugating agent is in an activated state. An example of the 
conjugation reactions in which the drug forms part of the active intermediate 
is the conjugation of acids with amino acids. For instance, benzoic acid is 
converted to an active form, benzoyl-coenzyme A, which is transferred by 
the enzyme glycine N-acylase to the conjugating agent glycine. Activation of 
the conjugating agent is more common. As such can be mentioned UDP-
glucuronate in glucuronidation, acetyl coenzyme A in acetylation, adenosine-
3'-phosphate-5'-phosphosulfate in sulfate conjugation, and 5-adenosylmethio-
nine in methylation. The final coupling between drug and conjugating agent 
is catalyzed by transferring enzymes. In this field extensive studies have been 
performed on the enzyme involved in glucuronide synthesis, the UDP-
ghicuronyltransferase. Kinetic evidence has been presented that this trans-
ferase exists in more than one molecular form (Dutton, 1966; Halac and 
Reff, 1967). Some of the products of the conjugation reactions may be 
removed from the body with the urine, but most of them are eliminated by 
biliary excretion (see Parke and Williams, 1969). 
II, 7. FACTORS INFLUENCING THE METABOLISM OF XENOBIOTICS 
The extent to which the organism makes use of biotransformation processes 
in order to eliminate xenobiotics depends on various factors. Besides the 
chemical properties of the drug, its dose, route of administration, and 
effects of distribution and excretion, the qualitative and quantitative differ-
ences in the properties of the drug-metabolizing enzyme systems are especially 
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important. The capacity of animals to convert xenobiotics varies with several 
endogenous factors, such as genetic factors, hormonal changes, sex, and 
age, and with exogenous factors, among which certain environmental con-
ditions, the nutritional status and the ingestion of other alien chemicals. 
In this discussion attention will be mainly directed to the stimulation of drug 
biotransformation by the administration of alien chemicals in vivo. The 
enhanced drug metabolism evoked by pretreatment with drugs may lead to a 
tolerance or an increased sensitivity of the organism to the action of xeno-
biotics. The phenomenon of enhanced drug-metabolizing capacities was 
first described in 1954 by Brown and coworkers. They administered poly-
cyclic hydrocarbons to rats and mice. Subsequently, a wide variety of drugs, 
insecticides, and carcinogens have been detected as stimulators of drug 
metabolism. 
The increase in drug-metabolizing capacity appears to be mainly due to an 
increase in the concentration of enzyme protein; the stimulation observed is 
referred to as enzyme induction. The extensive studies in this field have 
been reviewed by Remmer (1962 and 1969), Burns et al. (1963), Conney 
(1967) and Street (1969). Recent studies have shown that enzyme induction 
in drug metabolism cannot only be observed in animals exposed to certain 
xenobiotics, but also in vitro in isolated rat liver cells (Henderson, 1971), and 
in hamster fetus cell cultures (Nebert and Gelboin, 1968). 
A peculiar aspect of the situation is that the modification of the enzymatic 
activity is not restricted to the enzyme system converting the drug studied, 
but has a much more general character. Also compounds practically not 
metabolized themselves, such as the insecticide chlordane, are potent stimul-
ators for a variety of drug-metabolizing enzyme systems (Hart and Fouts, 
1965; Conney et al., 1966). The inducers can be categorized into two groups, 
viz. a group of inducers mainly consisting of drugs and insecticides, that 
enhance the metabolism of a wide variety of drugs, and a group mainly 
comprising polycyclic hydrocarbons that stimulate the metabolism of only 
a few drugs. Phénobarbital is the prototype of the first group of inducers; 
3-methylcholanthrene and 3,4-benzpyrene are the most frequently employed 
agents in the latter group. The different action of the two groups of inducers 
does not only reveal itself in relation to quite different types of reactions such 
as oxidation, reduction, hydrolysis, and conjugation (Conney 1967), but also 
when only one type of reaction is concerned. Here again the question arises 
whether in one type of reaction one or more enzymes are involved. The 
extensive studies of Rubin et al. (1964) supported evidence that a single 
enzyme system would be responsible for the metabolism of many drugs. 
They showed that many substrates are competitive inhibitors of each other's 
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enzymatic oxidation. These authors, however, already pointed out that these 
results were contradictory to the different inductive effects of the polycyclic 
hydrocarbons and phénobarbital. For instance, phénobarbital administered 
to male rats stimulated the N-demethylation of both ethylmorphine and 
3-methyl-4-methylaminoazobenzene (3-MMAB), while 3-methylcholanthrene 
and 3,4-benzpyrene stimulated the N-demethylation of 3-MMAB only (Sla-
dek and Mannering, 1969a and 1969b). These data suggest a diversity in 
the oxidative enzyme system, in which the two groups of inducers may 
produce an effect via different induction mechanisms. It was suggested that 
the administration of polycyclic hydrocarbons caused the synthesis of a micro-
somal hemoprotein differing from the original one in that it is capable of 
participating in the AZ-demethylation of 3-MMAB but not of ethylmorphine. 
These findings support the data which indicate the existence of more than one 
molecular species of cytochrome P-450 (Kuntzman et al., 1968; Alvares 
et al., 1968a; Levin and Kuntzman, 1969a and 1969b). However, at present 
data of the various investigators working in this field seem contradictory. 
It must be remembered that the enzyme proteins involved have a complex 
structure and that they are "embedded" in microsomal lipids. Therefore, the 
differences in the metabolism of different substrates and the diversity in the 
induction processes may also be related to changes in the structure of the 
microsomal lipids and so to changes in the functional state of the enzyme 
systems. 
The increase in the drug-metabolizing enzymatic capacities under the in-
fluence of inducing agents might be caused by several mechanisms. As such 
can be mentioned: a) enhancement of enzyme synthesis; b) synthesis of a 
more active enzyme; c) direct or indirect activation of existing enzyme, or 
d) stabilization of enzyme against degradation. 
An effect of the agents on the possible level of activators or inhibitors has 
not been observed as yet. Removal of endocrine glands does not prevent the 
induction of drug metabolism. These data (cf. Conney, 1967) argue against 
an enhancement on the basis of a direct or indirect activation. At present 
there is much evidence that the increased enzymatic activity is mainly due to 
a de novo enzyme synthesis (Kato et al., 1966; Piper and Bousquet, 1968; 
Baron and Tephly, 1969; Levin and Kuntzman, 1969a and 1969b; Bresnick 
and Madix, 1969). Inhibitors of protein or nucleic acid synthesis such 
as cycloheximide, ethionine, actinomycin D, and puromycin prevent enzyme 
induction (see Conney, 1967). Comparative data on the properties of the 
newly formed and the existing enzyme are somewhat contradictory. In the 
past it was generally accepted that the affinity of the enzyme for the sub-
strates was not changed after induction (Leibman and McAllister, 1967; see 
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also Conney, 1967). The studies of Guarino et cd. (1969) and Alvares et al., 
1968b), however, showed changes in the apparent Michaelis constants 
(apparent Km) in drug-metabolizing reactions after induction. Concerning 
apparent Km-values in drug-metabolizing reactions it has to be remarked that 
these values are determined by measuring only the formation of an end 
product, the disappearance of the initial substrate, or the disappearance of 
the initial electron donor. As has been discussed before in this chapter, the 
drug-metabolizing reaction includes several steps between the electron donor 
and the substrate. In view of this, and of the use of a rather impure isolated 
enzyme system such as the microsomal preparation, the kinetic data obtained 
in drug-metabolizing reactions are of limited value. 
Some studies have shown that as well as de novo synthesis of microsomal 
components, a decrease in catabolism, by means of a stabilization of the 
components or by a repressing effect on catabolizing enzymes, is probably 
also involved in the induction phenomenon (Holtzman and Gillette, 1968; 
Greim and Remmer, 1969). 
Treatment of animals with inducing agents not only enhances the drug-
metabolizing capacity but also causes a broad spectrum of changes in the 
biochemical and morphological composition of the liver. The papers of 
Orrenius el al. (1965 and 1969), Kunz et al. (1966a and 1966b), and Conney 
(1967) are relevant in this respect. 
II, 8. SPECIES DIFFERENCES IN THE METABOLISM OF XENOBIOTICS 
In pharmacology it is a normal observation that a certain dose of a drug 
has a profound effect in one animal species, but has little or no effect in 
another species. In many cases these differences are caused by differences in 
the pathways or in the rates of drug metabolism (Quin et al., 1958: Kato and 
Gillette, 1965). Here again a parallel must be drawn with normal inter-
mediary metabolism. In view of the possibility that the enzymes involved in 
the biotransformation of xenobiotics may also operate in the metabolism of 
physiological substances, the species variations in drug metabolism may well 
be a reflection of the variations in the metabolism of the normal intermediary 
compounds. Further, it is likely that in evolution the development of the 
qualitative and quantitative differences in the metabolism of xenobiotics is 
influenced by the environmental conditions of the organism. For example, 
an adaptation of the drug-metabolizing capacity may well be caused by the 
components in the food for which the animal is specialized, and by the 
exposure to various xenobiotics over long periods of time. It is likely that 
herbivorous animals in their normal diet encounter a larger amount and 
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diversity of foreign compounds, for instance alkaloids, terpenes, dyes, 
aromatic compounds, than carnivorous animals do. 
It appears from the rather few surveys of the literature in this field of study 
that the basic pattern of drug metabolism is common to most animal species 
(Smith, 1964; Symposium Comparative Patterns of Drug Metabolism, 1967). 
A study of Strittmatter and Umberger (1969) shows similarities between the 
microsomal mixed function oxidase system of avian and mammalian liver. 
A comparison of some characteristics of several drug-metabolizing reactions 
in different animal species, especially fishes, will be presented in the next 
chapters. 
In spite of the extensive studies on drug metabolism, in the last decade, 
comparative investigations with a wide range of species have scarcely been 
performed. Certain comparative studies (Dring et al., 1966; Ellison et al., 
1966; Bridges et al., 1969a and 1969b; see also review of Williams, 1967), 
which are only based on in vivo experiments with measurements of the 
metabolites appearing in urine and faeces are difficult to interpret. The data 
thus obtained can hardly be taken as representative of the respective import­
ance of the various drug-metabolizing reactions. The rate of elimination of 
substances by the kidney depends on the lipid-solubility and on the degree 
of ionization (dependent on the рКд-value of the compound and on the pH of 
the urine), and on the involvement of active transport systems. These factors 
may all result in variable patterns of the excreted metabolites. In studies where 
xenobiotics are orally administered to animals or man, the metabolism by 
gastrointestinal microorganisms and further enterohepatic circulation of the 
drug and metabolites is not always taken into consideration. This means that 
differences found in the metabolic fate may be a reflection of, for instance, 
differences in intestinal flora (Scheline, 1968a, 1968b, and 1968c). For DDT, 
for example, it has been shown that the intestinal microflora plays a major 
role in its detoxication in the rainbow trout (Wedemeyer, 1968). 
In vitro studies have shown that species differences in drug-metabolizing 
reactions can be the result of variations in the absolute amount and the 
kinetic properties of the enzymes. Several investigators have shown this for 
the N-demethylation of ethylmorphine in mouse, rat, rabbit, and guinea pig 
(Castro and Gillette, 1967; Davies et al., 1968; Davies et al., 1969; Gillette 
and Gram, 1969). The data obtained in these studies cannot explain the 
interspecies differences in the reaction mentioned, on the basis of differences 
in the microsomal cytochrome P-450 content. That the amount of cytochrome 
P-450 in microsomes of various species does not differ very much has also 
been reported by Remmer et al. (1968a). 
It has to be remarked that as well as differences in the amount of the enzymes 
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other factors may also be responsible for interspecies differences. For 
instance, the amount and properties of natural activators or inhibitors of the 
drug-metabolizing enzymes, the enzymes reversing the reactions, and the 
extent of competing reactions using the same substrate, may play a role. 
The above discussion, which shows that rather little information is available 
in the area of comparative drug metabolism, indicates the urgency of the 
need of further study. 
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CHAPTER HI 
M A T E R I A L S A N D M E T H O D S E M P L O Y E D IN 
T H E S T U D Y O F T H E E N Z Y M A T I C 
C O N V E R S I O N O F X E N O B I O T I C S 
IH, 1. CHEMICALS 
Biochemicals used were obtained commercially: glucose-6-phosphate (diso-
dium salt), glucose-6-phosphate dehydrogenase (E.C. 1.1.1.49), NADP (diso-
dium salt), NADPH (tetrasodium salt), and UDPglucuronate (disodium salt) 
from C. F. Boehringer and Soehne GmbH, Mannheim, Germany; bovine 
serum albumin, DL-isocitrate (type I, trisodium salt), and isocitrate dehy-
drogenase (E.C. 1.1.1.42, Sigma type IV) from Sigma Chemical Company, 
St. Louis, U.S.A.; calf thymus DNA from the British Drug Houses Ltd., 
Poole, London, U.K.; saccharo-l,4-lactone from Calbiochem, Los Angeles, 
U.S.A. 
Pyrazolone derivatives were obtained from Merck A.G., Darmstadt, Ger-
many, except 4-monomethylaminoantipyrine which was donated by Farb-
werke Hoechst A.G., Frankfurt, Germany. 
Dieldrin (containing 1,2,3,4,10,10-hexachloro-6,7-epoxy-l,4,4a,5,6,7,8,8a-
octahydro-l,4,5,8-dimethanonaphthalene) was obtained from Fluka A.G., 
Buchs, Switzerland; DDT (l,l,l-trichloro-2,2-bis(p-chlorophenyl)ethane, 
technical grade) and atrazine (2-chloro-4-ethylamino-6-isopropylamine-s-tria-
zin) were donated by N.V. Orgachemia, Boxtel, the Netherlands. 
In thin-layer chromatography TLC-plates silicagel F254 and TLC-plates sili-
cagel without fluorescence indicator (layer thickness 0.25 mm or 2 mm) 
obtained from Merck A.G., Darmstadt, Germany, were used. 
All other chemicals were obtained commercially in the highest purity avail-
able and were not further purified, except aniline which was distilled before 
use and p-aminophenol which was recrystallized from ethanol. 
Ill, 2. ANIMALS 
Mammals: golden hamster (Mesocricetus auratus, L.), mouse {Mus musculus, 
L., Swiss mouse), rat (Rattus norvegicus, L., strain Wistar). 
Birds: zebra finch (Taeniopygia guttata, L.), hen (Gallus gallus gallus, L.) 
pigeon (Columba livia, L.). 
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Reptiles: lizard {Lacerta viridis, L.). 
Amphibians: frog {Rana esculenta, L.). 
Fishes: hatchery-reared fishes, viz. golden orfe (Leuciscus idus, L. var. Idus 
orfus, L.) and rainbow trout (Salmo irideus. Gibbons) were furnished by 
the Koninklijke Nederlandse Heide-Maatschappij, Arnhem, the Netherlands; 
wild fishes were obtained from the river Waal (Rhine) near Nijmegen, the 
Netherlands, viz. bream (Abramis brama, L.), carp (Cyprinus carpio, L.), 
tench (Tinca tinca, L.), white bream (Blicca bjoerkna, L.), dace (Leuciscus 
leuciscus, L.), ide (Leuciscus idus, L.), roach (Leucticus rutilus, L.), rudd 
(Scardinius erythrophthalmus, L.), twait (Aiosa finta, L.), loach (Nemachilis 
barbatula, L.), houting (Coregonus oxyrhynchus, L.), salmon (Salmo salar, 
L.), eel (Anguilla anguilla, L.), perch (Perca fluviatilis, L.), pike (Esox 
lucius, L.). Besides the above mentioned animals two other water-dwelling 
animals have also been investigated, viz. the sea lamprey (Petromyzon mari-
nus, L.) and an invertebrate species, the wool-handed crab (Eriocheir sinensis, 
De Haan), both obtained from the river Waal. 
In the comparative study the wild animals investigated have been assayed 
for drug-metabolizing enzymatic activity on the day of capture. In certain 
experiments fishes were maintained alive in the laboratory, in tanks with 
continuously running tap water (6001/h) until used experimentally. 
III. 3. PREPARATION OF TISSUE 
Animals were killed by decapitation and exsanguinated. Tissues were imme­
diately excised and placed in beakers immersed in ice. All subsequent 
operations were carried out at 0 - 4 "С. Twenty-five per cent (w/v) homo-
genates in 0.25 M sucrose containing ΙΟ-3 M sodium ethylenediamine 
tetraacetate (EDTA-Na) and 5 χ I O 2 M Tris-HCl buffer (pH 7.4) were 
prepared with a Potter homogenizer having a Teflon pestle. The homo-
genization was performed during 1 min with 3 up and down strokes at 2500 
revolutions per minute. The homogenates were centrifuged at 9000 g for 
20 min. Either the "9000 g supernatant" fractions, or microsomes isolated 
from these fractions, were used in the enzymatic assays as the enzyme source. 
The microsomal fractions were isolated by centrifugation of the 9000 g 
supernatants at 105000 g during 60 min. After removal of the supernatant 
the sediments were suspended in the above mentioned homogenization 
medium, recentrifuged, and then resuspended in the homogenization medium 
to a final volume equal to the original 9000 g supernatant volume. 
In the study of the intracellular localization of the enzymes in liver tissue 
besides the above mentioned fractions, the cell fractions sedimenting between 
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0 and 1000 g, 1000 and 9000 g, 9000 and 18000 g as well as the 105000 g 
supernatants were tested for enzymatic activity. 
For the measurement of the N-demethylating and p-hydroxylating enzymatic 
activities the tissue preparations were used as described above. The UDP-
glucuronyltransferase activity was assayed after ultrasonication of the tissue 
preparations according to Henderson (1970) in a MSE 100 Watt Ultrasonic 
Disintegrator for 60 seconds ( 6 x 1 0 seconds with intervals of 1 minute). To 
avoid heating, the tubes containing the homogenates were cooled with ice 
or a freezing mixture during the ultrasonic treatment. 
HI, 4. ENZYME ASSAYS 
Before a standardization of the enzyme assays applied in this study was 
accomplished, the influence of various reaction conditions on the enzymatic 
activity in vitro was evaluated. The experiments performed with respect to 
the influence of different reaction conditions are extensively described in 
chapter IV. The standard procedures and conditions of the enzymatic reac­
tions finally employed during the whole investigation will be listed here. 
All enzyme assays were carried out in duplicate and referred to similarly 
treated blanks to detect non-enzymatic or endogenous formation of products 
and other interfering substances. Product formation was calculated by 
reference to calibration curves, obtained with solutions with decreasing con­
centrations of the substances being estimated, in mixtures which contained all 
reaction components including heat-denatured enzyme extract, and which 
were equally and simultaneously treated. 
III. 4.1. Standard incubation procedure for oxidative N-demethylation and 
aromatic hydroxylation 
For the measurement of enzymatic activity in the N-demethylation of amino-
pyrine and p-hydroxylation of aniline in vitro the following incubation mix­
ture was used: 5 χ 10-2 м tris-HCl (pH 8.0), 8 χ IO"* M MgCl2, 8 χ 10"« M 
MnCl2, 5 χ IO
-3
 M sodium isocitrate, 50 «g isocitrate dehydrogenase (capable 
of reducing 0.3 ¿(moles NADP per min), 1.3 χ IO-4 M NADP, and the sub­
strate, aminopyrine or aniline, of which the concentrations employed are 
presented in chapter IV, 3.4, table 9. The 9000 g supernatant or other tissue 
fraction was added in a suitable concentration, generally in amounts equiv­
alent to 60 - 100 mg fresh tissue. The total volume was 3 ml. During the 
incubation the test media were saturated with air by shaking. The incubation 
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periods for the enzymatic reactions studied were short so that substrate con­
version remained linear with time (chapter IV, 3. 1). 
Enzyme reactions were started by adding the enzyme extracts after a 
preincubation of the assay media for 10 min to ensure temperature constancy 
and complete reduction of NADP to NADPH. The employment of the 
glucose-6-phosphate dehydrogenase reaction as an NADPH-generating system 
instead of the isocitrate dehydrogenase reaction — 5 χ IO-3 M glucose-6-
phosphate and 5 //g glucose-6-phosphate dehydrogenase (capable of reduc­
ing 0.7 /(moles NADP per min) — proved as good. 
III. 4.2. N-Demethylation of aminopyrine 
In the N-demethylation reaction with aminopyrine used as the substrate, 
enzymatic activity was defined as the amount of formaldehyde produced per 
hour per gram fresh tissue. In order to trap the formaldehyde formed, a 
neutralized solution of scmicarbazide hydrochloride was added to the reaction 
mixture to a final concentration of 5 χ ΙΟ"3 M. 
After the incubation the reaction was stopped by the addition of 0.5 ml 25 % 
ZnS04.7 H 2 0 and 0.5 ml saturated Ba(OH)2. After cooling, the precipitated 
protein was removed by centrifugation at 18000 g for 10 min. The amount 
of formaldehyde in the supernatant was determined according to the method 
of Nash (1953) as modified by Cochin and Axelrod (1959): 2 ml of super­
natant were mixed with 1 ml of double-strength Nash reagent (a solution of 
4 M ammonium acetate, 0.1 M acetic acid, and 0.04 M acetylacetone in 
water); the mixture was heated for 15 min at 60 °C and cooled, and its 
extinction was determined at 412 nm. 
The N-demethylated pyrazolone derivatives were quantified, in reaction 
mixtures in which semicarbazide was omitted, by the colorimetrie methods 
of Brodie and Axelrod (1950) and of Brun (1951). In the first assay the 
protein in the reaction mixture was precipitated by the addition of 1 ml of 
a solution of 20% trichloric acid (La Du et al., 1955). After cooling, the 
precipitated protein was removed by centrifugation at 18000 g for 10 min. 
To 3 ml supernatant 0.3 ml 0.2% sodium nitrite solution was added, cooled 
for 10 min, and then thoroughly mixed with 0.3 ml 1% ammonium sulpha-
mate solution. After 3 min 0.1 ml of a 3% solution of resublimed a-naphthol 
in absolute alcohol was added, followed by 0.6 ml of 4N NaOH. After 10 min 
0.3 ml of concentrated HCl was added, after which the dye was extracted 
in 1 ml isoamyl alcohol. The optical density of the solution was determined 
at 540 nm. In the assay according to Brun the protein in the reaction mixture 
was precipitated by the addition of 1 ml of a solution of 9% trichloroacetic 
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acid. After cooling, the precipitated protein was removed by centrifugation 
at 18000 g for 10 min. Subsequently 2 ml of the supernatant were mixed 
with 2 ml freshly prepared Brun reagent (0.07 M p-dimethylaminobenzalde-
hyde in 60% alcohol). After 15 min the extinction was determined at 
430 nm. An evaluation of the various colorimetrie assays applied in the 
studies on the N-demethylation of aminopyrine in vitro is given in chapter V. 
In the assays of N-demethylating enzymatic activity, incubated blanks con­
taining all components of the incubation mixture except substrate, which was 
added after protein precipitation, were used to correct for formaldehyde 
produced during incubation by reactions not involving aminopyrine. 
Ill, 4.3. p-Hydroxylation of aniline 
In the hydroxylation reaction in which aniline was used as the substrate, 
enzymatic activity was expressed as the amount of p-aminophenol produced 
per hour per gram fresh tissue. The amount of p-aminophenol was determined 
with a method based on the procedures of Brodie and Axelrod (1948), 
Dixon et al. (1964) and Jaccarini and Jepson {1968). After incubation the 
reaction mixture was extracted with ethyl acetate, once with 2 ml and 
subsequently twice with 1 ml. To the combined extracts 2 ml 0.01 N HCl 
were added. After shaking for 10 min, the ethyl acetate layer was removed 
and 2 ml of 5% phenol in 1 M N a 2 C 0 3 were well mixed with the aqueous 
layer. After 20 min the blue indophenol colour was determined at 630 nm. 
In the blanks no endogenous formation of p-aminophenol or interference 
by other substances could be detected. 
Ill, 4.4. GI ucuro nidation of p-nitrophenol 
The activity of UDPglucuronyltransferase (UDPglucuronate glucuronyltrans-
ferase, E.C. 2.4.1.17) was determined using p-nitrophenol as acceptor sub­
strate. The incubation mixture contained 5 χ 10'- M tris-HCl (pH 7.4), 
3.3 χ I O 3 M MgCl2, 6.0 χ 10
 3
 M uridine-5-diphosphoglucuronate (UDP­
glucuronate), IO-3 M saccharo-l,4-lactone, 14 χ IO-4 M p-nitrophenol, and 
tissue homogenate in concentrations equivalent to 18 - 75 mg fresh tissue in 
a total volume of 1.5 ml. Blanks contained all reagents except UDPglucu­
ronate. The reaction was stopped by adding 1 ml ethanol. The glucuronide 
formation was measured indirectly by determination of the disappearance of 
p-nitrophenol. After centrifugation, aliquots of the deproteinized medium 
were diluted with 0.1 N NaOH and spectrophotometrically measured at 
398 nm. 
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Ill, 5. IDENTIFICATION OF PRODUCTS FORMED IN THE IN VITRO 
N-DEMETHYLATION OF AMINOPYRINE 
In order to know whether in the N-demethylation of aminopyrine in vitro 
one or two methyl groups are split from the dimethylamino group in the 
molecule, reaction products were extracted from the reaction mixture, 
separated by thin-layer chromatography (TLC) and further analysed. In all 
experiments, appropriate blanks and standards were carried through the 
entire procedure. 
Ill, 5.1. Extraction of reaction products 
Immediately after incubation the reaction mixtures, standard solutions with 
known concentrations of reference substances, and blanks, were brought to 
pH 9 with NaOH and extracted with 1,2-dichloroethane. The organic phases 
were evaporated to dryness in a stream of air and residues were taken up in 
ethanol. 
Ill, 5.2. Thin-layer chromatography 
In preparative chromatography of extracts of large volumes — 0.5 to 1.0 ml, 
originating from reaction mixtures with a total volume of 150 to 300 ml — 
samples were applied in bands on plates coated with silicagel with a layer 
thickness of 2 mm. For the analysis of small samples 10 to 50 μΐ were 
applied in spots on plates with a silicagel layer, thickness of 0.25 mm. 
The following solvent systems were used: 
system A: chloroform — diethylether — methanol (70-30-10, vol.), and 
system B: n-butanol — acetic acid — water (80-20-10, vol.). 
Chromatography was carried out in the dark at room-temperature. Devel­
opment time lasted until about 16 cm length of run. 
Ill, 5.3. Identification of pyrazolone derivatives 
III, 5.3.1. Absorption measurements 
After TLC, bands or spots were visible under ultraviolet light. Rf-values 
were calculated. 
UV-absorbing areas were scraped from the plates, eluted with ethanol, and 
UV-spectra of the eluates were measured. The spectra were corrected for 
the absorption of an eluate from a blank area in the chromatogram. 
In some experiments a quantitative estimation of the spots on the chromato-
grams was achieved. Reaction mixtures (3 ml) were extracted twice with 
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1.5 ml 1,2-dichloroethanc as described above. Samples were subjected to 
TLC on plates without fluorescence indicator with solvent system A. After 
development of the chromatograms the absorption of ultraviolet light by the 
spots was directly measured with a Zeiss-chromatogram-spectrophotometer 
(PMQ II) at 275 nm, and recorded. Calculation was performed by referring 
the areas of the peaks found for the reaction products to those found for 
mixtures with known concentrations of the pyrazolone derivatives involved. 
Ill, 5.3.2. Staining procedures 
The spots were stained by spraying the chromatograms with the following 
reagents (cf. Stahl, 1967), which were freshly prepared before use: 
a. 0.5% aqueous solution of Fast blue salt B, followed by 0.1 N NaOH. 
b. 1 % iron (III) chloride solution, followed by heating to 80 0 C. 
с 1 % 2,6-dichloroquinone chlorimide in ethanol, followed by exposure to 
ammonia vapour. 
d. a mixture (1 : 1) of a 0.5% aqueous solution of phenol and a 5% 
ammonia solution, followed by 2% aqueous solution of potassium ferri-
cyanide (Emerson and Beegle, 1943). 
Colours formed by reaction of the reagents and the reference substances 
aminopyrine (DMAP), 4-monoethylaminoantipyrine (MMAP), and 4-amino-
antipyrine (AAP) are given in table 2. 
TABLE 2 - Staining of aminopyrine (DMAP), 4-monomethylaminoantipyrine (MMAP), 
and 4-aniinoantipyrine (AAP) by various reagents 
reagent* 
b 
с 
DMAP 
red-brown 
violet-blue 
yellow 
violet-blue 
reference substances 
MMAP 
yellow 
pink 
yellow 
afterwards 
grey-green 
pink 
afterwards 
pink-violet 
AAP 
red-brown 
afterwards brown 
red-violet 
yellow 
yellow 
* reagents a, b, c, d are described in the text; pyrazolone derivatives were stained after 
TLC. 
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Ill, 5.3.3. Mass-spectrometry 
Eluates were evaporated to dryness and the residues were subjected to mass-
spectrometry in a LKB 9000, direct inlet, electron energy 70 eV. 
Ill, 6. ASSAY OF PROTEIN 
The protein of liver homogenates was determined according to the method 
of Lowry et al. (1951), using bovine serum albumin as a reference standard 
in the calculation of the protein content. 
Ill, 7. ASSAY OF DNA 
DNA was determined by the diphenylamine test according to the method 
of Burton (1956) after a preextraction according to Wanka (1962). Calf 
thymus DNA was employed as a reference standard in the calculation of the 
DNA content. 
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CHAPTER IV 
S O M E C H A R A C T E R I S T I C S O F T H E 
E N Z Y M A T I C N - D E M E T H Y L A T I O N O F 
A M I N O P Y R I N E , p- H Y D R О X Y L AT Ι Ο N O F 
A N I L I N E , A N D G L U C U R O N I D A T I O N 
O F p - N I T R O P H E N O L IN VITRO 
IV, 1. INTRODUCTION 
In this study an effort was made to obtain more knowledge of the quantitative 
differences in the xenobiotic-metabolizing capacities in different animal 
species. The parameter used was the biotransformation capacity of tissue 
preparations, especially of liver preparations. The terms biotransformation 
capacity and enzymatic drug-metabolizing capacity are used in this report to 
denote the maximally measurable rates of conversion in vitro. It remains 
disputable, however, whether the capacities measured in vitro can be con­
sidered representative for the drug-metabolizing capacity in vivo, especially 
as far as the quantitative aspects are concerned. 
A comparison of the in vitro assays of drug-metabolizing reactions report­
ed in the literature reveals a striking lack of uniformity in the methods 
used. For this reason the data obtained for different animal species in 
different laboratories are not readily comparable. Some standardized proce­
dures for the assay of the drug-metabolizing enzymatic capacities of various 
animal species used in the present investigation, have been listed already in 
chapter III. This will be extended here by giving some elucidative examples 
of experiments performed for the determination of adapted reaction con­
ditions. 
This investigation concerned the following enzymatic reactions: the N-de-
methylation of aminopyrine, the p-hydroxylation of aniline, and the glucuro-
nyl conjugation of p-nitrophenol. As outlined in chapter II, oxidative N-âc-
alkylation, aromatic hydroxylation and glucuronidation represent major path-
ways in the hepatic processes involved in the biotransformation of xenobiotics. 
The compounds employed in this study are commonly used as model sub-
strates for these types of reaction. The factors considered in the choice of 
the enzyme preparation and the reaction conditions employed will be dis-
cussed in detail now. In this connection the intracellular localization of 
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hepatic drug-metabolizing enzymes, and the influence of various treatments 
of the enzymatic preparations will be discussed. Further, various reactions 
conditions will be discussed such as temperature, incubation time, pH, nature 
of NADPH-generating system, concentrations of various additives, concen-
trations of substrates and cosubstrates, and enzyme concentration. 
IV, 2. THE ENZYME PREPARATION 
As described in chapter II, most drug-metabolizing enzymes are localized 
within the liver cell, bound to the membranes of the endoplasmic reticulum. 
Therefore, the activity of these enzymes is generally measured with the 
supernatant obtained by centrifugation of a liver homogenate at 9000 g, 
indicated by the term 9000 g supernatant, or with the sediment obtained by 
centrifugation of the 9000 g supernatant at 105000 g, indicated by the 
terms J 05000 g pellet or microsomal fraction. In order to choose the enzyme 
preparation considered in the present investigation as being representative 
for measurements of drug-metabolizing enzymatic capacities, homogenates 
and various fractions were tested for enzymatic activity. 
IV, 2.1. Intracellular localization of hepatic drug-metabolizing enzymes 
Pilot experiments showed that the patterns of distribution of the enzymes 
over the various fractions studied were equal with respect to different animal 
species. Therefore, as an example, only the drug-metabolizing enzymatic 
activities observed in homogenate and fractions of the liver of one fish 
species, the rainbow trout, will be discussed here. The results are presented 
in figure 6. 
It appears that, if the enzymatic activities are expressed as the amount of 
drug metabolized per g fresh liver, the highest values for the oxidative 
reactions are found in the 9000 g supernatant (fraction 4), and for the 
glucuronidation reaction in the homogenate. However, if the reaction rates 
are expressed per mg protein in the respective fractions, for the 3 reactions 
studied the highest activities are observed in the fraction sedimented by 
centrifugation of the 18000 g supernatant at 105000 g (fraction 6). This 
indicates a microsomal localization of the enzymes involved. From the 
activities expressed per g fresh liver, however, it can be seen that from the 
microsomal fraction (fraction 6) a considerable amount of the enzymatic 
activity has disappeared. It will be unlikely that the lower enzymatic activity 
is caused by a change in the enzyme-substrate interaction, since experiments 
in which the relationship between the enzyme preparations and different 
substrate concentrations was studied, revealed for the N-demethylation of 
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aminopyrine and for the p-hydroxylation of aniline, too, for 9000 g super-
natant and 105000 g pellet, equal apparent Michaelis constants. 
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FIGURE 6. Intracellular localization of drug-metabolizing enzymes in trout liver. Blocks 
represent the means of 3 separate experiments. Enzymatic activity is defined as substrate 
turnover: in the AMemethylation of aminopyrine as nmoles formaldehyde produced per 
hour; in the p-hydroxylation of aniline as nmoles p-aminophenol produced per hour; 
in the glucuronidation as nmoles p-nitrophenol conjugated per hour. Fractions: 1, total 
homogenate: 2, 0 - 1000 # pellet; 3, 1000 - 9000 g pellet; 4, 9000 g supernatant; 5, 
9000 - 18000 g pellet; 6, 18000 - 105000 g pellet; 7, 105000 g supernatant. Glucuro­
nidation was measured after ultrasonic treatment of the fractions (for details see 
chapters III, 3 and IV, 2. 2). 
Note: if substrate turnover is expressed per g fresh liver, the highest capacities fot 
N-demethylation and p-hydroxylation are found with the 9000 g supernatant (fraction 
4), and for glucuronidation with the total homogenate. If substrate turnover is ex­
pressed per mg protein of the fractions involved, the highest capacities for the 3 reac­
tions are found with the microsomal fraction (fraction 6). 
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TABLE 3 - Microsomal ЛГ-demethylalion in relation to the liver preparation 
enzyme preparation 
I 9000 g supernatant 
II 9000 g supernatant** 
III 9000-105000 g pellet § 
+ 
105000 g supernatant 
IV 9000-105000 g pellet § 
+ 
105000 g supernatant 
V 9000-105000 g pellet ! 
mg tissue 
equivalent 
in reaction 
mixture 
100 
100 
100 
+ 100 
100 
+ 10 
100 
enzymatic activity* 
rat 
(n=9) 
100 
96 ± 2 
85 ± 2 
70 ± 2 
79 ± 3 
trout 
(n=6) 
100 
69 ± 5 
66 ± 6 
58 ± 6 
47 ± 4 
expressed as a percentage of the enzymatic activity in the 9000 g supernatant 
(100%); means = S.E.M. 
the number of separate sets of experiments; in each set of experiments the N-
demethylation activities of enzyme preparations I-V were assayed. 
9000 g supernatant centrifuged for 1 hour at 105000 g, then gently remixed with a 
Potter homogenizer. 
9000-105000 g pellet gently resuspended in 0.25 M sucrose containing 10-3 M 
EDTA-Na and 5 χ IO-2 M Tris-HCl. 
significantly different, rat: I - II (p < 0.05) 
II - III (p < 0.01) 
III - IV (p < 0.01) 
IV - V (p < 0.02) 
trout: I - II 
I - I I I 
I I I - V 
(p < 0.01) 
(p < 0.01) 
(p < 0.01) 
The decrease in enzymatic activity observed for the microsomal fraction may 
be ascribed to mechanical damage to the enzyme system during the longer 
preparative procedure or to the absence of certain factors in the soluble 
fraction (fraction 7). That these factors may play a role is suggested by the 
data presented in table 3. If the 9000 g supernatant of liver homogenate 
was centrifuged at 105000 g for 1 hour, and remixed, both for the rat and 
the trout a significant decrease in the enzymatic activity was observed 
(enzyme preparation II). This may imply an injurious effect of the exper­
imental procedure on the enzyme system studied. If the 105000 g pellet 
was separated from the supernatant, resuspended in the homogenization 
medium and assayed for N-demethylating enzymatic activity, both for the 
rat and the trout still lower enzymatic activities were observed (enzyme 
preparation V). The effect of the omission of the soluble fraction on the 
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enzymatic activity, which was more pronounced for the microsomes of the 
trout liver, indicates that the microsomal enzyme systems requires the soluble 
fraction for full activity. This may be confirmed by the data obtained in 
experiments in which the microsomal fraction in the reaction mixture was 
supplemented by the soluble fraction (enzyme preparation III), which 
suggest a restoration of enzymatic activity. A remarkable effect was observed 
in the rat, when only a small amount of the soluble fraction was added 
(enzyme preparation IV). In this case a significantly lower enzymatic activ-
ity appeared. An increase in microsomal drug oxidation by addition of 
soluble fraction has been described earlier by Chan et al. (1967). These 
investigators observed an enhancement of aldrin epoxidation by rat liver 
microsomes supplemented with either rat or trout liver soluble fraction. 
Later on, Terriere and Chan (1969) partially purified and characterized a 
heat-stable factor from the soluble fraction which increased aldrin epoxidation 
and ethylmorphine Af-demethylation by rat liver microsomes. 
IV, 2.2. Influence of various treatments on drug-metabolizing enzymatic 
activity 
The sensitivity of the drug-metabolizing enzyme preparations of rat liver 
to various experimental conditions has been investigated earlier (McLuen 
and Fouts, 1961; Leadbeater and Davies, 1964; Janson, 1968; Chan and 
Terriere, 1969). It appeared that various treatments resulted in decreased 
enzymatic activities in the oxidative reactions. In contrast, for the glucuroni-
dation of p-nitrophenol an enhancement of the enzymatic activity has been 
observed by ageing and by treatment of enzyme preparations of rat liver 
with detergents (Winsnes, 1969; Mulder, 1970) or with ultrasound (Hen-
derson, 1970). Table 4 shows the influence of various treatments on the 
enzymatic activities of the liver preparations in the present study. The data 
presented confirm the findings of the studies mentioned above. Positive or 
negative effects of the treatments appeared both in rat and roach liver 
preparations. 
The effects observed may be explained by reference to the conception, 
that a disturbance of the structural properties of the lipoproteinic micro-
somal membranes on the one side leads to a decrease in the oxidative 
drug-metabolizing enzymatic activities by change of an essential lipophilic 
microenvironment of the enzyme proteins (see chapter II), on the other 
hand it may cause an increase in glucuronidating enzymatic activity by 
removal of barriers between protein and substrate and/or cosubstrate 
(Winsnes, 1969; Hänninen et al., 1970; Henderson, 1970; Mulder, 1970). 
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TABLE 4 - Influence of various treatments on drug-metabolizing enzymatic activity 
treatment 
storage 
(5 h at room temperature) 
storage 
(15 h at-15 0 Ο 
storage (at -15 0C) with 
repeated freezing and 
thawing (24, 48, and 
72 h after preparation) 
bile fluid 
(enzyme preparation + 
bile = 4 + 1 , vol.) 
deoxycholate (added to 
enzyme preparation until 
0.05% deoxycholate) 
ultrasound*** 
per cent stimulation ( + ) or inhibition (—) 
N-demethylation* p-hydroxylation* 
of aminopyrine of aniline 
rat roach rat roach 
-14 —42 —5 —15 
—16 —13 -8 -10 
—50 —48 —30 —25 
_ 2 3 —86 —9 —81 
glucuronidation** 
of p-nitrophenol 
rat roach 
+ 16 + 6 2 
+ 4 1 +30 
-t-150 + 7 5 
+ 65 + 4 0 
—80 —92 —68 —75 +1250 +450 
—26 —32 —39 —27 + 400 +140 
Each value is the mean of the results of 2 separate experiments which never differed 
more than 30%. 
* assayed in 9000 g supernatant 
** assayed in total homogenate 
*** MSE 100 Watt Ultrasonic Disintegrator, 60 seconds at maximum output 
IV, 2.3. Choice of enzyme preparation for the present study 
The data of IV, 2.1. indicate the occurrence of a decrease in enzymatic 
capacity during the preparation of the microsomal fraction and a require­
ment for the soluble fraction. The studies of Dallner and Ernster (1968) 
showed that the composition of the microsomal fraction is related to the 
origin of the tissue and to its sensitivity to the isolation procedure. On the 
basis of these data it seemed preferable, in the present comparative study 
about the differences in drug-metabolizing capacities of different animal 
species, to measure the capacities for oxidative reactions with the 9000 g 
supernatants of the liver homogenates, and for glucuronidation with the total 
homogenates. The preparative procedure had the advantage that there was 
only a short interval between the excision of the liver from the animal and 
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the final enzyme assay. The preparation of tissue was performed for each 
animal species in a standardized way (chapter III, 3). Reproducibility was 
proven for various liver samples of similar origin. Nevertheless, for this 
investigation it was necessary to presume that a possible difference in the 
sensitivity of the livers of different animal species to the preparative proce-
dure had not led to essential differences in the composition of the homo-
genates and 9000 g supernatants employed. 
According to the observations reported in this chapter (IV, 2.2.), for the 
oxidative reactions freshly prepared 9000 g supernatants were always used, 
and for the glucuronidation reaction freshly prepared homogenates. Before 
the assay of glucuronidation the homogenates were activated by ultra-
sonication (Henderson, 1970). 
IV, 3. MEASUREMENT OF THE ENZYMATIC ACTIVITY 
In preliminary experiments, the influence of changes in temperature, 
incubation time, pH, and concentration of the various reaction components 
on the substrate turnover were studied. Each time only one of the reaction 
conditions was changed whereas the others were kept constant. The inform-
ation obtained about the optimal range of the various conditions was used 
to perform the experiments described here. One of the reaction conditions 
was changed again, while all other factors were kept constant (chapter III). 
IV, 3.1. Influence of temperature, incubation time, and pH on enzymatic 
activity 
The xenobiotic-metabolizing activities of 9000 g supernatants of liver homo-
genates from various animal species were determined at different temperat-
ures, whereas the other reaction conditions (incubation time, pH, ionic 
strength) were kept constant (for details see chapter III). Figure 7 shows that 
differences can be observed in the temperatures at which the liver preparations 
studied exhibited their maximal N-demethylating activities (incubation time 
10 min). The temperature for measurement of maximal enzymatic activity 
FIGURE 7. TV-Demethylation of aminopyrine by 9000 g supernatants prepared from 
liver homogenates of various animal species. iV-demethylating activity was assayed in 
various separate sets of experiments. In each set activity was measured for 10 min at 
different temperatures. The values of each series were expressed in relation to the 
maximal value (numerically 100). 
Note the differences in the temperature at which the enzyme preparations from different 
species exhibit their maximal activities. 
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activity 
100 
100 
100 
100 
Л0 6 0 
temperature ('С) 
40 бО 
tem pera ture С С ) 
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TABLE 5 - Af-demethylation and p-hydroxylation in vitro in relation to the incubation 
temperature 
incubation temperature (0C) per cent activity§ 
animal species 
pigeon 
hen 
hamster 
rat 
lizard 
frog 
bream 
white bream 
orfe 
roach 
tench 
eel 
perch 
pike 
salmon 
trout 
sea lamprey 
range 
optimum* 
45 — 50 
45 — 50 
40 — 45 
40 — 45 
40 — 45 
35 — 40 
35 — 40 
35 — 40 
35 — 40 
35 — 40 
30 — 40 
35 — 40 
35 — 40 
30 — 40 
30 — 35 
25 — 30 
30 — 35 
operative 
temperature 
42 
42 
37 
37 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
25 
/V-demethylation 
of aminopyrine 
83 
85 
93 
89 
46 
64 
53 
46 
46 
61 
48 
50 
54 
47 
65 
85 
80 
± 
-
± 
± 
± 
± 
± 
± 
± 
+ 
+ 
5 
3 
8 
8 
7 
3 
3 
6 
8 
4 
3 
p-hydroxyla 
of aniline 
85 ± 3 
85 
84 ± 4 
72 ± 4 
86 ± 4 
83 
87 ± 7 
67 ± 13 
72 ± 3 
68 ± 6 
63 
75 
77 + 7 
87 
93 ± 4 
85 
§ enzymatic activity measured at the operative temperature as a percentage of the 
maximal activity; means of at least 4 experiments ± S.E.M. 
* temperature range of the two reactions for measurement of maximal activity; incuba­
tion time: JV-demethylation, 10 min; p-hydroxylation, 30 min. 
for the p-hydroxylation of aniline by liver preparations from various animal 
species (incubation time 30 min) were found within the same range as those 
for the /V-demethylation of aminopyrine. In the present study, as the oper­
ative temperature for study of the enzyme reactions in vitro — unless other­
wise stated — were chosen for the avian species 42 'C, for the mammalian 
species 37 0C, and for the Poikilothermie species 25 "С. The main reasons 
for this choice were: the temperatures chosen approximate the physiological 
temperatures of the animals; they allow the employment of incubation periods 
during which the enzymes studied remain stable (product formation linear 
with time), whereas product formation can continue until a well-measurable 
amount. However it has to be stressed that the values obtained at the 
operative temperatures were not the maximally obtainable in vitro activities. 
The maximal enzymatic activities (obtained at fixed incubation times) can 
be derived from table 5. 
Since the temperature at which maximal enzymatic activity can be measured 
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FIGURE 8. N-Demethylation of aminopyrine measured at different temperatures with 
9000 g supernatants prepared from liver homogenates of rat and trout. The enzymatic 
activities are expressed as «moles formaldehyde produced per g fresh liver per hour. 
The activities were measured during different incubation periods · · trout, 10 min 
incubation; о о trout, 60 min incubation; · - - - - · rat, 10 min incubation; 
о о rat, 60 min incubation. 
is the resultant of two opposed factors — the increase in the substrate turn­
over and the enhanced time dependent denaturation of the enzyme at higher 
temperature — the length of the period during which the enzymatic activity 
is determined, is an important factor. Figure 8 illustrates this for the 
yV-demethylation of aminopyrine by the 9000 g supernatant from liver 
homogenates of trout and rat. After an incubation time of 10 min a clear 
difference in the temperature at which the maximal enzymatic activities were 
found, became manifest. After much longer incubation periods — for instance 
60 min — this distinction was less striking in view of the fact that the 
denaturation of the enzymes was further progressed. 
The decrease in the enzymatic activities at different temperatures as a 
function of time is shown in figure 9. The N-demethylating activity of the 
trout liver enzyme at 25 "C remained constant for 20 - 30 min and then 
declined. At 37 0 C the drop in activity started much earlier and was more 
pronounced. The N-demethylating enzyme of the rat, too, appeared to 
be more stable at 25 0 C, but the maximal activity at this temperature was 
only a fraction of the maximal activity at 37 0 C. At 37 °C the N-demethyl-
ating activity of the rat liver enzyme remained constant only for 5 - 1 0 min, 
and then rapidly declined. 
Product formation in N-demethylation and p-hydroxylation, and the dis­
appearance of free p-nitrophenol in glucuronidation in the course of the 
''"\ 
Г KW 
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10 
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55 
formaldehyde (jumolea/g l ivenh) -
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tncubdhon time (min) 
FIGURE 9. The decrease in the N-demethylaling enzymatic activities in the 9000 g 
supernatants prepared from liver homogenates of rat and trout at 37 and 25 0 C as a 
function of time. Enzymatic activities are expressed as «moles formaldehyde produced 
per g fresh liver per hour. 
Note: the initial reaction velocity remains constant only for a short period. 
f o r m a l d e h y d e — 
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FIGURE 10. The production of formaldehyde in the N-demethylation of aminopyrine 
by 9000 g supernatants prepared from liver homogenates of various animal species as 
a function of time. The amount of formaldehyde produced is expressed as «moles 
formed per g fresh liver. Incubation temperatures: 42 0 C (hen, pigeon); 37 "C (rat); 
25 °C (trout). 
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incubation period is shown for various species in figures 10, 11 and 12 
respectively. In comparison with the N-demethylation of aminopyrine the 
two other reactions proceeded in a linear fashion over longer periods, which 
is in accordance with earlier observations on time course studies of these 
reactions in rat and rabbit (Leadbeater and Davies, 1964; Gram and Fouts, 
1966a; Schenkman et al, 1967a). In the figures 10, 11 and 12 it can be 
seen that during the incubation period the enzymatic activities for the 
p-aminophenol (μ molee/g- l i v e r ) 
incubation t ime (min) 
FIGURE 11. The production of p-aminophenol in the p-hydroxylation of aniline by 
9000 g supematants prepared from liver homogenates of various animal species as 
a function of time. The amount of p-ammophenol produced is expressed as «moles 
formed per g fresh liver. Incubation temperatures: 42 °C (pigeon); 37 "C (rat); 25 °C 
(roach, trout). 
various species may decrease at different rates. This confirms the work 
of Gram and Fouts (1966a), who reported the relative lability of several 
rat-liver microsomal drug-metabolizing enzymes and the relative stability 
of those in the rabbit. 
The decrease in reaction velocity during the incubation period described 
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FIGURE 12. The disappearance of free p-nitrophenol in the glucuronidation reaction 
by total liver homogenates of pigeon, rat, and trout as a function of time. The amount 
of p-nitrophenol coupled is expressed as //moles conjugated per g fresh liver. Incuba­
tion temperatures: 42 °C (pigeon); 37 "C (rat); 25 °C (trout). 
above was not caused by exhaustion of the substrate or cofactor system, 
since these were added in saturating concentrations (chapter IV, 3.4), but 
rather by inactivation of the enzyme. This could be confirmed by experiments 
in which further addition of substrate and cosubstrate during the incubation 
period could not prevent the loss of activity, and by experiments in which 
preincubation of the enzyme preparation prior to the start of the in vitro 
reaction resulted in a substantial loss of activity. Gram and Fouts (1966a, 
1966b) reported that preincubation of microsomal preparations, especially 
in the presence of NADPH, resulted in a deterioration of enzymatic activ­
ity similar to the inactivation that occurred in the reaction system. Schenkman 
et al. (1967a) confirmed this and noticed that during the enzyme inactiva­
tion clumps were appearing in the previously homogeneous suspension. 
This agglutination of particles was considered to contribute to the observed 
decline in enzymatic activity. Furthermore, it was suggested that a damage 
to enzymes and other proteins caused by lipid peroxidation (Roubal and 
Tappel, 1966) plays a role in microsomal deterioration. However, Gram and 
Fouts (1966b) showed that inhibition of the lipid peroxidation by the anti­
oxidant «-tocopherol was without effect on the early decline in drug-oxida­
tion activity. Moreover, in agreement with the work of Orrenius et al. (1964), 
Gram and Fouts (1966b) found that aniline and aminopyrine, the sub-
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strates of drug-metabolizing reactions, inhibited lipid peroxidation. On 
the other hand, the inhibition of lipid peroxidation in microsomes has been 
found to stimulate aldrin epoxidation (Lewis et al., 1967). It can be con-
cluded that, at the present, the factors underlying the loss of microsomal 
enzymatic activity during incubation, which apparently depends upon the 
reaction and the animal species studied, are only partially understood. 
In view of the decrease in enzymatic activity during incubation, for the 
assays of the initial velocities of the enzymes of the various species relatively 
short incubation periods were chosen in the present study (product forma-
tion remained linear with time), viz. for N-demethylation always shorter than 
15 min, and for p-hydroxylation and glucuronidation always shorter than 
30 min. 
To study the influence of the pH, the drug-metabolizing enzymatic activities 
were compared in test systems prepared with Tris-HCl buffer solutions of 
different pH. In this way, information was obtained about the range of pH 
within which the hepatic enzyme preparations of various animal species ex-
hibited their maximal capacities of substrate turnover (table 6). According to 
these observations pH 8.0 was chosen for the in vitro assay of the enzymatic 
activity of the oxidative reactions and pH 7.4 for the glucuronidation 
reaction. However, it can be questioned whether these pH-values are also 
optimal for the other tissue preparations studied. 
TABLE 6 - pH-range for measurement of maximal activity* 
N-demethylation p-hydroxylation glucuronidation 
of aminopyrine of aniline of p-mtrophenol 
pigeon 7.8 — 8.2 — 7.0 — 7.5 
rat 7.9 — 8.1+ 7.9 — 8.3 7.1 — 7.5 
roach 7.0 — 8.0 7.1 — 8.1 — 
trout 7.9 — 8.4+ 7.7 — 8.2 6.5 — 7.6 
* pH was determined in the reaction mixtures during the incubation period 
+ (Dewaide and Henderson, 1968). 
IV, 3.2. Effect of various additives on enzymatic activity 
Many investigators have reported that semicarbazide and nicotinamide are 
indispensable in measuring oxidative /V-demethylating enzymatic activities 
(La Du et al., 1955; Smith et al., 1963; Orrenius, 1965; Anders and Man-
nering, 1966; Soyka, 1969; Ackermann, 1970). Semicarbazide is used to 
trap the formaldehyde, produced in the enzymatic reaction, as the semicarba-
zone. Nicotinamide, also employed in many other oxidative drug-metabolizing 
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TABLE 7 - Influence of nicotinamide and semicarbazide on the M-demethyladon of 
aminopyrine 
nicotinamide 
concentration 
( K H M ) 
0 
5 
20 
50 
0 
0 
0 
0 
0 
semicarbazide 
concentration 
(10^ M) 
5 
5 
5 
5 
0 
5 
8 
20 
50 
per cent determined 
rat liver 
(37°, 10 min 
incubation) 
100 
94 
82 
69 
82 
100 
97 
62 
7 
formaldehyde* 
trout liver 
(25°, 20 min 
incubation) 
100 
65 
51 
42 
76 
100 
94 
63 
9 
* The amounts of produced formaldehyde are expressed as percentages of the maximal 
values; means of the results of 3 experiments. Maximal and minimal value never 
deviated more than 5% of the mean given. 
reactions, inhibits the breakdown of NADP by liver NADPnucleosidase 
(E.C. 3.2.2.6). However, an inhibition by nicotinamide of the aminopyrine 
/V-demethylation and aniline p-hydroxylation has been reported by Schenk­
man et al. (1967a). 
In the present study the decrease in the N-demethylating activity by the 
addition of nicotinamide to the reaction mixture in concentrations of 5 to 
50 χ ΙΟ"3 M was confirmed. Table 7 shows that the inhibiting action of 
nicotinamide was more pronounced in the ЛГ-demethylation by trout liver 
enzyme than by rat liver enzyme. In view of the inhibition of nicotinamide 
on the initial reaction velocity, nicotinamide was omitted in the assays 
described in this report. 
Semicarbazide used in concentrations higher than 5 χ ΙΟ-3 M also caused an 
inhibition (table 7). The decrease in the amounts of formaldehyde measured 
with the method of Nash (1953) was found to be due to an interference 
of semicarbazide with the colorimetrie determination. This could be demon­
strated by quantitative assays of standard formaldehyde concentrations in the 
presence of increasing amounts of semicarbazide, which below 5 χ 10 3 M 
had no influence, but in concentrations of 20 χ ΙΟ-3 M and 50 χ ΙΟ-3 M 
depressed colour development to about 80 per cent and about 10 per cent 
respectively. In view of the data of table 7 it was decided to use semicarbazide 
in the reaction mixture in a concentration of 5 χ ΙΟ-3 M. 
As far as the application of divalent cations in the reaction mixtures is 
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concerned, it has been shown that Mgt+ and МП++ both stimulate the NADPH-
generating enzyme systems employed (Komberg, 1950; Cooper and Brodie, 
1955), and many of the microsomal drug-metabolizing reactions (Trivus 
and Spirtes, 1964). Recently the influence of magnesium and some other 
divalent cations on hepatic oxidative microsomal drug metabolism in vitro 
has been extensively investigated by Peters and Fouts (1970a and 1970b), 
whereas the enhancement of glucuronidation reactions in vitro by Mg^ has 
been reported by Mulder (1970). 
In the glucuronidation reaction a possible enzymatic hydrolysis of the 
glucuronide by endogenous /?-glucuronidase was prevented by the addition 
of saccharo-l,4-lactone (10 я M), which is a known inhibitor of the 
hydrolytic enzyme (Lewy and Conchie, 1966). 
The inhibitory action of carbon monoxide and /9-diethylaminoethyl diphenyl-
propylacetate (SKF 525A) on the oxidative drug-metabolizing enzyme 
systems of mammals is well-known (chapter II). In this study it appeared 
that the N-demethylating and p-hydroxylating activities of enzyme prepara­
tions from various fish species were also strongly inhibited (50% decrease) 
in the presence of these substances (30 sec bubbling of CO during incubation 
or addition of IO* M SKF 525A). This indicates similarities in the prop­
erties of drug-metabolizing enzymes of mammals and fish. 
IV, 3.3. Effect of the nature of the NADPH-generating system 
The cofactor NADPH was supplied to the reaction mixture as NADP in 
combination with a reducing system, such as glucose-6-phosphate and glu-
TABLE 8 - Effect of the nature of the NADPH-generating system on the N-demethyl-
ation of aminopyrine 
N-demethylation of aminopyrine4-
(«moles/g liver . h) § 
cofactor system* rat trout 
NADPH 9.88 ± 0.74** 1.40 ± 0.19** 
G-6-PD 14.81 ± 0.20 1.12 ± 0.03 
ICD 14.35 ± 0.26 1.15 ± 0.07 
+ concentration: 16.7 χ 10-* M. 
§ values are the means of 10 experiments -t S.E.M. 
* NADPH (13.3 χ 10-» M) was added without reducing enzyme system; NADP (13.3 
χ 10-' M) was added in combination with glucose-6-phosphate and glucose-6-phos-
phate dehydrogenase (G-6-PD) or with isocitrate and isocitrate dehydrogenase 
(ICD). Concentrations are given in chapter III, 4. 1. 
** Significantly different from the values obtained with the reducing enzyme systems 
at Ρ < 0.01 (Wilcoxon two-sided two-sample test). 
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cose-6-phosphate dehydrogenase, or isocitrate and isocitrate dehydrogenase. 
Table 8 presents the N-demethylating activities of rat and trout liver in the 
presence of either NADPH as such or NADP with the reducing systems 
mentioned. The results are in accordance with the findings of Gram and 
Fouts (1967) and of Janson (1968), who reported, for rabbit and rat 
respectively, lower activities with NADPH as such for the N-demethylation 
of aminopyrine and some other drug-metabolizing reactions. For the trout, 
however, in the case of NADPH addition, significantly higher activities have 
been observed. This increase in enzymatic activity appeared to be 1 0 - 2 5 % 
in a number of fish species, e.g. roach, bream, and trout. For practical 
reasons — the rather low stability of the cosubstrate in the reduced form and 
for reasons of economy — it was decided, however, for the measurement of 
oxidative drug-metabolizing reactions for fish also to make use of one of 
the NADPH-generating systems described above. 
IV, 3.4. Substrate and cosubstrate concentrations 
In enzymatic reactions for the enzymes of different origin differences may 
be observed in the interaction between the enzyme proteins and the sub­
strate and cosubstrates, and in the rate of substrate conversion. According 
to the Michaelis-Menten kinetics for enzyme reactions mathematically two 
parameters can be derived: the maximum velocity of the reaction (Vmax) 
and the affinity between the enzyme protein and the substrate. The latter 
is expressed as the dissociation constant (K,), which is often assumed to 
equal the Michaelis constant (K
m
), which represents the substrate concen­
tration at И^шах. Both kinetic parameters can be derived from enzyme-
substrate saturation curves: the transformation rates of the substrate at 
different concentrations by purified enzyme. It has to be noted, however, 
that from the viewpoint of enzymology the application of the above men­
tioned kinetic parameters in the study of oxidative drug-metabolizing 
enzyme reactions is disputable. The microsomal enzyme proteins are 
embedded in structural proteins and phospholipids, and it is the whole 
structure which participates in the metabolic process. In view of this complex 
structure, it appeared hitherto impossible to perform a reaction with the 
purified enzyme system. Moreover, regardless of the complexicity of the 
reaction system, which requires multiple steps between the initial electron 
donor and the substrate, the measurements are only based either on the 
formation of an end product, the disappearance of the initial substrate, or 
the disappearance of the electron donor. In this study, however, enzyme-
substrate saturation curves were still made in order to determine the sub-
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FIGURE 13. Initial reaction rates of the N-demeihylation of aminopyrine by 9000 g 
supematants prepared from liver homogenates of various fish species in relation to 
different concentrations of the substrate. The other reaction conditions (e.g. saturating 
concentrations of cosubstrate) are described in chapter III. In the lower part of the 
figure the kinetic data are plotted according to Lineweaver-Burk. 
strate concentration at which the enzyme preparations exhibited their 
maximal transformation rates. This can be illustrated for the N-demethylation 
of aminopyrine (figure 13), the p-hydroxylation of aniline (figure 14), 
and the glucuronidation of p-nitrophenol (figure 15) for the enzyme prepar­
ations derived from various species. From the lower parts of these figures 
in which the values are plotted according to Lineweaver-Burk, it can be 
derived that the crude enzyme systems behave regarding the substrates 
as described in Michaelis-Menten kinetics. However, the question remains, 
as to how far the kinetic parameters derived from those graphs — indicated 
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FIGURE 14. Initial reaction rates of the p-hydroxylation of aniline by 9000 /> super-
natants prepared from liver homogenates of various animal species in relation to differ­
ent concentrations of the substrate. The other reaction conditions (e.g. saturating con­
centrations of cosubstrate) are described in chapter III. In the lower part of the figure 
the kinetic data are plotted according to Lineweaver-Burk. 
further as "apparent Km" and "apparent Vmax" — represent the true kinetic 
properties of the enzymes. A comparative survey and a discussion of the re­
sults obtained are given in chapter VI. Here it will only be stressed that the 
concentration level at which the substrate and cosubstrate saturate the enzyme 
system applied can be different for the various animal species. Therefore, in 
the enzymatic reactions in vitro in order to measure maximal reaction veloc­
ities, the substrate and cosubstrate concentrations were kept at or above salur-
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FIGURE 15. Initial reaction rates of the glucuronyltransferase in ultrasonicated total 
liver homogenates of various species in relation to different concentrations of the sub­
strate. The other reaction conditions (e.g. saturating concentrations of cosubstrate) are 
described in chapter III. In the lower part of the figure the kinetic data are plotted 
according to Lineweaver-Burk. 
ating levels. Table 9 presents the concentrations of substrates and cosubstrates 
used. These concentrations were standardized for the various groups of 
animals. In the experiments described under this heading it was verified 
that with these concentrations, for each animal species, maximal initial 
rates of substrate conversion were measured. In figure 13 it can be seen 
that, at high aminopyrine concentration, for the trout and the eel, an 
inhibition of the enzyme activity occurred. 
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TABLE 9 - Substrate and cosubstrate concentrations for measurement of maximal enzymatic activity in liver preparations of 
different animal species § 
enzyme reaction iV-demethylation p-hydroxylation glucuronidation 
substrate aminopyrine aniline p-nitrophenol 
concentration 33.4 χ IO-* M fishes (except trout) 22 χ IO-1 M all animals (except trout) 1.4 χ ICH M all animals 
16.7 χ IO-3 M all other animals 5.5 χ 10 a M trout 
{including trout) 
cosubstrate NADP* NADP* UDPGA 
concentration 13.3 χ KH M all animals 13.3 χ 10-^  M all animals 6.0 χ ΙΟ-3 M all animals 
§ animal species investigated are given in chapter III. 
* NADPH was supplied via enzymatic reduction of NADP. 
The saturation level of the cosubstrate NADPH in the oxidative reactions was 
determined by the addition of increasing amounts of NADP in combination 
with one of the reducing systems mentioned above (chapter III, 4.1. and 
chapter IV, 3.3.). 
IV, 3.5. Enzyme concentration 
As a final test whether the assays described here could be used for meas­
urement of drug-metabolizing enzymatic capacities in vitro, experiments were 
performed with decreasing amounts of the enzyme preparation in the reaction 
mixture. In the figures 16, 17 and 18, representing the ЛГ-demethylation, p-
hydroxylation, and glucuronidation respectively, the amounts of enzyme prep-
formaldehyde 
(¿umoles/ml reaction mixture-h) 
FIGURE 16. The formation of formaldehyde, expressed as ¿(moles produced per ml 
reaction mixture per hour, in the N-demethylation of aminopyrine by 9000 g super-
natants prepared from liver homogenates of pigeon, rat, and trout in relation to the 
amount of enzyme preparation present. The amount of 9000 /> supernatant employed is 
expressed as the amount of protein added to 1 ml reaction mixture. 
arations are given in mg tissue protein per ml reaction mixture. Taking into 
account these observations, the standard assays of the capacity of the oxidative 
enzymes for the various animal species were carried out with enzyme 
preparations with amounts of liver protein within the range of 1.5 - 2.5 mg 
per ml reaction mixture (amounts of 9000 g supernatant equivalent to 
20 - 33 mg fresh liver; see chapter III, 4.1.). The glucuronyl conjugation 
capacity of the fish species was measured with enzyme preparations with 
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an amount of hepatic protein within the range of 4 - 8 mg per ml reaction 
mixture (amounts of homogenate equivalent to 25 - 50 mg fresh liver). 
The glucuronyl conjugation capacity of the mammalian and avian species 
was measured with enzyme preparations with an amount of liver protein 
p-aminopheno[ 
£/i moles/ml reachon mixture h) 
m j protein / m l reaction mixture 
FIGURE 17. The formation of p-aminophenol, expressed as «moles produced per ml 
reaction mixture per hour, in the p-hydroxylation of aniline by 9000 g supernatants 
prepared from liver homogenates of pigeon, rat, and trout in relation to the amount of 
enzyme preparation present. The amount of 9000 g supernatant employed is expressed 
as the amount of protein added to 1 ml reaction mixture. 
within the range of 2 - 4 mg per ml reaction mixture (amounts of homo-
genate equivalent to 12 - 24 mg fresh liver) (see chapter III, 4.4.). 
The proportionality between the rate of conversion and the amount of liver 
preparation employed has been verified for all species studied. This may 
indicate that the values obtained with the methods used in this study are 
useful parameters for the enzymatic capacities of the liver preparations 
investigated. 
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p-nitrophenol • 
i/imolee/ml reaction mixture-h) 
mg protein/ml reaction mixture 
FIGURE 18. The glucuronidation of p-nitrophenol, expressed as emoles conjugated per 
ml reaction mixture per hour by ultrasonicated total liver homogenates of rat, roach, 
and trout in relation to the amount of enzyme preparation present. The amount of 
homogenate employed is expressed as the amount of protein added to 1 ml reaction 
mixture. 
IV, 4. CONCLUSION 
From the results presented in this chapter as a main conclusion it can be 
stated that xenobiotic-metabolizing activities can be observed in liver prepara-
tions from aquatic animal species. This is inconsistent with previous data 
from other studies in which these in vitro activities have not been detected. 
As far as general phenomena are concerned, such as the intracellular localiza-
tion, the sensitivity of the enzyme preparations to various treatments, the 
requirements of various cofactors, and the inhibiting action of carbon 
monoxide and SKF 5 25A on the oxidative enzymes, the properties of the 
drug-metabolizing enzymes of the various animal species appear to have 
much in common. On the other hand, in a more detailed view, the nature 
of the enzymes of various species shows differences, for instance in stability, 
and optimal substrate and cosubstrate concentrations. The data from the 
literature about the lack of an enzymatic xenobiotic-metabolizing capacity in 
fish may be explained in view of the fact that the species differences discussed 
in this chapter were left out of account in the enzyme assays in previous 
studies. 
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CHAPTER V 
P R O D U C T F O R M A T I O N IN THE 
N - D E M E T H Y L A T I O N OF A M I N O P Y R I N E 
IN VITRO 
V, 1. INTRODUCTION 
Studies on the biotransformation of aminopyrine in various mammalian 
species revealed the presence of a great variety of metabolic products in 
blood and urine (Halberkann and Fretwurst, 1950; Brodie and Axelrod, 
1950; Pechtold, 1964; Preuss and Voigt, 1965; Schiippel and Soehring, 1965; 
Vecerková et al., 1967; Klug, 1970). From these studies it appeared that 
N-demethylation is of major importance in the metabolism of aminopyrine: 
in all of the metabolic products one or both methyl groups have been found 
to be split from the original dimethylamino group of the parent compound. 
It can be expected that the N-demethylation of aminopyrine (DMAP) 
N-DEMETHYLATION OF AMINOPYRINE 
ί£ς£Φ_^ к д а - ' ¡Scoi 
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 А
д р + Н - С - 0 
FIGURE 19. Two-step mechanism in iV-demethylation of aminopyrine. 
proceeds through two steps (figure 19). The first in vitro measurements of 
this reaction were performed by La Du et al. (1955). The assays were based 
both on the formation of formaldehyde and of 4-aminoantipyrme (AAP). La 
Du and co-workers found that the ratio of formaldehyde to AAP produced 
was 2 : 1 , which indicated that the substrate DMAP was N-demethylated to 
AAP only. If the intermediate product 4-monomethylaminoantipyrine 
(MMAP) were also formed, then the ratio formaldehyde/AAP would have 
been greater than 2. A ratio for formaldehyde/AAP greater than 2 has 
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been reported by Gram et al. (1968), who studied the N-demethylation of 
DMAP both for rabbit and rat liver microsomes. Using thin-layer chromato-
graphy (TLC), they also showed that incubation of DMAP in reaction 
mixtures with 9000 g supernatants led to the formation of relatively large 
amounts of MMAP but only small quantities of AAP. The identification 
of the substances was only based upon comparison of Rf-values. 
A more thorough identification of the N-demethylation products was 
performed in the present study. Experiments with regard to the interesting 
question whether the two steps of the N-demethylation of DMAP are 
catalyzed by the same enzyme or whether different enzymes are involved 
could not be performed, since the amount of MMAP available was too small 
for use as a substrate in the reaction. Therefore, the experiments described 
here were restricted to the oxidative in vitro N-demethylation of DMAP. 
Since the studies reported in the literature were all based upon colorimetrie 
measurements of the formaldehyde and/or AAP produced, it was of interest 
to measure to what extent the N-demethylation of DMAP follows the two 
steps assumed (figure 19). Emphasis was put upon the methods for quan-
titative measurement of the reaction products MMAP, AAP, and formal-
dehyde. 
V, 2. IDENTIFICATION OF THE REACTION PRODUCTS 
The extraction of the reaction products and the analytical methods employed 
in order to elucidate their nature are described in chapter III, 5. TLC of 
the extracts yielded spots of which the Rt-values are given in table 10. 
A comparison of these values already gives some indication about the 
identity of the products of the reaction. In the chromatograms 3 spots were 
mostly observed, with Rf-values corresponding to those of the reference 
pyrazolone derivatives: spot number 1, a very intense and large spot with 
an Rf-value corresponding to that of the substrate DMAP; spot number 2, 
a clear small spot with an Rf-value corresponding to that of reference MMAP; 
spot number 3, having an Rf-value corresponding to that of reference AAP. 
The latter spot had a very weak intensity, and was sometimes not detected. 
The spot was absent in the chromatograms developed for reaction mixtures 
in which high substrate concentrations (16.7 - 33.4 mM) and short incuba-
tion time (10 min) were employed. Therefore, in the methods used it can be 
imagined that the large quantity of DMAP present hampered the detection 
of a possibly small amount of AAP produced. Also the possibility exists that 
the second step in the N-demethylation reaction (from MMAP to AAP) is 
inhibited by high DMAP concentrations. 
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TABLE 10 - Thin-layer chromatography of pyrazolone derivatives 
samples 
to TLC 
sample 
number 
I 
II 
III 
IV 
V 
VI 
VII 
VIII 
IX 
subjected 
origin of 
the sample 
DMAP (reference) 
M MAP (reference) 
AAP (reference) 
blank reaction 
mixture, DMAP 
16.7 mM*, 10 min 
incubation 
reaction mixture, 
rat liver preparation, 
DMAP 16.7 mM, 
10 min incubation 
reaction mixture, 
rat liver preparation, 
DMAP 0.33 mM, 
30 min incubation 
reaction mixture, 
roach liver preparation, 
DMAP 33.4 mM, 
10 min incubation 
reaction mixture, 
roach liver preparation, 
DMAP 0.33 mM, 
30 min incubation 
reaction mixture, 
trout liver preparation, 
DMAP 16.7 mM, 
15 min incubation 
spot 
number 
1 
2 
3 
1 
1 
2 
3 
1 
2 
3 
1 
2 
1 
2 
3 
1 
2 
spot 
intensity 
+ + 
+ + 
+ 
+ + 
+ 
+ + 
+ 
+ + 
+ 
+ + 
solvent system 
A В 
Rf-value 
0.69 
0.54 
0.38 
0.70 
0.68 
0.51 
0.35 
0.67 
0.53 
0.36 
0.69 
0.53 
0.69 
0.54 
0.37 
0.70 
0.52 
Rf-value 
0.29 
0.35 
0.53 
0.29 
0.28 
0.33 
0.51 
0.29 
0.32 
0.53 
0.27 
0.34 
0.29 
0.35 
0.54 
0.28 
0.33 
Rf-value 
correlates 
with 
DMAP 
DMAP 
M MAP 
AAP 
DMAP 
MMAP 
AAP 
DMAP 
MMAP 
DMAP 
MMAP 
AAP 
DMAP 
MMAP 
solvent system A: chloroform - diethylether - methanol (70-30-10, vol.); 
solvent system B: /t-butanol - acetic acid - water (80-20-10, vol.); 
spot intensity: —, weak; + , high; - f + , very high; 
* blank reaction mixture: DMAP was added after incubation; 
Liver preparations used were 9000 g supernatant fractions. 
The methods used are described in chapter III, 5. 
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FIGURE 20. Qualitative absorption spectra of pyrazolone derivatives in ethanol. The 
upper part of the figure shows the spectra of reference substances, the lower part those 
of eluates from bands on thin-layer chromatograms. The code of the elution samples VI, 
1.2.3. refers to the samples mentioned in table 10. 
In the chromatogram spots were also observed the nature of which was 
unknown. The Rf-values for these spots in chromatograms developed with 
solvent system A were 0.80 and 0.30. Since these spots were also present 
in the control chromatograms, they must represent additional material 
extracted from the incubation mixtures as such and not be due to substrate, 
or metabolites thereof. 
After staining of the chromatograms with various reagents, the spots in 
the colour patterns showed an exact resemblance to the corresponding 
colours obtained with the reference pyrazolone derivatives (table 2, chapter 
III, 5. 3. 2). 
In order to obtain the reaction products in larger amounts, preparative TLC 
(solvent system A) was performed with extracts from reaction mixtures 
with a total volume of 240 ml (chapter III, 5.2). Bands were eluted with 
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ethanol and concentrated by evaporation to a concentration suitable for 
measurement in a spectrophotometer. However, a definitive proof about 
the identity of the reaction products could not be obtained on the basis of 
measurement of the absorption spectra of the eluates because of the 
close resemblance between the qualitative spectra of MMAP and AAP 
(figure 20). From this figure it may only be concluded that the substances in 
the elution samples originate from a pyrazolone molecule. 
More relevant information could be obtained by again subjecting the differ-
relative intenerty ( % ) 
ΙΟΟτ 
Ö0-
60 
АО 
20 
HjC-
H,C-
iL j. i j j j 1 " Ι., ι 
100 
eo 
6 0 -
4 0 
20 
elution sample V , 1 
JII ill J J Ι " ι 1 Ιί,^ 
АО 60 120 160 200 240 
m/e* 
Figure 21. Mass spectra of DMAP and of the substance in the eluate of a band on 
thin-layer chromatograms. The code of the elution sample V, 1 refers to table 10. 
Note the peak for the molecular ion at m/e+ 231. 
ent eluates to TLC, both separately and in combination with reference 
DMAP, reference MMAP or reference AAP (mixed-chromatograms). It 
was carefully ensured that equal quantities of the reaction products and 
references were applied on the plates. In TLC with both solvent systems 
the chromatograms for mixtures expected to contain MMAP showed a clear-
cut resolution of the substance from the reference substances DMAP and 
AAP, but not from reference MMAP. The chromatograms for the mixtures 
expected to contain AAP showed a clear resolution of the substance from 
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FIGURE 22. Mass spectra of MMAP and of the substances in eluates of bands on 
thin-layer chromatograms. The code of the elution samples V, 2 and VII, 2 refers to 
table 10. 
Note the peak for the molecular ion at m/e+ 217. 
the references DMAP and MMAP, but not from reference AAP. The shape 
and intensity of the unresolved mixed-spots, both under UV and after 
staining were identical to the spots obtained with the double concentration 
of the reference substances. 
As a decisive test in the present study, after preparative TLC of extracts 
from reaction mixtures with a total volume of 300 ml, ethanol eluates of 
the bands on the chromatograms were evaporated to dryness and the residues 
subjected to mass spectrometry. The mass spectra of the reference pyrazolone 
derivatives and the samples are presented in figures 21, 22, and 23. In view 
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FIGURE 23. Mass spectra of AAP and of substances in eluates of bands on thin-
layer chromatograms. The code of the elution samples VI, 3 and VIII, 3 refers to 
table 10. 
Note the peak for the molecular ion at m/e+ 203. 
of the close resemblance of the spectra an identification can only be done 
on basis of the distinction observed in the peaks at m/e' 231 (molecular 
ion, M) for DMAP, at m/e+ 217 (molecular ion, M) for MMAP, and at 
m/e+ 203 (molecular ion, M) for AAP. In the lower parts of the figures 
21, 22, and 23 it can be seen that the substances from the elution samples 
which were expected to be DMAP, MMAP, and AAP respectively, show 
mass spectra with characteristic molecular peaks corresponding with those 
of the reference substances. It has to be noted that in the mass spectra of 
the samples derived from TLC eluates with low concentrations of AAP, in 
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some cases the base peak was shifted from m/e+ 56 to m/e' 57, whereas an 
obvious peak at m/e+ 149 appeared. The reason for this discrepancy is not 
clear as yet. The molecular ion, however, was still present at m/e+ 203. 
The mass spectra of the residues of eluates from the unknown spots in the 
chromatograms mentioned above were quite different from those for the 
pyrazolone derivatives. It was not tried to identify these substances further. 
V, 3. N-DEMETHYLATION OF AMINOPYRINE IN VITRO AT DIFFERENT 
SUBSTRATE CONCENTRATIONS 
In the TLC experiments performed in order to identify the ЛГ-demethylation 
products of aminopyrine (chapter V, 2) a difference was observed in the 
product formation at different substrate concentrations. At high substrate 
concentrations (16.7 - 33.4 mM) sometimes only one product (MMAP) 
was detected, whereas at low concentration (0.33 mM) the presence also of a 
second product (AAP) was observed. One of the explanations given was 
that the removal of the methyl group from the MMAP molecule might be 
inhibited by high DMAP concentrations. This possibility has already been 
suggested earlier by Gram et al. (1968). If such a reaction mechanism indeed 
is involved it will have consequences for measurements of enzymatic activity 
based upon the formation of formaldehyde. The formaldehyde, measured 
in mixtures with high (saturating) DMAP concentration, originates pre­
dominantly from the first step of the N-demethylation reaction. In reaction 
mixtures with low DMAP concentrations, however, the formaldehyde comes 
from a two-step N-demethylation mechanism in which the amount of 
MMAP produced is partly further N-demethylated to AAP. This complex 
reaction mechanism may explain, at least in part, that in certain cases a 
nonlinear relationship in the Lineweaver-Burk plots for the A/-demethylating 
activities at increasing substrate concentrations are found (figure 24a, 
formaldehyde, solid line). The nonlinearity in the curves of Lineweaver-Burk 
plots was only observed with reaction mixtures containing liver preparations 
with relatively high enzymatic activity — as for instance from mammals 
and birds — if the aminopyrine was employed in a wide range of concen­
tration (0.33 - 33.4 mM). For enzyme preparations with a relatively low 
enzymatic activity — as for instance for the various fish species investigated 
— the N-demethylation of aminopyrine stayed below the detectable level if 
low substrate concentrations (below 1.5 mM) were employed. At the 
relatively high substrate concentrations used the curves of the Lineweaver-
Burk plots for the latter enzyme preparations were found to be linear 
(chapter IV, 3. 4, figure 13). The discrepancy in the Lineweaver-Burk 
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plots for liver preparations with different N-demethylating activity might be 
explained if the above assumption proves to be right, that at low substrate 
concentration the N-demethylation of aminopyrine by highly active enzyme 
preparations proceeds further until AAP. It may be expected therefore, 
that beside measurements of the amounts of formaldehyde formed, parallel 
assays of the amounts of MMAP and AAP will shed further light on the two 
steps involved in the N-demethylation of aminopyrine at different substrate 
concentration. 
V, 3. 1. Quantitative determination of reaction products formed by 
N-demethylation in vitro 
The AAP produced in the A/-demethylation of aminopyrine is generally 
measured by diazotization and coupling with a-naphtol (Brodie and Axel-
rod, 1950). A colorimetrie method not so extensively used is based on the 
yellow colour which compounds having an amino group give with p-dimethyl-
aminobenzaldehyde (Ehrlich's reagent) in acid solution (Brun, 1951). The 
advantage of the latter method is that it is rather simple and rapid. In the 
present study, however, it appeared that neither colorimetrie method is 
specific since not only AAP, but also MMAP develops a considerable colour 
in the presence of the reagents. 
In order to control the possible mutual interference of the /V-demethylated 
products in the colorimetrie assays mentioned, incubation mixtures were 
prepared which corresponded to those involved in the assay of enzymatic 
activity (chapter III, 4.1). After protein precipitation various amounts of 
reference formaldehyde, MMAP, and AAP were added. After centrifugation 
the supernatants were subjected to the colorimetrie assays of Nash (1953), 
Brun (1951), and Brodie and Axelrod (1950) (cf. chapter III, 4.2). The 
series of samples prepared for the assay of Nash contained 5 χ IO-3 M semi-
carbazide; in the series of samples for the assays of Brun, and of Brodie and 
Axelrod semicarbazide was omitted. Table 11 presents the extinctions found 
in the colorimetrie assays on incubation mixtures containing 100 nmoles 
of the reference substances. That the colour formed with MMAP is really due 
to the pyrazolone derivative and not to impurities in the reference material used 
is indicated by the persistent positive reaction after recrystallization and 
TLC of the substance. Moreover, the MMAP isolated from the reaction 
mixtures (chapter V, 2) also showed a positive reaction with the assays 
of Brun, and of Brodie and Axelrod. Nevertheless, in the reports of all 
previous studies on the N-demethylation of aminopyrine in which these 
two colorimetrie assays have been used the colours obtained are ascribed 
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TABLE 11 - Colour formation by formaldehyde, MMAP, and AAP in different colori­
metrie assays 
colorimetrie assay 
according to 
Nash 
Brun 
Brodie and Axelrod 
formaldehyde 
0.115 
nil 
nil 
extinction (Δ E) 
MMAP 
nil 
0.090 
0.185 
AAP 
nil 
0.470 
1.62 
Δ E: extinction of the sample minus the extinction of the blank (containing all 
reagents except the reference substance); the values given represent test solutions with 
100 nmoles test substance in 3 ml incubation mixture. 
Composition of incubation mixture and colorimetrie assays are described in chapter 
III, 4.1 and 2. 
solely to AAP. If the results of the present study (chapter V, 2) are taken 
into consideration, it may be clear that the colour obtained in colorimetrie 
assays will be due to the presence of MMAP. 
Quantification of the various products of the N-demethylation of amino-
pyrine at different substrate concentrations can still be achieved by the 
colorimetrie assays mentioned if a suitable combination of simultaneous 
measurements of the amounts of formaldehyde and pyrazolone derivatives 
is applied. In this study this was performed by measurement of the total 
amount of formaldehyde produced in one series of reaction mixtures con­
taining decreasing amounts of substrate with the method of Nash (1953), and 
by measurement of the total amount of AAP and MMAP in a correspond­
ing series of reaction mixtures with the method of Brun (1951). 
From the data presented in table 11 it will be clear that a sample 
containing χ nmoles AAP, y nmoles MMAP and 2x + y nmoles formalde­
hyde gives an extinction with the assay of Nash: 
AEs = (2x + y)· 0.115- 10-2 
and with the assay of Brun: 
ΑΕΒ = Χ· 0.470 · I O 2 + y • 0.090 · IO"* 
From these equations the amounts of AAP, MMAP, and formaldehyde 
formed in the two N-demethylating steps can be derived. The total amount 
of DMAP which is passed through the first iV-demethylating step is the 
sum of the amounts of MMAP and AAP produced. 
As demonstrated in figure 24, the Lineweaver-Burk plot for the relation­
ship between enzymatic activity and substrate concentration becomes more 
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FIGURE 24. Lineweaver-Burk reciprocai plots of AMeraethylating enzymatic activ­
ity (ν) versus substrate concentration. Enzymatic activity is defined as the amount 
of product formed per g fresh liver per hour. 
a. curve formaldehyde (solid line) is based on the total amount of formaldehyde pro­
duced. Formaldehyde is measured by the colorimetrie method of Nash (1953). Curve 
DMAP (dotted line) represents a plot according to Lineweaver-Burk based on the 
amount of DMAP which has passed the first iV-demethylating step (the sum of the 
amounts of MMAP and AAP produced). The amounts of MMAP and AAP are calcu­
lated by combination of the data obtained with simultaneous colorimetrie assays 
according to Nash (1953) and Bran (1951). The method of calculation is given in 
the text. 
b. Curve DMAP (solid line) represents the curve according to Lineweaver-Burk based 
on the amount of DMAP which has passed the first JV-demethylating step. The 
amounts of MMAP and AAP are directly quantitated after extraction and TLC 
(chapter III, 5.3.1). Curve formaldehyde (dotted line) is based upon the total amount 
of formaldehyde produced. This amount is calculated from the amounts of MMAP 
and AAP measured directly. 
linear if the above calculation is applied and enzymatic activity is based 
upon N-demethylation of only one methyl group (figure 24a, DMAP, dotted 
line). 
The results of the rather cumbersome approach to the mechanism of the 
N-demethylation of aminopyrine discussed above could be confirmed by 
direct measurements of the amounts of MMAP and AAP after extraction 
of these substances from the reaction mixtures, TLC, and direct measurement 
of the absorption of ultraviolet light by the spots (cf. chapter III, 5. 3. 1). 
Figure 24b shows that the Lineweaver-Burk plot for the relationship between 
enzymatic activity and substrate concentration, when only the first N-de-
methylating step is considered, is almost linear (figure 24b, DMAP, solid 
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line). From the values for MMAP and AAP at direct measurements of TLC 
spots, the amounts of formaldehyde formed can be calculated. The Line-
weaver-Burk plot with enzymatic activities based on these amounts shows 
an obviously nonlinear curve (figure 24b, formaldehyde, dotted line). 
As far as the amounts of the products formed at different substrate concen­
trations are concerned, it was observed with both the combined-colorimetric 
assays and the direct quantitations via TLC that at increasing substrate 
concentrations the amount of AAP produced was nearly constant (3-4 
nmoles per ml reaction mixture), whereas the amount of MMAP increased. 
The ratio between the two products at various substrate concentration is 
presented in table 12. From these observations it will be clear that at low 
substrate concentrations the second step in the N-demethylation reaction is 
of greater importance than at high, saturating, aminopyrine concentrations. 
TABLE 12 - Protluct ratio in the iV-demethylation of aminopyrine in vitro at different 
substrate concentration 
aminopyrine concentration 
(mM) 
0.33 
1.00 
1.67 
3.34 
10.0 
ratio MMAP/AAP 
8.2 
12.5 
17.4 
18.9 
30.0 
The amounts of MMAP and AAP were determined by direct measurement of spots on 
thin-layer chromatograms after extraction of the substances from reaction mixtures 
containing increasing amounts of the substrate DMAP. 
V, 4. DISCUSSION 
The results of the present study on the N-demcthylation of aminopyrine in 
vitro indicate that one or both methyl groups can be split from the dimethyl-
amino group in the substrate molecule. Formaldehyde, MMAP, and AAP 
were measured as products of the reaction. Quantitative measurements of 
these substances indicate that at increasing substrate concentrations the first 
step of the reaction occurs predominantly. Since at saturating substrate 
concentration the second step, the ЛГ-demethylation of MMAP to AAP, is 
negligible compared with the first one, the production of formaldehyde can 
be used for approximate determination of the enzymatic capacity of con­
verting DMAP to MMAP. 
It was shown that the demethylated pyrazolone derivatives formed in the 
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in vitro reaction — AAP as well as MMAP — give a colour formation in the 
colorimetrie assays according to Brodie and Axelrod (1950) and Bran (1951). 
Since this was not recognized as yet, the results of previous studies in which 
the aim was to measure the formation of AAP only (whereas MMAP was 
the main reaction product), have to be interpreted with serious reservation. 
Since the N-demethylation of aminopyrine involves the removal of one 
or two methyl groups, it is conceivable that in the reciprocal plot of enzymatic 
activity versus substrate concentration nonlinearity occurs, if enzymatic 
activity is based upon the total amount of formaldehyde produced. However, 
figure 24 shows that in this case the apparent Km-value for the first step 
in the N-demethylation can be approximately estimated from the nonlinear 
plots when only that part of the curve is considered, which is obtained at 
relatively high substrate concentrations (3 - 20 mM). 
On the basis of the nonlinearity in the Lineweaver-Burk plots in the 
N-demethylation of aminopyrine, Pederson and Aust (1970) concluded that 
the reaction is catalyzed by more than one enzyme. However, the import-
ance of the two-step mechanism in this reaction was not fully evaluated. The 
question whether different enzymes catalyze the two steps of the N-demethyl-
ation of aminopyrine awaits further investigation. 
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CHAPTER VI 
C O M P A R I S O N OF W-DEMETHYLATION, 
p-HYDROXYLATION AND G L U C U R O N I D A T I O N 
IN V A R I O U S A N I M A L S P E C I E S , 
P A R T I C U L A R L Y IN S P E C I E S OF F I S H 
VI, 1. INTRODUCTION 
In chapter IV it has been shown that liver preparations from fishes, like those 
from other animal species, are capable of metabolizing compounds foreign to 
the body. The data presented confirm the findings of other studies on the 
occurrence of drug metabolism in fish. Enzymatic activities have been re­
ported for the activation of thiophosphate insecticides (Potter and O'Brien, 
1964; Murphy, 1966), the aromatic hydroxylation of 2-acetylaminofluorene 
(Lotlikar et ed., 1967), of biphenyl (Creaven et al., 1965), and of aniline 
(Buhler and Rasmusson, 1968a), the dealkylation of alkoxybiphenyls (Crea­
ven et ed., 1967), the epoxidation of aldrin (Chan et ed., 1967), the nitrore-
duction of various insecticides (Hitchcock and Murphy, 1967) and of p-nitro-
benzoic acid (Adamson et al., 1965; Buhler and Rasmusson, 1968b), and 
for the glucuronidation of oaminophenol (Dutton and Montgomery, 1958). 
In general, the reaction mechanisms involved in the biotransformation of 
xenobiotics by tissue preparations from fish and other animal species have 
many properties in common. However, besides these resemblances the present 
study shows, too, that differences in the characteristics of the individual 
enzymes of the various species exist. For instance, the duration of incubation, 
pH, and concentrations of substrates and cofactors at which the enzymes 
exhibit their maximal activities, appear to be species dependent (chapter IV). 
It is of interest, therefore, to compare enzymatic activities assayed with the 
employment of adapted in vitro conditions. 
In the present chapter attention will be mainly directed to the quantitative 
differences in the drug-metabolizing capacities of various animal species. 
In this study, the enzymatic activities which have been assayed in liver 
preparations at adapted reaction conditions are used as a measure for the 
drug-metabolizing capacity. Thus it is assumed that the enzymatic capacity 
measured in vitro represents to a certain degree the capacity in vivo. The 
imperfection of this extrapolation has to be realized well. The in vitro assays 
of the У -demethylating, p-hydroxylating, and glucuronidating enzymatic ac-
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tivities were carried out under the conditions described in the previous 
chapters. In mammals the drug-metabolizing enzymes are mainly found in the 
liver (chapter II). It has been investigated in this study whether the drug-
metabolizing enzymes of fishes are also situated mainly in the liver. Further 
it has been studied whether their level of hepatic drug metabolism is depen­
dent upon the sex and the weight (age) of the animals. 
VI, 2. ORGAN DISTRIBUTION OF DRUG-METABOLIZING ENZYMES 
Incubation of reactions mixtures with fractions from various tissues demon­
strated that p-hydroxylation, N-demethylation, and glucuronidation may 
proceed not only in the liver but also in other organs. Biotransformation 
activity could not be observed when the tissue preparations were preincubated 
for 10 min at 70 0C. It has been assumed that the reaction conditions 
TABLE 13 - p-Hydroxylation capacity of various organs in different species 
organ 
liver 
kidney 
heart 
lung 
gill 
gut 
muscle§ 
blood 
spleen 
pigeon 
V * 
v
max 
4.15 
2.20 
0.70 
2.40 
0.65 
0.50 
1.80 
К ** 
K-m 
1.31 
7.5 
35 
10 
>50 
>50 
15 
V 
1.10 
0.15 
0.25 
0.10 
0.27 
0.17 
nil 
0.10 
rat 
* ν »» 
0.05 
>50 
45 
30 
10 
>50 
>50 
trout 
V * 
"max 
0.49 
0.30 
0.58 
0.18 
0.12 
nil 
0.10 
0.23 
к ** 
0.48 
0.16 
35 
20 
5 
>50 
40 
roach 
V * 
Y
max 
0.88 
0.15 
0.87 
0.20 
nil 
0.35 
0.50 
K
m
· · 
2.4 
13 
> 5 0 
20 
> 5 0 
>50 
crab 
V * к ** 
T
 max ^m 
0.14t 50t 
0.03 
0.42 0.29 
p-Hydroxylation of aniline; each value represents the mean of at least 3 separate 
experiments; maximal and minimal values never deviated more than 25% from the 
mean. 
* V
m a x
: apparent maximal rate of conversion as measured in 9000 g supernatant 
fractions, expressed as /¿moles p-aminophenol produced per gram fresh tissue per 
hour. 
** Km: apparent Km, substrate concentration at И тах in mM; apparent V m a x and 
K
m
 were calculated from Lineweaver-Burk plots 
t assay on hepatoprancreas 
§ pigeon: breast muscle <M. pectoralis major), rat: leg muscle (Λί. rectus femoris), 
trout and roach: tail muscles (M. obliquus abdominis) 
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TABLE 14 - yV-Demethylating and glucuronidating capacity of various organs in the 
trout 
organ 
liver 
kidney 
heart 
gill 
gut 
muscle 
blood 
spleen 
ЛГ-demethylation of 
aminopyrine* 
1.20 
0.15 
0.15 
0.10 
0.14 
0.06 
0.02 
0.05 
glucuronidation of 
p-nitrophenol** 
1.7 
0.2 
0.3 
nil 
nil 
nil 
0.2 
* /imoles formaldehyde produced per gram fresh tissue per hour, assayed in 9000 g 
supernatant fractions. 
· * ¿«moles p-nitrophenol conjugated per gram fresh tissue per hour, assayed in ulta-
sonicated homogenates. 
Each value represents the mean of at least 3 experiments; the maximal and minimal 
values never deviated more than 25% from the mean. 
(temperature, incubation period, pH) for the measurement of maximal 
enzymatic activity would not greatly differ for the various organs of a 
certain species. Therefore, assay conditions were applied as described for the 
liver preparations (chapter IV). Tables 13 and 14 show that for the various 
species examined the greatest activity was found in liver preparations. 
Among the other organs investigated, the hydroxylating capacities of kidney 
and lung of the pigeon, and of the kidney of the trout were relatively high. 
For the p-hydroxylation of aniline in fish high activities were found in heart 
tissue. However, in view of the high apparent Km-values found for extra-
hepatic aromatic hydroxylation the importance of the reaction for the 
situation in vivo may be considered low as compared with the biotransforma-
tion in the liver. The relatively high p-hydroxylating activity with a low 
apparent Km-value for the substrate aniline found for the gill of the wool-
handed crab may be considered a remarkable phenomenon. It would be 
an interesting point of study, therefore, whether this organ forms the main 
site of drug metabolism in crustácea. 
VI, 3. DRUG METABOLISM IN FISH IN RELATION TO SEX 
A sex difference in drug metabolism has been reported for rats and mice. 
For instance, liver microsomal enzymes from adult male rats metabolize 
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TABLE 15 - Drug-metabolism in fish in relation to sex 
animal 
species 
trout 
bream 
pike 
roach 
roach 
trout 
sex 
6 
2 
Ô 
Î 
â 
2 
6 
9 
η 
10 
10 
5 
19 
5 
18 
15 
15 
10 
10 
10 
10 
g 
fresh 
liver 
1.13 -
1.15 ± 
1.27 ± 
0.95 ± 
1.50 ± 
1.05 ± 
4.44 ± 
4.22 ± 
6.10 ± 
5.85 ± 
1.20 ± 
1.16 ± 
0.32 
0.48 
0.53 
0.54 
0.73 
0.45 
1.15 
0.97 
1.62 
1.45 
0.28 
0.36 
N-demethylation of aminopyrine 
activity* per 
mg 
liver 
protein 
0.0084 ± 0.0024 
0.0083 ± 0.0034 
0.0108 ± 0.0037 
0.0090 ± 0.0039 
0.0242 ± 0.0150 
0.0122 ± 0.0055 
0.049 ± 0.013 
0.046 ± 0.015 
0.0090 ± 0.0024 
0.0088 ± 0.0029 
mg 
liver 
DNA 
0.70 -t 0.16 
0.72 ± 0.14 
0.69 ± 0.33 
0.49 ± 0.20 
1.82 ± 1.03 
1.07 ± 0.53 
1.50 ± 0.39 
1.40 ± 0.32 
2.75 ± 0.92 
2.84 ± 0.81 
0.66 ± 0.19 
0.69 ± 0.16 
100 g 
body 
weight 
assay in marc 
1.65 ± 0.44 
1.69 ± 0.41 
2.47 ± 1.24 
2.02 ± 0.91 
4.13 ± 1.49 
2.76 ± 1.35 
7.97 ± 3.43 
7.22 ± 3.03 
assay in 
12.81 ± 3.10 
13.40 ± 3.30 
1.70 ± 0.40 
1.68 ± 0.45 
g 
fresh 
liver 
h-april 1970 
0.40 ± 0.18 
0.51 ± 0.16 
0.15 ± 0.06 
0.12 ± 0.04 
1.10 ± 0.23 
1.09 ± 0.25 
October 1970 
1.65 ± 0.42 
1.80 ± 0.48 
0.31 ± 0.09 
0.29 ± 0.08 
p-hydroxylation of aniline 
activity** per 
mg 
liver 
protein 
0.0042 
0.0052 
0.0022 
0.0012 
0.0116 
0.0129 
0.0022 
0.0023 
± 
± 
± 
± 
± 
± 
0.0011 
0.0015 
0.0009 
0.0004 
0.0052 
0.0043 
0.0009 
0.0008 
mg 
liver 
DNA 
0.28 
0.30 
0.14 
0.11 
0.39 
0.37 
0.63 
0.75 
0.17 
0.13 
± 
± 
± 
± 
± 
± 
± 
0.12 
0.09 
0.06 
0.04 
0.08 
0.06 
0.32 
0.36 
0.04 
0.04 
100 g 
body 
weight 
1.27 
1.28 
0.29 
0.29 
1.99 
1.90 
3.65 
4.05 
± 0.61 
± 0.44 
± 0.08 
± 0.07 
± 0.76 
± 0.72 
± 0.98 
± 1.08 
0.41 ± 0.10 
0.44 ± 0.11 
η number of animals studied; values are means ± S.D. 
* /imoles formaldehyde produced per hour 
** /¿moles p-aminophenol produced per hour 
Note the great individuai variations. With Wilcoxon's two-sided twc-sample test no significant sex differences could be shown. 
For the roach the values obtained in October were significantly different from those in the period march-april (P < 0.01, Wilcoxon, two-sided two-sample 
test). 
various drugs, such as hexobarbital, pentobarbital, aminopyrine and mor­
phine (Quinn et al. 1958; Henderson, 1971), and sex steroids (Kuntzmann 
et αι., 1964) more rapidly than those from female rats. This type of sex 
difference has been observed only in rats. The reversed situation has been 
found for several strains of mice (Riimke and Noordhoek, 1969). The factors 
underlying these differences in the metabolism of drugs are not fully under­
stood up to now. 
In view of the possibility that in fish a sex difference in drug metabolism 
might depend on annual hormonal cycles, the drug-metabolizing enzymatic 
capacities have been assayed in the spring (spawning period march-april) 
and in autumn. In order to check whether the apparent differences were 
generated by differences in the amounts of the main liver constituents 
between the sexes the enzymatic capacities were expressed in relation to 
various parameters. The results are presented in table 15. From the 
standard deviations of the various mean values it can be concluded that 
the individual variations in the drug-metabolizing capacities of the fishes 
studied are rather great. With these intraspecies fluctuations signific­
ant differences in the N-demethylating and p-hydroxylating capacities of 
males and females were not found. Further, table 15 shows that the drug-
metabolizing capacity of the roach in autumn is different from that in the 
spring. This phenomenon will be discussed in detail in chapter VII. 
VI, 4. DRUG METABOLISM IN FISH IN RELATION TO BODY-WEIGHT 
The drug-metabolizing capacity of rat liver is dependent upon the age of 
the animal. For example, Henderson (1971) showed that the level of the 
enzymatic activities for the N-demethylation of aminopyrine in adult rats is 
higher than in newborn animals. Female and male rats reach their adult 
levels within 30 and 60 days respectively after birth. As far as the activities 
in old rats (about 600 days old) are concerned, Kato and Takanaka (1968) 
found lower levels compared with animals of 100 days old. 
In the present study the body-weight of the animals was taken as a rough 
parameter for the age of wild fishes. In order to check the influence of the 
body-weight on the drug-metabolizing capacity, wild roach were divided 
in three different weight classes in one set of experiments. The levels of 
the N-demethylating and p-hydroxylating capacities in these classes are 
presented in table 16. In order to exclude an apparent difference caused 
by possible variations in the overall composition of the liver, the enzymatic 
capacities are expressed in relation to different parameters. No significant 
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TABLE 16 - Hepatic drug metabolism of the roach in relation to body-weight 
N-demethylation of aminopyrine 
//moles formaldehyde | 
per hour per: 
g fresh liver 
mg liver protein 
mg liver DNA 
100 g body-weight 
p-hydroxylation of anil 
¿«moles p-aminophcnol 
per hour per: 
g fresh liver 
mg liver protein 
mg liver DNA 
100 g body-weight 
produced 
ine 
proc !uced 
10 - 25 g 
(η = 12) 
8.44 ± 1.93 
0.0636 ± 0.0169 
2.39 ± 0.53 
19.3 ± 7.0 
2.26 ± 0.31 
0.0166 ± 0.0024 
0.65 ± 0.10 
5.09 ± 1.34 
body-weight 
35 - 50 g 
(п = Ш 
8.06 ± 1.65 
0.0583 ± 0.0120 
2.54 ± 0.52 
21.9 ± 5.3 
2.17 ± 0.44 
0.0142 ± 0.0032 
0.63 ± 0.13 
5.35 ± 1.15 
90 
(1 
6.16 
0.0451 
1.74 
16.4 
1.90 
0.0139 
0.55 
5.39 
- 135 g 
η = 12) 
± 1.73* 
± 0.0120* 
± 0.36* 
± 5.5 
± 0.34** 
± 0.0028** 
± 0.10 
± 1.48 
Values are means ± S.D. 
enzyme assay in July 1970 
η represents the number of animals studied 
* significantly different from the weight class 10-25 g at Ρ < 0.02 
** significantly different from the weight class 10-25 g at Ρ < 0.05 
(Wilcoxon two-sided two-sample test) 
difference was found for the capacities in relation to the body-weight. 
However, if expressed per g fresh liver, per mg liver protein or per mg 
hepatic DNA, the N-demethylation of aminopyrine was significantly lower 
in the group of animals weighing 90-135 g than that observed in the group 
weighing 10-25 g. This was also the case for the p-hydroxylation of aniline, 
if expressed per g fresh liver or per mg hepatic protein. It has to be noted, 
however, that the difference in drug-metabolizing capacity between the 
groups of animals studied is relatively small. Nevertheless, in the comparative 
measurements described in chapter VII, the risk of a variation in enzymatic 
activity due to differences in the animal weight was reduced by the use of 
roach within a limited weight class (50-150 g). Within this class no individual 
correlation between the body-weight and the level of drug metabolism could 
be observed. 
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-demethylation of ammopyrine 
activity* per 
p-hydroxylation of aniline 
activity** per 
mg 
liver 
protein 
mg 
liver 
DNA 
100 g 
body-weight 
g 
íresh 
liver 
mg 
liver 
protein 
mg 
liver 
DNA 
4 ± 0.02 
1 ± 0.01 
± 0.01 
6 ± 0.004 
6 
8 ± 0.033 
í ± 0.005 
± 0.003 
± 0.004 
± 0.002 
± 0.004 
± 0.008 
± 0.004 
± 0.002 
± 0.013 
± 0.020 
± 0.002 
± 0.0009 
± 0.007 
0.002 
0.009 
0.008 
12 ± 3 
9.0 ± 1.4 
7.4 ± 1.5 
1.03 
4.58 
9.57 
0.19 
1.85 
0.0004 
2.29 ± 0.74 
0.37 ± 0.11 
0.45 ± 0.24 
0.45 ± 0.18 
0.33 ± 0.17 
0.70 ± 0.39 
0.72 ± 0.22 
0.62 
0.22 ± 0.07 
2.17 ± 0.75 
1.87 ± 0.89 
0.55 
0.61 ± 0.16 
0.05 ± 0.02 
1.22 ± 0.27 
0.29 ± 0.14 
1.23 i t 0.72 
0.38 ± 0.20 
0.12 ± 0.07 
97 
90 
59 
8.1 
± 16 
± 10 
± 9 
1.6 
46 ± 15 
14.3 ± 3.2 
2.1 ± 0.6 
2.1 
2.0 
1.2 
3.7 
3.8 
2.3 
0.7 
13.2 
10.8 
1.2 
1.7 
0.4 
4.0 
0.73 
3.02 
1.1 
0.2 
0.8 
1.3 
1.4 
0.3 
5.8 
6.1 
0.5 
0.2 
1.6 
0.23 
1.4 
3.4 ± 2.3 
2.8 ± 0.5 
5.8 ± 0.6 
1.3 ± 0.2 
1.82 ± 0.27 
11.0 
3.74 ± 1.95 
1.88 ± 0.23 
1.09 ± 0.35 
0.47 ± 0.15 
0.33 ± 0.24 
0.23 ± 0.09 
0.45 ± 0.29 
0.60 ± 0.23 
0.33 
0.18 ± 0.03 
1.23 ± 0.60 
0.87 ± 0.45 
0.30 
0.32 
0.35 ±: 0.10 
0.07 ± 0.02 
0.39 ± 0.16 
0.13 ± 0.09 
0.12 ± 0.05 
0.05 ± 0.03 
0.42 ± 0.18 
0.016 ± 0.003 
0.034 ± 0.003 
0.008 ± 0.001 
1.4 ± 0.3 
2.7 ± 0.4 
0.65 ± 0.10 
0.08 0.0134 ± 0.0018 0.54 
0.0602 5.0 
0.0275 ± 0.0063 1.65 ± 0.36 
0.0149 ± 0.0018 1.04 ± 0.36 
0.0083 ± 0.0029 0.25 ± 0.08 
0.0045 ± 0.0016 0.26 ± 0.12 
0.0037 ± 0.0025 
0.0020 ± 0.0008 
0.0034 ± 0.0022 
0.0041 ± 0.0017 
0.0027 
0.0015 ± 0.0003 
0.0103 ± 0.0050 
0.0093 ± 0.0046 
0.0020 
0.0021 
0.0028 ± 0.0008 
0.0005 ± 0.0002 
0.0036 ± 0.0016 
0.0011 ± 0.0008 
0.0014 ± 0.0007 
0.22 
0.14 
0.15 
0.19 
0.17 
0.06 
0.52 
0.47 
0.07 
0.19 
0.02 
0.30 
0.09 
± 0.12 
± 0.09 
±. 0.09 
± 0.09 
± 0.02 
± 0.22 
±0 .25 
0.05 
: 0.01 
: 0.12 
0.07 
0.12 ± 0.04 
0.0004 ± 0.0002 0.015 ± 0.007 
0.0052 ± 0.0011 0.80 ± 0.18 
glucuronidation of p-nitrophenol 
activity*** per 
100 g 
body-
weight 
11 ±2 
28 ± 3 
5.0 ± 0.8 
4.2 ± 0.9 
21 
46 
g 
fresh 
liver 
± 3 
i 13 
mg 
liver 
protein 
mg 
liver 
DNA 
100 g 
body-weight 
0.12 ± 0.02 
0.26 ± 0.07 
10 
22 
± 2 
± 6 
99 
184 
± 15 
± 4 5 
0.61 0.17 37 ± 9 185 ± 50 
6.5 ± 1.6 
1.42 ± 0.50 
1.19 ± 0.44 
0.56 ± 0.24 
0.40 ± 0.21 
0.73 ± 0.64 
0.94 ± 0.30 
0.61 
0.17 ± 0.06 
3.40 ± 1.55 
2.76 ± 1.67 
8.9 ± 
1.26 ± 
2.07 ± 
2.68 ± 
1.90 ± 
4.32 ± 
2.96 ± 
3.30 
1.90 ± 
5.79 ± 
4.84 ± 
2.3 
0.47 
0.98 
0.65 
0.53 
1.20 
1.06 
0.33 
1.15 
0.36 
0.071 ± 0.018 
0.010 ± 0.004 
0.019 ± 0.008 
0.028 ± 0.009 
0.018 ± 0.006 
0.033 ± 0.010 
0.020 ± 0.007 
0.026 
0.015 ± 0.003 
0.048 ± 0.015 
0.043 ± 0.013 
4.9 ± 1.8 
0.30 ± 0.08 
1.05 ± 0.44 
1.37 ± 0.39 
1.83 ± 0.82 
1.33 ± 0.50 
0.90 ± 0.41 
1.66 
0.60 ± 0.10 
2.90 ± 0.79 
2.26 ± 0.63 
31 
1.60 ± 
2.51 ± 
6.64 ± 
3.60 ± 
3.34 ± 
5.06 ± 
5.10 
1.73 ± 
13.3 ± 
12.0 ± 
0.60 
1.18 
1.68 
1.55 
1.55 
2.00 
0.38 
3.6 
0.7 
0.53 ± 0.14 
0.14 ± 0.04 
0.82 ± 0.46 
0.17 ± 0.13 
0.29 ± 0.08 
1.72 ± 
2.10 ± 
1.32 ± 
2.06 ± 
1.57 ± 
0.25 
1.13 
0.27 
0.90 
0.92 
0.014 ± 0.003 
0.015 ± 0.010 
0.011 ± 0.003 
0.011 ± 0.005 
0.015 ± 0.012 
0.95 ± 0.25 
0.72 ± 0.40 
0.73 ± 0.19 
1.30 ± 0.55 
1.43 ± 0.91 
2.60 ± 
3.94 ± 
2.16 ± 
3.55 ± 
3.84 ± 
0.65 
1.24 
0.85 
1.46 
2.71 
0.12 ± 0.05 nil 

VI, 5. SPECIES DIFFERENCES 'IN HEPATIC DRUG-METABOLIZING 
CAPACITIES 
The capacities of the enzymes involved in the oxidative N-dealkylation and 
aromatic hydroxylation, and in the glucuronidation in the liver preparations 
from various animal species are presented in table 17. In this survey the en­
zymatic activities are expressed in relation to various parameters. The reason 
for this is that differences in the relative amounts of the various components 
may occur in the livers of different animal species. For instance, in relation 
to other fish species the livers of the pike and carp showed, in correspondence 
with a fatty appearance, relatively low amounts of protein and DNA per gram 
fresh liver. In order to reduce the risk of a picture with species differences 
as artefacts evoked by expression of the drug-metabolizing enzymatic activ­
ities only in relation to 1 g liver fresh weight, the activities are also expressed 
per mg hepatic protein and DNA, and in relation to the total livers normaliz­
ed to animals of 100 g body-weight. For the present study the latter 
parameter may be considered to give the most rational impression of the 
differences in the drug-metabolizing capacities of the species investigated. 
In table 17 it can be seen that in the liver of all species tested enzymatic 
activity for the transformation of xenobiotics is present. Generally, the 
level of the drug-metabolizing capacity of the Poikilothermie animals is 
lower than that of the homeothermic species. Aquatic animal species with 
relatively high hepatic enzymatic activities are: roach, rudd, eel, and bream, 
and those with relatively low activities are: orfe, perch, salmon, tench, and 
trout. The liver preparations from the sea lampreys investigated exhibited no 
glucuronidating activity. Possible explanations for the species differences in 
drug-metabolizing capacity will be given in the discussion at the end of this 
chapter. 
VI, 6. SPECIES DIFFERENCES IN APPARENT K
m
-VALUES FOR 
SUBSTRATES AND COSUBSTRATES OF DRUG-METABOLIZING 
REACTIONS 
The apparent Michaelis-Menten constants for the substrates employed in 
the enzymatic reactions with liver preparations from various species are 
presented in table 18. Generally, the apparent constants derived for the 
oxidative reactions appear to be higher in the Poikilothermie animals than 
in the homeothermic ones. This phenomenon was also observed for the 
apparent Km-values of the cosubstrate required in the ЛГ-demethylation of 
aminopyrine (table 19). For glucuronidation no striking differences in the 
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TABLE 18 - Apparent Km-values of substrates for hepatic drug-metabolizing enzymes 
of different animal species 
hamster 
mouse 
rat 
hen 
pigeon 
lizard 
frog 
bream 
carp 
tench 
white bream 
roach 
rudd 
rainbow trout 
eel 
pike 
sea lamprey 
wool-handed crab t 
7V-demelhylation 
of aminopyrine* 
0.8 
1.3 
0.65 
0.6 
0.42 
3.23 
3.0 
6.1 
1.5 
7.6 
9.3 
6.5 
2.8 
3.5 
10 
8.0 
± 0.5 
± 0.20 
± 0.07 
± 0.7 
± 2.7 
± 0.6 
± 0.5 
± 0.9 
± 3.5 
p-hydroxylation 
of aniline** 
0.8 
0.29 
0.05 
1.31 
1.67 
2.4 
4.5 
4.2 
5.3 
10 
2.4 
2.6 
0.48 
1.7 
4.0 
5.5 
0.3 
± 0.04 
± 0.02 
± 0.34 
± 0.3 
± 1.3 
± 0.4 
± 0.12 
± 0.3 
± 2.0 
glucuronidation 
of p-nitrophenol § 
0.32 
0.72 ± 0 . 1 0 
0.64 ± 0.14 
0.33 
0.47 
0.83 
0.53 
0.97 
0.48 
1.3 ± 0.3 
0.67 
K
m
-values in mM; means of 2 or more determinations; for animals of which the 
apparent К
ш
- а1ие8 are determined by 4-10 determinations the standard error of the 
mean is given; 
* range of aminopyrine concentration used: 1.5-35 mM (see chapter V) 
** range of aniline concentration used: 0.1 - 22 mM 
§ range of p-nitrophenol concentration used: 0.14 - 1.4 mM 
t assayed with 9000 g supernatant of gill homogenate 
apparent Km-values for substrate and cosubstrate between the homeothermic 
and Poikilothermie animals investigated were observed (table 19). 
As has been shown in chapter IV, species differences exist in the temperature 
at which drug-metabolizing enzymes exhibit their maximal activities (at fixed 
incubation period). The influence of different incubation temperatures on the 
N-demethylation of aminopyrine by the hepatic enzyme preparations of rat, 
roach, and trout were also studied in relation to the apparent K
m
-values. The 
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TABLE 19 - Apparent Km-values of cosubstrates in hepatic N-demethylation and glu-
curonidation in different species 
N-demethylation of glucuronidation of 
aminopyrine; p-nitrophenol; 
cosubstrate NADPH* cosubstrate UDPglucuronate 
(x 10-« M) (x 10-3 M) 
rat 4 2.3 
hen 0.6 
pigeon 0.5 
lizard 8 1.0 
frog 7 
roach 8 1.0 
rainbow trout 22 0.6 
means of two determinations; calculation was done from Lineweaver-Burk plots. 
* the cosubstrate NADPH was supplied by the addition of NADP and a reducing 
system (cf. chapters III, 4.1; IV, 3.3; and IV, 3.4) 
results are plotted in figure 25. In order to eliminate the intraspecies varia-
tions, the biotransformation rates at the various temperatures are expressed 
as percentages of the maximum values in the respective temperature series 
(figure 25 a). The temperature for the measurement of maximal enzymatic 
activity of the N-demethylation reaction in vitro (incubation for 10 min) for 
rat, roach, and trout is about 42, 37, and 28 0C respectively. It should be 
emphasized that these results were obtained using concentrations of amino-
pyrine and NADPH high enough to saturate the enzyme preparations at all 
incubation temperatures used. This is important since the apparent Michaelis-
constant of the substrate aminopyrine for the enzymes in 9000 g supernatants 
appears to be temperature dependent (figure 25b). For the hepatic enzyme 
preparation of the roach the apparent Km-value shows a minimum over a 
wide temperature range. In contrast, for the trout and the rat a distinct 
minimum can be observed at 25 and 40 °C respectively. 
VI, 7. iV-DEMETHYLATING ACTIVITY OF COMBINED HEPATIC ENZYME 
PREPARATIONS FROM RAT AND TROUT 
In order to test whether the low enzymatic activities observed in fishes are 
caused by inhibitory factors present in the liver, experiments were performed 
in which the N-demethylating enzymatic activity was measured by using 
a combination of 9000 g supernatant from the liver of an animal species 
with a relatively high activity, viz. the rat, and from the liver of a species 
with a relatively low activity, viz. the rainbow trout. The results are given 
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% of maximal enzyme activity -
a 
apparent \(m (mM)" roach,trout 
25 -, 
2 0 -
15 
10 
rat 
гб 
Is 
ί-3 
M 
— ι 1 1 1 1 1 
20 40 60 
temperature ( e C) 
FIGURE 25. Oxidative N-demethylation of aminopyrine. Enzyme assays were carried 
out (incubation 10 min) with 9000 g supernatants from liver homogenates of trout, 
roach, and rat. Enzymatic activity was assayed with different substrate concentrations 
at various temperatures and expressed as the amount of formaldehyde produced per h 
per g fresh liver, a, Enzymatic activities are plotted as percentages of the maximum 
values of the respective temperature series. Mean values ± S.E.M. for at least 10 ani­
mals. b, Apparent K
m
-values represent the substrate concentrations at J^
 т а х
 in mM. 
Calculation was done from Lineweaver-Burk plots. Means of at least 6 determinations 
± S.E.M. (Dewaide, 1970). 
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TABLE 20 - 7V-demethylating activity of combined 9000 g super natants from rat and trout livers 
nmoles formaldehyde produced in 3 ml reaction mixture 
incubation 
temperature 
25 0 C 
37 0 C 
9000 g supernatant 
from rat liver 
(equivalent to 100 mg 
fresh tissue) 
(A) 
134 ± 12 
255 ± 25 
9000 g supernatant 
from trout liver 
(equivalent to 100 mg 
fresh tissue) 
(B) 
24 ± 4 
17 ± 6 
combined 9000 g supematants 
from rat and trout liver 
(equivalent to 50 mg fresh 
rat liver + 50 mg fresh 
trout liver 
(C) 
84 ± 3 
166 ± 8 
(C) 
И(А) + И(В) 
1.06 ± 0.10 
1.22 ± 0.09* 
Means of 7 experiments ± S.E.M. Incubations were carried out at 25° and 37 "C under adapted assay conditions as described in 
chapter III and IV. 
* In each experiment the value for С/(ИА + ИВ) was found to be greater than 1 
TABLE 21 - Microsomal iV-demethylating activity of rat and trout liver with interchange of the soluble fractions 
nmoles formaldehyde produced in 3 ml reaction mixture 
9000 - 105000 g pellet R 9000 -105000 g pellet R 9000 - 105000 g pellet Τ 9000 - 105000 g pellet Τ 
incubation + + + + 
temperature 105000 g supernatant R 105000 g supernatant Τ 105000 g supernatant Τ 105000 g supernatant R 
25 0 C 
37 "С 
112 ± 5 
207 ± 14 
115 ± 6 
209 ± 15 
15 ± 2 
12 ± 3 
19 ± 4 
10 ± 4 
Means of 7 experiments ± S.E.M. 
R: fraction derived from rat liver (equivalent to 100 mg fresh tissue) 
T: fraction derived from trout liver (equivalent to 100 mg fresh tissue) 
Incubations were carried out for 10 min at 25 and 37 °C under adapted conditions as described in chapter 111 and IV. 
Note that the activities of the microsomal fractions (9000 - 105000 g pellets) are not influenced by the interchange of the soluble frac­
tions (105000 g supematants). 
in table 20. It appears that no inhibition occurs in the mixed enzyme 
preparation. On the contrary, a significant increase was found in the assay 
at 37JC: the favourable temperature for the rat enzyme. In chapter IV, 2. 1. 
with respect to the low /V-demethylating activity in rat liver microsomes 
(9000 - 105000 g pellet) observed in the presence of small amounts of 
soluble fraction (105000 g supernatant), the possibility of inhibitory factors 
present in the rat liver was considered. It is of interest, therefore, to study 
whether the stimulation of the activity of rat liver in the presence of trout 
liver preparation, as described above, is the result of a suppression of 
possible inhibitors in the rat liver by factors from the fish. In order to 
check this, rat and trout liver microsomes were assayed for N-demethylating 
activity with interchange of the soluble fractions. The results presented in 
table 21 show no significant differences for fish and rat liver microsomes in 
the presence of the different soluble fractions. Thus, the results presented 
in chapter IV, 2. 1. and those described above indicate that the activity 
of the microsomal fraction can be increased by the addition of the soluble 
fraction, but, both for rat and trout it does not matter which soluble fraction 
is employed. 
VI, 8. DISCUSSION 
This study shows that in all vertebrates investigated the liver has to be 
considered as a very important site for the biotransformation of xenobiotics 
(tables 13 and 14). For the reactions studied extractsi of this organ exhibit 
higher rates of conversion and lower apparent Km-values for the substrates as 
compared with other organs. In the wool-handed crab, the only invertebrate 
species investigated, the greatest in vitro capacity for aromatic hydroxylation 
was not found in the hepatopancreas — the organ in crustácea which is con-
sidered to resemble in some of its functions the liver of vertebrates (Vonk, 
1960) — but in the gill (table 13). This may suggest that these water-dwelling 
arthropods make use of drug transformation in the gill in order to get rid 
of xenobiotics. This phemonenon contrasts with the rather poor drug-
metabolizing capacity in vitro of the gills of fishes (tables 13 and 14). 
In order to study the relationship between the age of the fishes and their 
drug-metabolizing capacity, efforts were made to correlate the level of drug 
transformation to the body-weight of the animals. The experiments performed 
with wild roach are suggestive of a slight decrease in the capacity of the 
drug-metabolizing processes in the animals of the heaviest weight class 
(table 16). 
As far as the influence of the sex of the fishes is concerned, for 4 species 
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no significant differences in the drug-metabolizing enzymatic activities of 
males and females were observed (table 15). In relation to the possible 
presence of differences in drug metabolism under the influence of age and 
sex it has to be noted that in the present study differences may remain 
hidden by the great intraspecies differences observed. These intraspecies 
differences are determined by a lot of internal and external factors (chapter 
II, 7). In this connection it is well imaginable that small distinctions due to 
age or sex are overshadowed by more influential factors such as, for 
instance, exposure to certain xenobiotics. Therefore, a definite conclusion 
concerning the influence of age and sex on drug metabolism in fish cannot be 
made until a study has been performed with a sufficient number of animals 
with comparable genetic properties under controlled environmental cir-
cumstances. 
As far as the interspecies differences in drug metabolism are concerned, 
with a view on the possible fluctuations in the relative amounts of the 
various components in the livers of different species, a comparison of the 
enzymatic activities is most reasonable if the activities are standardized in 
respect of a comparable parameter. Therefore, in this study enzymatic 
activities were expressed as a ratio to an amount of liver corresponding to 
a total body-weight of 100 g. With the present approach, these values are 
assumed to give a useful impression of the drug-metabolizing capacity of 
the various animals studied. 
Generally, the enzymatic activities studied are found to be lower in the 
extracts of the livers from the Poikilothermie animals than those observed for 
the homeothermic ones (table 17). That these lower activities represent lower 
concentrations of the drug-metabolizing enzymes rather than an inhibition of 
the enzymatic activity by unknown factors is suggested by the uninhibited, or 
even stimulated, activities of combined rat and trout enzyme preparations 
(tables 20 and 21). A similar phenomenon of an enhancement of enzyme 
activity with mixed rat and trout liver enzyme preparations has been observed 
earlier by Chan et al. (1967) for the microsomal aldrin epoxidation, whereas 
Buhler and Rasmusson (1968a) reported an unexpected increase in the en-
zymatic activity in the aromatic hydroxylation of aniline. At the present time, 
the mechanism through which this enhancement in the combined system of 
rat and trout liver is achieved, awaits further characterization. 
As far as the apparent Km-values of the substrates and cosubstrates for the 
oxidative reactions studied are concerned, the lower constants found for 
the homeothermic species indicate, too, more favourable conditions for the 
systems involved in the metabolism of xenobiotics in these animals as 
compared with the cold-blooded animals (tables 18 and 19). In this connec-
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tion striking differences which were observed in the iV-demethylation of 
aminopyrine in relation to the incubation temperature must be stressed. 
The temperatures for measurement of maximal reaction velocities for rat, 
roach, and trout liver preparations are about 42, 37 and 28 0 C . As far as 
the variation of the apparent K
m
-values of aminopyrine with the assay tem­
perature is concerned species differences also appeared (figure 25). For the 
ЛГ-demethylating enzyme of the liver of the roach the minimum apparent 
Kju-value is rather temperature independent and ranges from 25 to 45 0 C . 
In contrast, both for the rat and the trout, a more distinct minimum is found 
at 40 and 25 0 С respectively. Correlations between the properties of other 
enzymes and the body or environmental temperature have been described 
earlier both for homeothermic and Poikilothermie animals (Kaplan, 1965; 
Cowey, 1967; Hochachka and Somero, 1968). Possibly, the species differen­
ces in drug metabolism as described here may be a reflection of the different 
physiological conditions of the organisms, adapted to their natural habitat. The 
trout, which lives preferentially at low environmental temperatures, will be 
served best by enzymes showing maximal activities at low temperatures. 
The wild roach will be adapted to the naturally occurring thermal fluc­
tuations of its aquatic environment. The properties of enzymes in the 
homeothermic rat will correspond with the higher internal body temper­
ature. 
It is difficult and hazardous to draw conclusions from the in vitro meas­
urements about the rate of biotransformation of xenobiotics in vivo. Never­
theless, it is tempting to give an explanation for the differences in the 
xenobiotic-metabolizing capacities of the enzyme preparations from the 
various animal species. The speculative character of the following dis­
cussion, therefore, has to be stressed. One of the conclusions may be that 
the capacity of the Poikilothermie animals to metabolize xenobiotics is 
lower than that of the homeothermic mammals and birds. The question 
remains, whether — besides the possibility that in water-dwelling animals 
other mechanisms for the disposition of xenobiotics are present, for example 
diffusion through the gills — the apparently low drug-metabolizing capacity 
in fish will be, nevertheless, sufficient to dispose of xenobiotics. Here the 
experimental data and conclusions of Brodie and coworkers (Brodie et al. 
1958; Brodie and Maickel, 1962) must be recalled. Their conclusion that 
fishes do not possess drug-metabolizing capacity are clearly disproved by 
the experimental data of the present study. Their theory that fish would 
have no need for such a capacity can be invalidated by stating the 
importance of the drug-metabolizing reactions which decrease the lipophilic 
character of xenobiotics. The products are more restricted in their distribution 
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in the body to the extracellular phase. This favours, for fishes too, the disposal 
of xenobiotics from the body. Relating the different levels of drug-metaboliz-
ing capacity in totally different species, like homeotherms and poikilotherms, 
to a basic parameter such as standard metabolism — which in its turn is 
related to the food intake and therefore to the degree of exposure to xeno-
biotic compounds — might help to explain the difference in detoxificating 
capacities reported. 
Further, it is of importance that the level of drug-metabolizing capacity of 
the wild fishes investigated may be dependent upon certain xenobiotic 
chemicals present in their polluted environment. Perhaps the observation that 
the enzymatic activities in the livers of the roach and the rudd are several 
times higher than those in the other species belonging to the family 
of the Cyprinidae has to be explained on this basis. It is imaginable that as 
compared with the white bream, the bream, the carp, and the tench — which 
are all relatively slow-swimming fishes, and which find their food consisting 
of plants, grubs, and worms near the bottom of the water — the roach and 
the rudd — which have a higher mobility in collecting a relatively great 
amount of food consisting of plankton, plants, small aquatic animals, and 
insects near the surface of the water — encounter in their environment a 
greater amount and variety of xenobiotics. The difference in drug-metaboliz-
ing capacity of roach belonging to different classes of weight (table 17) 
might also be explained on this basis: small roach, which are rapidly growing, 
consume a relatively greater amount of food and are thus possibly confronted 
with a greater amount of xenobiotics. 
Among the family of Cyprinidae the hatchery-reared golden orfe shows a 
much lower drug-metabolizing capacity than the wild species. In this connec-
tion it may be asked to what degree the fact that the orfes have lived in non-
polluted hatchery water, has played a role. 
That external factors may play a role with regard to the level of the drug-
metabolizing capacity will be supported by the experimental results presented 
in the next chapter. 
Speculation about the dietary aspects of the evolution of enzymes dealing 
with the metabolism of xenobiotics, for instance between carnivorous and 
herbivorous fishes, cannot be done on basis of the data obtained in this 
study. 
Finally, in relation to the chemical pollution of the water of the river Rhine, 
it may be asked whether the low detoxifying capacity of salmon and trout 
observed in this study and the high capacity especially of roach and rudd 
have played a role in the extinction of the first-mentioned species, and the 
rather fair maintenance of the last-mentioned species. 
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CHAPTER VII 
THE I N F L U E N C E OF E X T E R N A L F A C T O R S 
ON THE L E V E L OF H E P A T I C DRUG 
M E T A B O L I S M IN F I S H 
VII, 1. INTRODUCTION 
Changes in the drug-metabolizing capacity of animals can be evoked by a 
wide variety of endogenous and exogenous factors, among which are age, 
sex, diet, environmental temperature, and exposure to xenobiotics (chapter 
II, 7). The observations of these phenomena mainly concern mammals. 
As far as various fish species are concerned, studies in the past on the 
metabolism of xenobiotics failed to show alterations in their drug-metaboliz-
ing capacity under the influence of a change of diet, and of xenobiotics such 
as DDT and phenylbutazone (Buhler and Rasmusson, 1968a and 1968b; 
see also Adamson, 1967). 
In the previous chapters evidence has been presented which may disprove the 
idea that water-dwelling animals do not have the ability to metabolize 
substances alien to the body. It was concluded that for the recognition of 
such a capacity in vitro the employment of adapted assay conditions is of 
primary importance (chapter IV). 
In this study, besides the influence of internal factors such as sex and 
age of the animals (chapter VI, 3 and 4), the effect of certain external 
factors was also investigated. 
VII, 2. SEASONAL VARIATION IN HEPATIC DRUG 
METABOLISM IN THE ROACH 
From March 1968 onwards, at set times, roach were caught in the river 
Waal (the main branch of the river Rhine delta flow) near Nijmegen, 
immediately transported to the laboratory, killed, and tested for hepatic 
drug-metabolizing enzymatic activities within 1 hour after arrival. From 
figure 26 it appears that the enzymatic activities involved in the N-de-
methylation of aminopyrine and in the p-hydroxylation of aniline at different 
times of the year were not constant. This was confirmed statistically (P « 
IO5) by the test of Kruskal and Wallis (1952). The highest drug-metaboliz-
ing capacities were found during the summer months. For both N-demethyl-
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FIGURE 26. Seasonal variation in hepatic drug-metabolizing capacity in the wild 
roach. Measurements were performed with 9000 g supernatants derived from liver 
homogenates. Curves are drawn through the median values of the samples. 
Note that the drug-metabolizing capacities in summer are higher than in winter. 
ation and p-hydroxylation the capacities measured in July, August, and 
September were always significantly different from the capacities measured 
in December and January (Wilcoxon two-sided two-sample test, Ρ < IO-3). 
The differences in the biotransformation capacities — defined in figure 26 
as /¿moles of the products formed per hour per gram liver — are not 
generated as artefacts under the influence of changes in the overall composi-
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TABLE 22 - Liver weight, and hepatic protein and DNA contents of wild roach at 
different times of the year 
assay date 
April 19, 1968 
May 14, 1968 
September 10, 1968 
September 17, 1968 
December 17, 1968 
January 17, 1969 
March 8, 1969 
April 16, 1969 
June 12, 1969 
June 25, 1969 
July 23, 1969 
August 7, 1969 
September 1, 1969 
September 9, 1969 
September 23, 1969 
October 14, 1969 
October 31, 1969 
November 21, 1969 
December 24, 1969 
January 23, 1970 
January 27, 1970 
March 2, 1970 
March 23, 1970 
April 3, 1970 
April 16, 1970 
May 1, 1970 
May 15, 1970 
May 28, 1970 
June 22, 1970 
July 6, 1970 
August 11, 1970 
August 17, 1970 
September 11, 1970 
no. of 
animals 
15 
6 
17 
5 
6 
12 
8 
9 
10 
5 
4 
10 
10 
10 
10 
10 
10 
20 
16 
10 
10 
8 
10 
17 
16 
18 
10 
15 
20 
36 
10 
20 
10 
liver fresh 
weight (g/100 g 
body-
2.1 
2.4 
2.4 
2.3 
2.3 
2.9 
2.6 
2.8 
2.2 
2.2 
3.2 
3.0 
2.5 
2.2 
2.1 
2.2 
weight) 
H ; 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
± 
+ 
+ 
± 
0.4 
0.5 
0.4 
0.4 
0.5 
0.6 
0.4 
0.6 
0.6 
0.6 
0.8 
0.7 
0.5 
0.5 
0.3 
0.5 
protein 
(mg/g fresh liver) 
141 ± 17 
156 ± 24 
140 ± 12 
150 ± 5 
138 ± 21 
150 ± 27 
167 ± 13 
162 ± 14 
150 ± 21 
152 ± 22 
161 ± 21 
138 ± 20 
145 ± 8 
163 ± 9 
120 ± 13 
155 ± 17 
152 ± 14 
126 ± 13 
115 ± 10 
124 ± 17 
130 ± 14 
120 ± 9 
135 ± 16 
125 ± 12 
138 ± 12 
163 ± 24 
148 ± 25 
147 ± 16 
138 ± 8 
151 ± 10 
146 ± 13 
167 ± 6 
DNA 
(mg/g fresh liver) 
2.4 ± 
2.6 ± 
2.6 ± 
2.5 ± 
2.5 ± 
2.2 ± 
2.3 ± 
2.6 ± 
2.1 ± 
2.3 ± 
2.7 ± 
2.4 ± 
2.1 ± 
2.3 ± 
2.4 ± 
1.9 ± 
2.5 ± 
2.3 ± 
1.8 ± 
1.9 ± 
2.7 ± 
2.0 ± 
2.3 ± 
2.6 ± 
2.0 ± 
2.4 ± 
2.8 ± 
2.4 ± 
2.3 ± 
2.3 ± 
0.4 
0.4 
0.3 
0.3 
0.2 
0.3 
0.4 
0.5 
0.3 
0.2 
0.4 
0.4 
0.4 
0.4 
0.4 
0.3 
0.2 
0.2 
0.3 
0.4 
0.4 
0.6 
0.5 
0.5 
0.5 
0.5 
0.4 
0.4 
0.6 
0.3 
Mean values with standard deviation 
Note: the limits within which the liver weight, and the hepatic protein and DNA con-
tents vary indicate that the seasonal variation in the drug-metabolizing capacities pre-
sented in figure 26 is not generated as an artefact by differences in the amounts of 
certain liver constituents. 
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tion of the liver. This can be derived from the relative constancy of the 
hepatic protein and DNA contents (table 22). Moreover, the fluctuations in 
the capacities plotted in figure 26 are not generated by a possible change 
in the water content of the fish liver because of the clear constancy observed 
for the liver dry weight (storage at 110 0C until weight remained constant): 
24 5 ± 1.9 per cent of the liver fresh weight. The values for the liver 
fresh weight as a percentage of the body-weight (table 22, period 1970) 
indicate that, if the hepatic drug-metabolizing capacities were expressed per 
unit of body-weight, a picture similar to that of figure 26 would have been 
obtained. 
The results presented above indicate that in wild roach the capability of 
metabolizing xenobiotics is high during the summer months. During this 
period the N-demethylation capacity of roach approximates that observed 
for rats, whereas the p-hydroxylation capacity exceeds even that found in 
rat liver (cf. table 17). 
In another fish species, viz. the rudd, different levels of drug metabolism 
have also been observed at different times of the year (table 23). 
TABLE 23 - Hepatic drug oxidation in the rudd at different times of the year 
N-demethylation of 
aminopyrine 
activity* per 
date of assay 
March 12, 1970 June 29, 1970 
(n=25) ( n = l l ) 
g fresh liver 1.37 ± 0.52 3.60 ± 1.83 
mg liver protein 0.0119 ± 0.0042 0.0379 ± 0.0197 
mg liver DNA 0.63 ± 0 . 2 8 1.87 ± 0 . 8 9 
100 g body-weight 2.40 ± 0.86 10.8 ± 6.3 
p-hydroxylation of 
aniline 
activity** per 
g fresh liver 0.41 ± 0 . 1 7 0.87 ± 0.45 
mg liver protein 0.0035 ± 0.0015 0.0093 ± 0.0046 
mg liver DNA 0.19 ± 0.09 0.47 ± 0.25 
100 g body-weight 0.72 ± 0.28 2.76 ± 1.67 
Means with standard deviation 
n: number of animals investigated 
* |Umoles formaldehyde produced per hour 
** «moles p-aminophenol produced per hour 
The corresponding values of the two dates are significantly different at Ρ < 0.01 
(Wilcoxon two-sided two-sample test) 
Note: the drug-metabolizing capacities of the rudd in March and June are significantly 
different independent of the way of expression. 
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VII, 3. HEPATIC DRUG OXIDATION IN RELATION TO CHANGES 
IN ENVIRONMENTAL TEMPERATURE 
It has been reported that exposure of mammals to low environmental 
temperatures may result in an alteration in drug metabolism (Inscoe and 
Axelrod, 1960; Gillette, 1965; Inscoe et al., 1965 ; Fuller and Bousquet, 1967; 
Stitzel and Furner, 1967; Furner and Stitzel, 1968). In view of the fact that 
especially Poikilothermie animals, such as fishes, may be affected by changes 
in the environmental temperature, questions arise about their adaptability 
with respect to the biotransformation of xenobiotics. These questions are 
the more urgent as our technological society is modifying the aquatic 
environment in certain areas not only chemically but also thermally. 
Also, in connection with the high level of hepatic drug metabolism in roach 
during the summer months which has been described above, it may be 
asked whether the difference in environmental temperature between summer 
and winter is the cause of the seasonal difference in their ability to metabolize 
xenobiotics. The drug-metabolizing abilities of hatchery-reared rainbow 
trout and wild roach were measured after keeping the animals in water of 
different temperatures. The drug-metabolizing capacities were also compar-
atively studied in two homeothermic species, Wistar rat and golden hamster, 
after exposure to different temperatures. 
Before exposure to different ambient temperatures the fish species were 
kept for 1 week in tanks with running tap water (600 1/h) at 9 0C. Sub-
sequently the fishes were kept in tanks with standing tap water at 5 or 
18 UC for 2 weeks. Twice a week the water was refreshed. The mammals 
studied were exposed to an environmental temperature of 5 or 23 0C 
for 2 weeks. During the cold exposure the hamsters were not hibernating. 
During the whole period the roach and one group of trout were starved; 
another group of trout, the rats and the hamsters were fed ad libitum. Trout 
at 18 0C exhibited more aggressive feeding behaviour than those kept at 5 "C. 
In contrast, mammals at 5 "C tended to ingest greater amounts of food 
than those living at 23 0C. 
After the period with different environmental temperatures the body-weight, 
the liver weight (wet and dry weight), the hepatic protein and DNA content, 
and the enzymatic capacities for N-demethylation and p-hydroxylation were 
measured. For the fish the whole procedure of temperature exposure and 
succeeding measurements was repeated 4 times with different groups of 
animals separately. The differences between the groups of animals exposed to 
different temperatures were statistically tested with a method based on a com-
bination of independent two-sample tests of Wilcoxon (van Eiteren, 1960). 
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TABLE 24 - Influence of change in environmental temperature on body-weight and liver weight 
hamster (fed) 
rat (fed) 
roach (starved) 
trout (fed) 
trout (starved) 
temperature 
"C 
5 
23 
5 
23 
5 
18 
5 
18 
5 
18 
body-weight 
g 
89 ± 12 (18) 
98 ± 9 (17) 
N.S. 
244 ± 19 (8) 
271 ± 12 (8) 
Ρ < 0.01 
62 ± 18 (37) 
62 ± 22 (32) 
N.S. 
145 ± 20 (26) 
157 ± 19 (26) 
N.S. 
143 ± 15 (23) 
139 ± 13 (14) 
N.S. 
liver wet 
g 
4.2 ± 0.6 (18) 
4.0 ± 0.5 (16) 
N.S. 
10.4 ± 1 . 1 (8) 
10.7 ± 1.3 (8) 
N.S. 
1.5 ± 0.6 (39) 
1.1 ± 0.5 (55) 
Ρ < 0.01 
2.4 ± 0.5 (43) 
2.0 ± 0.5 (51) 
Ρ < 0.01 
2.0 ± 0.6 (23) 
1.6 ± 0.4 (14) 
Ρ < 0.01 
weight 
g per 100 
g body weight 
4.7 ± 0.4 (18) 
4.1 ± 0.5 (16) 
Ρ < 0.01 
4.3 ± 0.1 (8) 
4.0 ± 0.3 (8) 
N.S. 
2.3 ± 0.7 (37) 
1.6 ± 0.4 (29) 
Ρ < 0.01 
1.6 ± 0.4 (26) 
1.3 ± 0.3 (26) 
Ρ < 0.01 
1.5 ± 0.4 (23) 
1.1 ± 0.3 (14) 
0.05 > Ρ > 0.01 
Results are expressed as means with standard deviation; the number of animals is given 
in parentheses. 
N.S. Not significantly different (Wilcoxon two-sided two-sample test) 
The results are presented in tables 24-27, and figure 27. It appears that an 
alteration in the environmental temperature causes an obvious change in 
some components and enzymatic capacities of the liver. The effects are 
essentially equal both for the homeothermic mammals and for the Poikilo­
thermie fishes. For the trout they also appear independent of the nutritional 
status. 
The influence of the different environmental temperature on the overall 
composition of the liver can be most clearly seen from the significantly 
lower weight of the total liver in the warmth-treated animals compared with 
the cold-treated ones, especially if the liver weight is related to the body-
weight (table 24). The difference is not due to a variation (per g liver) in the 
water content of the liver tissue (figure 27). These findings are in accordance 
with earlier reports on the influence of low environmental temperature on 
the golden hamster (Smit-Vis and Smit, 1969), on the rat (Kaiser and Kunig, 
1969), and on the goldfish (Das, 1967). 
Figure 27 shows that cold-exposed fish have a higher amount of total liver 
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per cent charge 
FIGURE 27. Per cent changes in the livers of cold-exposed animals compared with 
warmth-exposed animals. Calculation: (cold/warmth - 1) χ 100%. Liver wet weight is 
related to 100 g body-weight. Water content has been derived from the dry/wet 
weight ratio. Blocks represent average changes ± S.D. Number of animals investigated 
is given in table 24. * indicates a significant difference at Ρ < 0.05 (Wilcoxon two-
sided two-sample test). 
protein than the fish kept at elevated temperature. In earlier studies a 
clear-cut increase in the level of total hepatic protein and in the incorporation 
of 14C-leucine in total hepatic protein of fishes in cold water as compared 
with fishes in warm water has been observed for goldfish (Das, 1967; Das 
and Prosser, 1967) and for rainbow trout (Dean and Berlin, 1969). On the 
other hand no temperature-induced differences in the amount of hepatic 
protein of goldfish have been found by Caldwell (1969). Probably the reason 
for the inconsistent observations for the hepatic protein in the above mention­
ed studies is that a change in the amount of protein, if expressed per g fresh 
liver, is obscured due to a shift in the relative amounts of other liver compo­
nents. Here also, species differences, the nutritional status of the animals, and 
the length of the period of exposure may play a role. 
That an inaccurate picture of the overall change in the liver can be 
obtained if the components are expressed as concentrations (mg/g wet 
tissue) is also demonstrated in figure 27. As far as the concentrations of 
protein and DNA are concerned, it might be erroneously concluded that 
under the influence of exposure to different temperatures the amount of 
hepatic protein of the trout did not change and the amount of hepatic 
protein of the warmth-exposed roach increased, whereas in the liver of the 
warmth-exposed fishes a pronounced increase in DNA occurred. However, 
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TABLE 25 - Influence of change in environmental temperature on drug metabolism* 
hamster (fed) 
rat (fed) 
roach (starved) 
« ."* 
"*" 
trout (fed) 
trout (starved) 
temperature 
0C 
5 
23 
5 
23 
5 
18 
5 
18 
5 
18 
activity per g 
fresh liver 
28.0 ± 3.9 (18) 
23.0 ± 3.7 (17) 
Ρ < 0.01 
23.5 ± 2.8 (8) 
20.4 ± 1.6 (8) 
Ρ < 0.01 
3.49 ± 1 . 1 7 (44) 
2.45 ± 0.86 (39) 
Ρ < 0.01 
1.51 ± 0.41 (38) 
0.90 ± 0.30 (37) 
Ρ < 0.01 
1.35 ± 0.50 (16) 
0.71 ± 0.16 (9) 
Ρ < 0.01 
N-demethylation of aminopyrine 
activity per mg 
liver protein 
0.162 ± 0.017 (18) 
0.142 ± 0.020 (14) 
0.05 > Ρ > 0.01 
0.128 ± 0.010 (8) 
0.116 ± 0.012 (8) 
N.S. 
0.0278 ± 0.0096 (42) 
0.0174 ± 0.0067 (39) 
Ρ < 0.01 
0.0125 ± 0.0038 (38) 
0.0083 ± 0.0036 (37) 
Ρ < 0.01 
0.0114 ± 0.0051 (16) 
0.0061 ± 0.0015 (9) 
Ρ < 0.01 
activity per mg 
liver DNA 
15.2 ± 2.7 (18) 
12.5 ± 2.4 (15) 
Ρ < 0.01 
11.6 ± 1.0 (8) 
10.2 ± 1.3 (8) 
0.05 > Ρ > 0.01 
1.62 i t 0.61 (45) 
0.74 ± 0.34 (38) 
Ρ < 0.01 
1.05 ± 0.46 (38) 
0.39 ± 0.23 (36) 
Ρ < 0.01 
0.83 ± 0.51 (16) 
0.35 ± 0.09 (9) 
Ρ < 0.01 
activity per 100 g 
body-weight 
132.7 ± 20.0 (18) 
96.8 ± 16.0 (16) 
Ρ < 0.01 
99.8 ± 9.3 (8) 
80.7 ± 8.0 (8) 
Ρ < 0.01 
8.16 -L 2.06 (32) 
4.0 L ± 1.76 (28) 
Ρ < 0.01 
2.57 ± 0.95 (26) 
1.31 ± 0.39 (25) 
Ρ < 0.01 
1.73 -L 0.59 (16) 
0.77 ± 0.19 (9) 
Ρ < 0.01 
о 
* Activity is defined as «moles formaldehyde produced per hour; assayed with 9000 g supcmatants derived from liver homogenatcs 
at 37 °C for hamster and rat and at 25 "C for roach and trout; values are means ± S.D.; the number of animals is given in paren­
theses. 
N.S. Not significantly different (Wilcoxon two-sided two-sample test). 
TABLE 26 - Influence of change in environmental temperature on drug metabolism* 
hamster (fed) 
rat (fed) 
roach (starved) 
trout (fed) 
trout (starved) 
β 
temperatun 
0 C 
5 
23 
5 
23 
5 
18 
5 
18 
5 
18 
activity per g 
fresh liver 
3.99 ± 0.29 (12) 
2.78 ± 0.46 (13) 
Ρ < 0.01 
1.97 ± 0.45 (8) 
1.41 ± 0.30 (8) 
Ρ < 0.01 
1.09 ± 0.46 (40) 
0.62 ± 0.18 (36) 
Ρ < 0.01 
0.39 ± 0.08 (38) 
0.31 + 0.11 (37) 
Ρ < 0.01 
0.37 ± 0.07 (16) 
0.17 ± 0.03 (9) 
Ρ < 0.01 
p-hydroxylation of aniline 
activity per mg 
liver protein 
0.024 ± 0.002 (12) 
0.016 ± 0.003 (11) 
Ρ < 0.01 
0.011 ± 0.003 (8) 
0.008 ± 0.002 (8) 
0.05 > Ρ > 0.01 
0.0082 ± 0.0038 (37) 
0.0044 ± 0.0015 (36) 
Ρ < 0.01 
0.0032 ± 0.0008 (38) 
0.0027 ± 0.0010 (37) 
Ρ < 0.01 
0.0030 ± 0.0008 (16) 
0.0015 ± 0.0002 (9) 
Ρ < 0.01 
activity per mg 
liver DNA 
2.15 ± 0.34 (12) 
1.38 + 0.29 (12) 
Ρ < 0.01 
0.99 ± 0.28 (8) 
0.71 ± 0.15 (8) 
0.05 > Ρ > 0.01 
0.48 ± 0.23 (40) 
0.19 ± 0.10 (36) 
Ρ < 0.01 
0.27 ± 0.09 (38) 
0.12 ± 0.04 (36) 
Ρ < 0.01 
0.22 ± 0.12 (16) 
0.09 ± 0.03 (9) 
Ρ < 0.01 
activity per 100 mg 
body-weight 
18.87 ± 2.10 (12) 
10.95 ± 2.10 (13) 
Ρ < 0.01 
8.37 ± 2.00 (8) 
5.60 ± 1.40 (8) 
Ρ < 0.01 
2.67 ± 0.93 (32) 
1.12 ± 0.60 (28) 
Ρ < 0.01 
0.63 ± 0.20 (26) 
0.37 ± 0.15 (25) 
Ρ < 0.01 
0.46 ± 0.10 (16) 
0.18 ± 0.05 (9) 
Ρ < 0.01 
* Activity defined as pinoles p-aminophenol produced per hour; assayed with 9000 g supematants derived from liver homogenates at 
37 0 C for hamster and rat and at 25 "С for roach and trout; values are means ± S.D.; the number of animals is given in parentheses. 
Statistical comparisons were made by Wilcoxon's two-sided two-sample test. 
TABLE 27 - Influence of change in environmental temperature on liver composition and hepatic drug metabolism of the roach in 
summer 
JV-deniethylation of p-hydroxylation of 
liver wet weight liver protein liver DNA aminopyrine aniline 
temperature g per mg per rag per activity* per activity** per 
С C) 100 g body-weight 100 g body-weight 100 g body-weight 100 g body-weight 100 g body-weight 
5 2.6 ± 0.4 345 ± 60 5.25 ± 0.60 13.0 ± 4.0 4.7 ± 1.5 
18 1.8 ± 0.3 270 ± 35 5.10 ± 0.75 5.4 ± 2.9 2.7 ± 0.8 
Ρ < 2 χ 10-a Ρ < 2 χ 10-* N.S. Ρ < 2 χ 10-» Ρ < IO"1 
Values are means ± S.D.; 2 groups of 8 roaches were exposed for 1 week (first week of September) to different environmental tem­
peratures 
* Activity defined as /«moles formaldehyde produced per hour; enzyme assay at 25 "С 
** Activity defined as /«moles p-aminophenol produced per hour; enzyme assay at 25 "С 
Statistical comparisons by Wilcoxon's two-sided two-sample test 
Note the significantly higher values found for the animals kept at 5 0 C 
О 
-J 
the relative constancy of the DNA content of the total liver indicates that 
the higher amounts of DNA observed per g liver in roach and trout (figure 
27) are not caused by an increase in the absolute number of cells or absolute 
amount of DNA, but represent an increase of cells per g liver under the 
influence of changes in the amounts of other liver components. 
In the present study the amounts of glycogen and lipids were not determined. 
It has to be noted, however, that during the preparation of the liver tissue 
of the cold-exposed fishes after centrifugation of the homogenates a white 
fat layer was always observed on the 9000 g supernatant. This layer was 
absent on the 9000 g supematants of liver homogenates from the warmth-
exposed animals. 
In view of the changes observed for the hepatic constituents it seems reason-
able to express the drug-metabolizing capacities in relation to various para-
meters (tables 25 and 26). The livers of cold-exposed animals show signific-
antly higher capacities than those of the warmth-exposed ones. This change 
in drug-metabolizing capacities becomes manifest independent of whether 
they are expressed per unit of liver weight, per amount of protein, per 
amount of DNA, or per unit of body-weight. 
The experiments described above were performed in winter. Repetition of the 
experiments with roach in summer showed a similar effect of the exposure 
to different temperatures on liver composition and hepatic drug-metabolism 
(table 27). 
When the hepatic enzymatic activities of animals (hamster, rat, roach, and 
trout) exposed to different ambient temperatures were assayed at different 
incubation temperatures the enzymatic activities of the warmth-exposed 
animals were consistently lower over the entire temperature range. The 
apparent Km-values for aminopyrine in the N-dcmethylation reaction, assayed 
at 4 temperatures (20, 25, 35, and 40 0C) were found to be unchanged 
after the exposure of the animals to different ambient temperatures. 
VII, 4. THE INFLUENCE OF AN ALTERATION OF THE AQUATIC 
ENVIRONMENT ON HEPATIC DRUG OXIDATION IN THE ROACH 
Roach were caught and kept alive under different conditions. One group 
of fishes was kept in a fishing-boat in a reservoir freely accessible to the 
surrounding river water. Another group was transported to the laboratory 
and maintained for several weeks in tanks in running tap water (600 1/h, 
9 0C). The roach in captivity refused the food offered. 
At different times a sample of the various groups was taken and drug-
metabolizing capacities were determined in vitro. The results of an experi-
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FIGURE 28. Drug-metabolizing capacities of roach in captivity under different 
conditions. Blocks represent the median value of each sample. All values are 
expressed as percentages of a control value, which was the median of freshly caught 
and immediately investigated fishes (at the start of the experiment). •, p-Hydroxyla-
tion of aniline; • .W-demethylation of aminopyrine. a. Roach living in captivity in 
running tap water (9 "С), b. Roach living in captivity in river water (5 "С), c, Roach 
living in captivity in running tap water after a preceding captivity period of 4 weeks 
in river water (Dewaide and Henderson, 1970). 
Note: the drug-metabolizing capacities of roach living in running tap water decrease, 
those of roach living in river water do not decrease. 
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FIGURE 29. Drug-metabolizing capacities of the wild roach in captivity in river water 
and in standing tap water at 5 0C. Blocks represent mean values ± S.D.; the hepatic 
drug-oxidizing capacities are expressed as a percentage of a control value, which was 
the mean of a sample of freshly caught and immediately investigated fishes (at the 
start of the experiment); other fishes were kept for 30 days in river water and sub-
sequently in the laboratory in standing tap water, which was refreshed twice a week; 
number of animals is given in parentheses. Π Enzymatic capacity expressed per g 
fresh liver; • enzymatic capacity expressed per mg hepatic protein; 0 enzymatic 
capacity expressed per mg DNA; Ц enzymatic capacity expressed per 100 g body-
weight. * significantly different from control at Ρ < 0.05 (Wilcoxon two-sided two-
sample test). 
ment lasting from December 1968 to March 1969 are presented in figure 
28. In figure 28a it can be seen that after transfer of the fishes to running 
tap water their drug-metabolizing capacities decreased in 40 days by 50 per 
cent. In the animals kept in captivity in the river water ( ± 5 0C) no clear 
decrease in the drug-metabolizing capacities could be observed even after 
90 days (figure 28b). However, if a group of animals, after a captivity period 
of 4 weeks in river water, was transported to the laboratory and kept for 
40 days in running tap water, then again a decrease in the enzymatic capac­
ities became clear (figure 28c). 
110 
TABLE 28 - Decrease in hepatic drug-metabolizing capacities of roach living in 
running tap water (9 0C) in summer 
per cent remaining capacity 
stay in running tap water 
48 days 63 days 
(n = 10) (n = 8) 
N-demethylation 
of aminopyrine 
a 
b 
с 
d 
p-hydroxylation 
of aniline 
a 
b 
с 
d 
49 ± 
43 ± 
23 ± 
24 ± 
43 ± 
34 ± 
18 ± 
22 ± 
15 
11 
11 
6 
13 
13 
5 
6 
41 ± 
40 ± 
20 ± 
23 ± 
28 ± 
28 ± 
15 ± 
16 ± 
15 
13 
4 
10 
7 
6 
5 
7 
Drug-metabolizing capacity expressed as percentage of the capacity at the time of 
catch (June 1970); mean values with standard deviation; η is number of animals; 
a. capacity related to 1 g fresh liver; b. capacity related to 1 mg hepatic protein; c. ca­
pacity related to 1 mg DNA; d. capacity related to 100 g body-weight 
On the other hand, if a group of roach was kept in the laboratory in standing 
tap water (5 0C), which was refreshed only twice a week no decrease in their 
drug-oxidizing capacities could be observed during a relatively long period. 
Figure 29 shows that the capacities were not reduced by a stay of 30 days in 
the fishing-boat in river water and a subsequent stay of 25 days in standing 
tap water at 5 "C. In this experiment the drug-oxidizing capacities were 
also related to various parameters. The changes in the capacities 110 days 
after catch show no uniform picture (figure 29). It seems to depend chiefly 
upon the parameter in terms of which the capacity is expressed. The situa­
tion of long-lasting starvation presumably causes changes in the amounts 
of the various liver components. 
The phenomenon of the decrease of the drug-metabolizing capacity of roach 
due to a stay in running tap water was not only observed in winter but also in 
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summer (table 28). The observation that the decrease is most strongly pro-
nounced if the enzymatic capacities are expressed in relation to the amount 
of DNA or to the amount of liver normalized to 100 g body-weight, also 
suggest changes in the overall composition of the liver. 
The phenomena described above cannot be explained by reference to the 
difference in the aquatic temperature. The decrease in the drug-oxidizing 
capacity due to the transfer to running tap water becomes manifest both 
in summer, when the fishes are taken from an environmental temperature 
of about 18 0C to a temperature of about 9 °C, and in winter at a transfer 
from about 5 to 9 °C. Under these conditions a transfer to standing tap water 
causes no decrease. Also the nutritional status is of less importance with 
regard to the decrease observed: the animals were starved both in running 
and in standing tap water. The decrease in drug-oxidizing capacity observed 
presumably depends merely upon the continuous refreshment of the water. 
VII, 5. THE INFLUENCE OF XENOBIOTIC AGENTS ON THE DRUG-
METABOLIZING CAPACITY OF FISH 
As far as fishes are concerned no indications are available yet of an influence 
of the exposure to xenobiotic agents on the hepatic processes involved in 
drug metabolism. Buhler and Rasmusson (1968a and 1968b) reported that, 
in contradistinction to mammals, the enzymatic activities in oxidative and 
reductive drug-metabolizing reactions in rainbow trout were not affected by 
starvation, by feeding of diets high in protein or carbohydrate, nor by feeding 
or injecting DDT, chlordane, phénobarbital or phenylbutazone. In the present 
study, too, no changes could be observed in the drug-metabolizing capacity 
of rainbow trout and roach (living in standing tap water at 5 0C; cf. figure 
29) during starvation. However, the other data already presented in this 
chapter (seasonal variation, effects of temperature change and water refresh-
ment) argue against such a general view, i.e. that the drug-metabolizing 
capacity of fish would not depend upon factors in their environment. 
As far as the administration of potentially enzyme-inducing compounds is 
concerned, it was observed in this study that most fish species are more 
sensitive to manipulation than the commonly used mammalian laboratory 
animals. It appeared that treatment with drugs has to be preferentially 
performed by the addition of the substances to the food or to the surrounding 
water, rather than by intramuscular or introperitoneal injections. As far as 
oral treatment is concerned experiments could only be done with hatchery-
reared animals in the present study since wild fishes refused the food offered. 
In an experiment with rainbow trout one group of animals was fed during 
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TABLE 29 - Effect of oral administration of dieldrin and DDT on the drug-metaboliz­
ing capacity of trout liver 
JV-dcmethylation of aminopyrine p-hydroxylation of aniline 
(/«moles formaldehyde produced (/«moles p-aminophenol produced 
per hour per g fresh liver) per hour per g fresh liver) 
control animals 1.0 ± 0.3 (13) 0.27 ± 0.09 (21) 
animals treated 1.6 ± 0.5 (10) 0.34 ± 0.05 (18) 
with dieldrin* ρ < 0.05 ρ < 0.01 
animals treated 1.5 ± 0.4 (12) 0.29 ± 0.08 (10) 
with DDT* ρ < 0.05 N.S. 
* food with and without insecticide was supplied on alternating days; in a period of 
36 days on 18 days 0.25 mg insecticide per 100 g animal per day was given. Statistical 
comparisons were made by using the two-sided two-sample test of Wilcoxon. 
Note: enzymatic capacities of trout livers are significantly increased by a supply of 
insecticides in the food. 
36 days with normal food (Clark's trout pellets obtained from the breeder); 
other groups were fed on alternating days with equal amounts of normal food 
and with this food containing sublethal doses of DDT or dieldrin. The 
control group and the insecticide-treated groups were supplied with the 
same amount of food and all the food offered was seen to be consumed. The 
diet was arranged in such a way that the dose of insecticide consumed at 
each feeding was approximately 0.25 mg insecticide per 100 g body-weight. 
After 36 days (18 treatments) the animals were killed and assayed for drug-
metabolizing enzymatic activity. In this experiment the liver weight, and the 
hepatic protein and DNA contents of the animals were not determined. The 
results of the enzyme assays are given in table 29. The data show that the 
capacity for enzymatic N-demethylation in trout liver is significantly in­
creased in animals supplied with a diet containing dieldrin or DDT. The 
capacity for p-hydroxylation is only significantly increased in dieldrin-treated 
trout. 
In order to investigate whether the high drug-metabolizing capacities in wild 
roach and the changes therein during the various seasons of the year and 
during the stay in running tap water may be related to the presence of 
enzyme-inducing chemicals in the environment, experiments were performed 
in which roach were treated with dieldrin, DDT, and atrazin during the stay 
in running tap water. The treatment was performed by stopping the water 
flow and by adding the pesticide to the water in a dose of 0.1 mg per liter 
of water. After 1 hour the water flow was started up again. In a tank with 
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£ TABLE 30 - The influence of dieldrin on hepatic drug oxidation in the roach 
enzymatic capacity 
JV-demethylation of aminopyrine 
μ moles formaldehyde produced 
per hour 
per 
g fresh liver 
mg liver protein 
mg liver DNA 
100 g body-weight 
p-hydroxylation of aniline 
immoles p-aminophenol produced 
per hour 
per 
g fresh liver 
mg liver protein 
mg liver DNA 
100 g body-weight 
after catch 
untreated animals 
(n = 10) 
5.4 
0.036 
2.4 
11.0 
± 1.3 
± 0.009 
± 0.6 
± 2 . 5 
1.65 ± 0.48 
0.0107 ± 0.0030 
0.73 ± 0.25 
3.30 ± 0.58 
after a stay of 18 days in running tap water 
untreated animals animals exposed to dieldrin* 
(n = 12) (n = 14) 
3.8 
0.026 
1.8 
8.6 
± 0.4 
± 0.007 
± 0.6 
± 2.3 
1.09 ± 0.36 
0.0078 ± 0.0025 
0.55 ± 0.27 
2.50 ± 0.96 
4.8 
0.034 
2.2 
10.5 
± 0.9 
± 0.007 
± 0.6 
± 1.9 
1.54 ± 0.41 
0.0109 ± 0.0030 
0.73 ± 0.27 
3.42 ± 0.95 
Means with standard deviation; η is the number of animals; weight of the animals used was 65 - 90 g. 
* water flow was stopped on 10 days for 1 hour and dieldrin was added to the water in a dose of 0.1 mg of insecticide per liter of 
water. 
Enzymatic capacities of animals exposed to dieldrin are significantly different from those of untreated animals at Ρ < 0.05 (Wil-
coxon two-sided two-sample test). 
control animals the tap water flow was stopped for 1 hour, but no pesticide 
was added. After various administration periods animals were killed and 
assayed for drug-metabolizing enzymatic activity. In control animals, and in 
DDT- and atrazin-treated animals, the decrease in drug-metabolizing enzym-
atic activities was similar to that normally observed in roach staying in 
running tap water. In the dieldrin-treated animals, however, the decrease 
in the drug-metabolizing enzymatic activities was less pronounced. In order 
to check this observation an experiment was performed in which roach were 
treated with dieldrin during their stay in the laboratory. 
Freshly caught (September) roach were transported to the laboratory and 
kept in running tap water. After 4 days of acclimatization of the fishes to 
the laboratory conditions the exposure of the fishes to dieldrin was begun. 
On various days the water flow was stopped for 1 hour and dieldrin was 
added in a dose of 0.1 mg per liter of water. After arrival of the animals in 
the laboratory the scheme of treatment was as follows: 4 days of acclimati-
zation, 5 days of dieldrin treatment, 2 days of rest, 5 days of dieldrin 
treatment, 2 days of rest. Subsequently the fishes were killed and assayed 
for drug-metabolizing enzymatic capacities. The results are presented in table 
30 and show that a significant decrease in the drug-metabolizing capacity 
only occurred in the control animals, but not in the animals exposed to the 
insecticide. 
VII, 6. DISCUSSION 
Changes in drug-metabolizing capacities of fishes 
The results presented in this chapter indicate that the drug-metabolizing 
capacity of fishes depends upon external factors. In the wild roach the 
hepatic drug-oxidizing capacity, which appears to be relatively high as 
compared with that in other fish species studied, varies with the season of 
the year. Highest enzymatic capacities were found during the summer 
months. The decrease in enzymatic capacities in the liver of wild roach kept 
in captivity in running tap water, and the differences caused by the exposure 
of fish to different environmental temperatures and to certain xenobiotics, are 
further evidence of the variability of the level of xenobiotic oxidation in 
fish. 
For a clear view of the changes in drug-metabolizing capacity, it has been 
stressed that differences occur in the ratios of the various liver constituents 
in fishes living under different conditions. The changes in the relative 
amounts of the various liver components of fishes exposed to different aquatic 
temperatures may be taken as an example (figure 27). In connection with 
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the observed changes in liver weight and composition it should be emphasiz-
ed that they are only rough indications of alterations in function. The changes 
can have a multifactorial cause since the liver participates in many metabolic 
processes and functions simultaneously as a store of carbohydrates, and in 
the case of fishes, of lipids also (Mead and Kay ama, 1967). The differences 
in liver composition under different conditions of life may well be caused by 
a change in the synthesis or the mobilization of glycogen and lipids, which are 
used as fuel sources. For instance, an alteration in the level of hepatic 
energy reserves has been shown to occur in fish exposed to different temper-
atures (Dean and Goodnight, 1964). 
In view of the overall changes in the liver of animals under different con-
ditions, in the present study the parameters in relation to which the drug-
metabolizing capacities are expressed were considered to be important. It 
will be obvious, that in the case of changes in the amounts of other hepatic 
components, differences in enzyme concentrations (enzymatic activity ex-
pressed per g tissue) may be evoked or obscured as artefacts. Therefore, in 
the present study the biotransformation rates are not only related to 1 g 
fresh liver, but also expressed per mg hepatic protein, per mg liver DNA, 
and to a parameter in which the overall situation is taken into account, 
viz. the amount of liver corresponding to 100 g body-weight. 
Seasonal variation in hepatic drug metabolism in the roach 
For the seasonal fluctuations in the drug-metabolizing capacity of wild roach 
several factors have to be considered to underlie this phenomenon. 
Seasonal cycles in fishes with changes in metabolic and endocrine activity 
normally occur and seem to depend on external factors such as temperature 
and daylight (Hoar, 1957; Pavlovic, 1968). 
Dietary factors may play a role. Hence, it is possible with respect to the 
drug-metabolizing capacity that the observed seasonal fluctuations are related 
to differences in food intake and therewith to the degree of exposure to 
foreign compounds. The higher biological activity of the fishes during the 
summer months implies more close contact of the animals with the environ-
ment, involving high mobility, an increased consumption of food and a 
higher aquatic respiration through the gills. If this is taken into account 
together with the possible presence of higher concentrations of enzyme-
inducing chemical agents, among which are insecticides, in the river water 
due to a lower water level of the Waal, which is one of the chemically more 
polluted rivers in the Netherlands, an increase in the enzymatic capacities 
in the summer months is understandable. This hypothetical view is partially 
supported by the data plotted in figure 30, which represent some characteris-
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tics of the river water at different times of the year. Periods with low water 
flow (low water level) appear to occur in both summer and winter. In 
general, figure 30 shows that during such periods peaks can be observed for 
the concentration of chemical substances (phenols, Cb) in the river water. 
Additionally, a high B.O.D.5 (Biological Oxygen Demand in 5 days at 20 0C) 
can be observed in summer. The latter parameter is generally used as a 
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FIGURE 30. Drag-metabolizing capacity of the roach and characteristics of the 
river Waal, the main branch of the river Rhine delta flow. 
* The values for the drug-metabolizing capacity of the roach correspond with those 
of figure 26: · · , N-demethylation of aminopyrine; о o, p-hydroxylation 
of aniline. 
Parameters with respect to the river water were kindly furnished by RIZA (Rijks­
instituut voor Zuivering van Afvalwater), Voorburg, the Netherlands. The data con­
cern the water of the Rhine near Lobith. 
Note the peaks for the B.O.D.5 (Biological Oxygen Demand in 5 days at 20 0C), and 
for the concentrations of CI- and phenol in the periods of low water flow (low water 
level). One may assume higher concentrations of chemical substances in the river 
water in these periods. 
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measure of the total amount of oxidizable organic matter. However, data 
about the concentrations of substances which are potential enzyme inducers, 
for instance insecticides and herbicides, are not yet available. The possibil­
ity exists that such substances occur in higher amounts in spring and summer. 
Moreover it seems reasonable to assume that a low water level also has a 
concentrative effect on these pesticides. The absence of an inducing effect 
of the substances during the period of low water level in winter might be 
due to the low biological activity of the roach at low aquatic temperatures 
(Fry, 1957). The suggestion of a higher entrance of xenobiotics into fishes 
during the summer months is supported by the findings of Robinson et al. 
(1967). They showed, in marine fish species from the Eastern Coast of 
Britain (young cods and sand eels), 2 to 3 times higher concentrations of 
organochlorine insecticides (pp'-DDE and dieldrin) in summer than in winter. 
In this connection the experiments of Koeman et al. (1969b), who found a 
higher degree of accumulation of the herbicide diuron (3-(3,4-dichloro-
phenyl)-l,l-dimethylurea) in yearling carp during summer than in winter, are 
also significant. 
Changes in drug-metabolizing capacity due to a different environmental 
temperature 
Temperature differences between summer and winter are not the direct 
cause of the seasonal fluctuations in drug-metabolizing capacity. On the 
contrary, experiments in which various animals were exposed to a different 
ambient temperature showed that, just as happens in the livers of mammals 
(rat and hamster), in the livers of wild roach and hatchery-reared trout 
living at 5 0 C, higher drug-metabolizing capacities are present than in 
animals living at 18 "С. 
As far as metabolism in relation to temperature is concerned, studies are 
generally focused on the metabolic pathways involved with energy supply. 
Both in homeotherms and in poikilotherms it has been observed that 
exposure to low environmental temperatures is followed by an increased 
energy metabolism (Kanungo and Prosser, 1959; Freed, 1965; Hochachka, 
1967; Liu et al. 1969). The increase is seen as a compensatory adjustment of 
metabolism in relation to the ambient temperature. Coincidental to the 
adjustment of energy metabolism quantitative and qualitative changes in the 
components participating in mitochondrial and microsomal electron transport 
systems have been observed (Caldwell, 1969; Aithal et al., 1968). In view 
of these changes a concomitant change in the metabolic pathways involved 
in microsomal drug metabolism, which also requires electron transport, is 
conceivable. 
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From the exposures of animals to different environmental temperatures in 
this study it can be concluded that, in spite of the observed species differences 
in the hepatic metabolism of xenobiotics (chapter VI), in both mammals 
and fishes oxidative biotransformation rates are lowered by increase in the 
environmental temperature. Consequently, thermal pollution of the aquatic 
environment by increase in temperature may injure the drug-oxidizing capac-
ity of water-dwelling animals. 
As far as the influence of a higher aquatic temperature during the summer 
months is concerned, it can be supposed that the enzyme-inducing action 
of chemicals in the polluted environment predominates and masks the 
decreasing effect of the higher environmental temperature. This may be the 
case, since it has been found for the rat that chemical treatment and temper-
ature stress produce their changes in drug-metabolizing enzymatic activities 
through different mechanisms (Stitzel and Furner, 1967; Furner and Stitzel, 
1968). 
Influence of an alteration in the aquatic environment 
An indirect indication that not temperature differences but other factors 
are responsible for the seasonal fluctuations in drug-metabolizing capacity 
of the wild roach has been obtained from the experiments in which animals 
were kept in the laboratory in running tap water. It has been observed that 
during this stay both in summer, when the animals were transferred from an 
environmental temperature of about 18 CC to the laboratory water of 9 0C, 
and in winter from about 5 to 9 °C, the drug-metabolizing capacities decreas-
ed by 50 per cent. The influence of the deprivation of food during the 
captivity period is likely of minor importance for this decrease, since starva-
vation was also involved in the experiments in which the animals were kept in 
river water or in standing tap water. In spite of starvation, even after a 
relatively long captivity period (3 to 4 months), no significant decrease in the 
drug-metabolizing capacity was observed. 
An explanation for the decrease in the drug-metabolizing capacities to a 
low level in roach living in running tap water may be a termination of the 
exposure to inducing agents, presumably present in the chemically polluted 
river water. After removal of the animals from the river to the laboratory 
the foreign compounds may be removed from the body during the stay in 
clean, continuously running, tap water. 
It has to be noted further that, in the liver of the rainbow trout, no changes 
in the drug-metabolizing capacity were found under the influence of starv-
ation, season and removal from the presumably non-polluted hatchery water 
to the laboratory water. 
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Influence of exposure to xenobiotics 
As far as the influence of xenobiotic agents on the drug-metabolizing capac-
ity in fish is concerned, in the present study the exposure of trout and roach 
to enzyme-inducing compounds was not performed with a sufficiently wide 
variety of substances and dosage schedules to allow general conclusions to 
be reached. The experiments performed with rainbow trout and roach show 
that a slight increase in the hepatic N-dealkylating and aromatic hydroxylat-
ing capacities can be produced by exposure of the animals to the insecticides 
dieldrin and DDT, which are well-known inducers of drug metabolism in 
mammals. From this observation the expectation seems to be justified that 
further studies may show that the influence of xenobiotic compounds on the 
drug-metabolizing capacity of fishes and mammals will be much the same. 
The experiments which show that the hepatic drug-metabolizing capacity, 
which decreases in the wild roach living in running tap water, remains on a 
high level when the animals are chronically exposed to an insecticide, agree 
with the idea that the high level of the drug-metabolizing capacities of wild 
fishes, at least in part, may depend on the presence of certain — as yet 
unknown — enzyme-inducing agents in their polluted environment. 
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CHAPTER VIH 
AN A P P R O A C H T O E N V I R O N M E N T A L 
P H A R M A C O K I N E T I C S 
ПІ, 1. KINETICS OF CHEMICAL POLLUTANTS IN THE BIOSPHERE 
The study of pharmacokinetics includes in a broad sense all the investigations 
directed to all aspects of the distribution of xenobiotic substances in systems 
consisting of interrelated compartments. Emphasis is placed upon the 
concentration-time relationships. As has been discussed in chapter I, the 
studies on the distribution of xenobiotic substances in human and animal 
bodies are indicated by the term individual pharmacokinetics, whereas studies 
dealing with the concentration-time relationships of chemical pollutants in 
the various parts of the biosphere are described by the term environmental 
pharmacokinetics. Both the biological objects and the biosphere can be 
considered as multicompartment systems, in which a multiplicity of factors 
and processes is present in a state of dynamic equilibrium. For a visualization 
of the kinetics of xenobiotic substances in the biological systems studied in 
individual pharmacokinetics, mathematical models are constructed which 
more easily permit an interpretation of the time-dependent nature of the 
various phenomena involved. In these formulations the events in the compart­
ments are defined as mathematical entities. Thus, the word compartment is not 
only applied in order to indicate anatomically and physiologically well-defined 
parts of the body such as the vascular system, and the various organs and 
tissues, but refers also to constituents which are present in a more diffuse 
distribution in the biological object. Here can be mentioned the various body 
fluids, and the components (blood cells, proteins, and lipids), which are able 
to bind certain drug molecules. In all of these cases, the quantitative aspects 
of the interaction of a drug with a body constituent can be represented by a 
mathematical expression. Analogous to the procedures employed in individual 
pharmacokinetics, one may attempt in environmental pharmacokinetics to 
divide the biosphere into compartments, viz. atmosphere, soil, water, and bio-
mass (figure 1), which in turn can be subdivided. 
According to the classification of compartment systems of Rescigno and 
Segre (1966) one can say that the biosphere belongs to the class of strongly 
connected compartment systems, since a chemical substance can in principle 
reach the various compartments from the initial compartment into which it is 
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introduced, and subsequently it remains possible to reach every other com­
partment from any compartment. For substances which are eliminated by 
processes of physicochemical and biological transformation the compartment 
system can be called open, for substances which cannot leave the biosphere 
the compartment system can be defined as a dosed system. In a study on 
environmental pharmacokinetics it will hardly be possible to reckon with 
all the phenomena involved: every compartment or process which is taken 
into consideration may be subdivided on closer inspection into many more 
compartments or processes. Therefore, it has to be stressed that the 
mathematical expressions used in this study represent rather simplified 
descriptions of the real situations. However, it is an empirical finding of 
other fields of study in which mathematical models are applied (hydro­
dynamics, electronics, aeronautics, individual pharmacokinetics), that 
simplified models can simulate surprisingly well the major attributes of the 
real system and offer insight into the dominant forces operating in it. Since 
it is evident that certain processes are dominant whereas others may contrib­
ute to a much smaller degree, it seems reasonable to attempt to compile the 
main processes in simple mathematical formulations. Prior to initiating a 
mathematical consideration of the fate of chemical pollutants in the biosphere 
it will be informative to go briefly into some of the more important aspects 
of chemical contamination. 
Ш, 2. SOME GENERAL ASPECTS OF CHEMICAL POLLUTION 
The chemical substances involved in environmental pollution can be divided 
into various categories. Table 31 represents a division on the basis of the 
susceptibility of the pollutants to biodégradation. The categories I and II 
include the pollutants that can be utilized as nutrients by organisms, 
especially microorganisms. These categories are predominantly made up of 
substances that arc already naturally occurring: the compounds and minerals 
which are ordinary constituents of organic matter. For example, large 
amounts of organic material arc introduced into the environment as 
domestic sewage, and as wastes from agriculture and food-processing 
industry. The presence of organisms in nature which are capable of breaking 
down the organic materials can, in principle, limit this kind of pollution. 
Thus, the introduction of organic matter is no real problem so long as 
ecosystems are not overloaded. If overloading occurs with respect to organic 
compounds and minerals utilized by only a few species of organisms, the 
artificial eutrophication will create several problems: e.g. an excessive increase 
in the number of adaptive organisms may eventually inhibit — or completely 
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TABLE 31 - Categories of chemical pollutants 
Susceptibility 
to 
biodégradation 
I 
highly 
susceptible 
II 
moderately 
susceptible 
HI 
poorly 
susceptible 
IV 
not 
susceptible 
NON-TOXIC 
elimination rate 
environmentai 
pollution** 
harmful 
side-effect 
high 
low 
eutrophicationt 
moderate 
moderate 
low 
high 
nil 
unlimited 
TOXIC* 
elimination rate 
environmental 
pollution** 
harmful 
side-effect 
moderate 
moderate 
enhanced 
accumulation of 
other pollutants 
delayed 
progressive 
progressive 
accumulation of 
other pollutants 
strongly 
delayed 
strongly 
progressive 
unlimited 
strongly progessive unlimited 
accumulation of accumulation of 
other pollutants other pollutants 
to 
* potential damage to the biodégradation system 
** accumulation at continual disposal 
t excessive increase in the number of organisms utilizing the pollutants as nutrients 
abolish — other fonns of life (especially aerobic organisms). In the approach 
to environmental pharmacokinetics which will be developed in this chapter, 
the problems related to artificial eutrophication will not be considered. 
The categories III and IV are largely made up of the poisons and chemicals 
that are not normally present in nature, but are synthesized and introduced 
by man. The diversity in this class of substances is great. Substances that 
can be easily broken down and utilized by organisms belong in principle 
to categorie^! and II. Generally speaking, however, most of the synthetic 
compounds, Tor instance many pesticides, detergents, lubricants, food-addit-
ives, and plastics, are rather resistent to biodégradation. Therefore, the risk 
of accumulation of these kinds of pollutants, which are being continuously 
introduced into nature, is great. This risk is still greater for substances that 
can damage the biodégradation processes: such substances can progressively 
accumulate and enhance the accumulation of other pollutants. In view of 
this, the substances which can damage biodégradation have to be considered 
as the most dangerous ones. 
VIII, 3. THE FATE OF CHEMICAL POLLUTANTS IN ECOSYSTEMS 
For an understanding of the kinetics of chemical pollutants in the biosphere, 
the fate of the substances in ecosystems can be taken as a model. Ecosystems 
represent basic functional units in nature, including balanced populations of 
organisms and the nonliving environment, each influencing the properties of 
the other and both necessary for maintenance of life. An ecosystem taken 
as a multicompartment system, differs only from the biosphere in that an 
ecosystem is always open: a pollutant can move in principle from one eco-
system to another. 
In the following discussion no emphasis is put upon differences in pharma-
cokinetics between the various types of ecosystems on the earth due to 
structural and functional variations in these sy^fems. Attention is only 
directed towards factors which play a determining role with regard to the 
concentration-time relationship of the chemical pollutants in ecosystems in 
general. 
After introduction of a dose (ΟΛΌ;) of a pollutant into an ecosystem, the 
fate of the compound can be represented by the very simplified scheme 
shown in figure 31. 
From a kinetic point of view, when a given substance is introduced into an 
ecosystem that substance will enter one of the main compartments of the 
system, viz. air, soil, water, or organisms, and then be distributed to the 
other compartments and to their various parts. Later the substance may be 
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eliminated The elimination may proceed by migration of the pollutant to 
another ecosystem, by sequestration occurring when the substance is irre-
versibly bound to constituents of the ecosystem, by physicochemical disinte-
gration, and by biodégradation. Migration of the chemical compounds to 
various ecosystems is important for the actual concentrations reached in 
the respective ecosystems, but not strictly for the total amount of pollutants 
present in the biosphere. Practically, however, the exchange between eco-
systems will have an effective influence on the total amount of a substance 
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FIGURE 31. Schematic rspresentation of some processes which determine the con­
centration-time relationships in environmental pharmacokinetics Qj-(0) represents 
the dose of a chemical pollutant introduced into an ecosystem Arrows indicate 
possible flows of the compound in the ecosystem The introduction site compartment 
or initial compartment (I) can be the atmosphere, water, or soil The pollutant can 
exchange between these areas It can also be taken up by compartment O, which 
represents the biomass (all organisms) in the ecosystem The pollutant can reach the 
environmental compartments from compartment О when the substance is excreted 
chemically unchanged from the organisms, or when organisms decompose after death. 
In various compartments the pollutant can be reversibly bound to components of the 
ecosystem compartment В Compartment В functions as a depot. The pollutant can 
be eliminated from the ecosystem 1) by migration into another ecosystem (dose 
Qxdp 2 ) by physicochemical disintegration (Dp), which can occur in all compartments, 
3) by biological degradation (D,,), which can be performed by the various organisms 
living in the ecosystem, and 4) by sequestration (S), which implies irreversible binding 
of the pollutant to components of the ecosystem. 
in the biosphere in the cases where the pollutant migrates into systems 
with different capacities of sequestration or biological degradation. The 
processes which effectively decrease the concentration of pollutants m 
the biosphere, viz. sequestration, physicochemical disintegration, and bio-
degradation, will be summarized as purification. Biodegradation plays a 
major role among the processes of purification. The breakdown of chem­
ical pollutants in soil and water is mainly performed by microorganisms. 
This phenomenon is generally indicated with the term biological self-
purification. 
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Vili, 3.1 Some aspects of biological self-purification 
In a brief discussion of some aspects involved in biological self-purification 
it seems valid to take as examples ecosystems with a high biodégradation 
capacity. As such the ecosystems artificially developed for the purification 
of sewage water may be used. The use of such a concrete model system may 
have the advantage that the present approach can be more accurately evalu-
ated. Further it opens the possibility to control experimentally the math;-
matical expressions derived, since the biological systems operating in sewage 
purification stations lend themselves to studies on a small scale in the 
laboratory. 
Most of the modern sewage purification stations make use of the activated 
sludge procedure. This procedure is based upon aerobic degradation of the 
substances in the sewage water which is performed by various populations 
of bacteria. The contact between microorganisms, dissolved oxygen and 
substrates is intensified by dispersing the bacteria through the sewage water 
s into which air is being continuously dissolved. The sewage water flows 
into a tank — fitted with means for agitation and aeration — at such a 
rate that its retention time is long enough to achieve the desired strate of 
oxidation. 
Many of the chemical pollutants which are degraded by bacteria have a 
nutritive function for the organisms. Therefore, a growth of the bacterial 
population will result. 
The disappearance of chemical pollutants from soil and water is dependent 
upon the number of bacteria capable of degrading the substances and will 
be therefore directly related to the growth of the bacterial population. For 
the kinetics of growth of microbial populations the review of Painter and 
Marr (1968) may be referred to. In the discussion presented here only phases 
generally observed in the growth of bacterial populations will be taken into 
consideration. Generally the rate of bacterial population growth may be 
roughly divided into the phases described by Monod (1949): 
1) Lag phase (initial stationary phase) 
2) Exponential growth phase (logarithmic growth phase) 
3) Stationary phase (maximum stationary phase) 
4) Exponential death phase (logarithmic death phase). 
Figure 32 gives a graphical representation of the various phases mentioned. 
With regard to the capacity of biological self-purification processes it seems 
adequate to differentiate between a constant biological self-purification 
capacity, when the number of organisms involved remains constant, an 
expanding biological self-purification capacity, when the population of 
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organisms is growing, and a decreasing biological self-purification capacity, 
when the number of organisms involved is decreasing. 
In considering the events in sewage purification plants it seems reasonable 
to assume a steady state situation. The average composition of the sewage 
water will be nearly constant if it is considered over the time periods of 
weeks or months. Within these periods fluctuations in the sewage composition 
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FIGURE 32. Phases of growth of microbial populations (generalized curve). Only 4 
phases are considered here: 1, Lag phase; 2, Experimental growth phase; 3, Stationary 
phase; 4, Exponential death phase. The transition between two subsequent phases is 
not abrupt. These transitions will not be discussed. 
can occur under the influence of daily different disposal of domestic and/or 
industrial materials and by environmental factors such as temperature and 
light. The steady state in the purification stations can be disturbed by 
accidental disposal of substances which do not normally occur in the sewage 
water. Changes in the size of the bacterial population are controlled by 
measurement of the amount of the activated sludge. On the basis of these 
measurements the number of bacteria which increases in the normal situation, 
is kept roughly constant by proper dilution of the activated sludge at regular 
times. 
Ш, 4. MATHEMATICAL MODELS IN ENVIRONMENTAL 
PHARMACOKINETICS 
The mathematical models presented here are based on the factors which have 
been indicated above as playing a primary role in the kinetics of chemical 
pollutants in ecosystems. First of all attention will be directed to the con­
centration-time course of a pollutant introduced into an ecosystem in a single 
dose. This can be easily imagined to occur in practice in the case of acci­
dental pollution. Later on the kinetics of pollutants will be considered at a 
constant rate of introduction. This may represent the case in which pollutants 
are continuously disposed of as industrial or domestic sewage. 
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TABLE 32 - Symbols employed in environmental pharmacokinetics 
symbols description 
example of units 
(dimensions) 
С 
CX(0)' Cx(t) 
ко 
L 
Q 
Qj(o)y Qx(t) 
r
elo 
r
clt>(o)'' rr!4(t) 
r
el\(a)' reh(t) 
'ir» 'a 
t 
tVi 
τ 
ν-,ν, 
ν 
r
ma£ 
v
mux(o) 
concentration 
concentration of X at time o; time t 
rate constant in zero-order kinetics 
purification rate constant in 
first-order kinetics 
concentration oîXa.t]/2
 тах 
concentration at which the purification 
capacity is 50% destroyed (LD50) 
quantity 
quantity of X at time o; time t 
elimination rate constant in zero-order 
kinetics 
r i7() at time o; time / (changing 
elimination capacity) 
elimination rate constant in 
first-order kinetics 
г1.ц at time o; time t (changing 
elimination capacity) 
growth and death rate constants 
(exponentially expanding and decreasing 
purification capacity) 
time 
half-life time (first-order elimination) 
time constant for first-order elimination 
volume; fictive volume 
maximal velocity of pollutant 
degradation 
v
»mi initially present (changing 
degradation capacity) 
mg.H; ^g.ml-1; M 
mg.h-1; moles.h-1; 
//g.min-1 
l.h-'; ml.min-1 
mg.H; ftg.ml-1; M 
mg.H; .Mg.mH; M 
mg; «g; moles 
mg.H .h-1; 
moles.H.h-'; 
¿(g.mH.min-1 
h-1; min-1 
h-1; min-1 
h; min 
I; ml 
mg.h-1; moles.h-1; 
.tig.min-1 
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It has already been pointed out that the concentration-time course of a 
pollutant in an ecosystem depends upon the rates of introduction and eli-
mination. The kinetics of the processes leading to elimination of the pollu-
tants will receive primary attention. 
As far as the distribution of pollutants over the receiving systems is concern-
ed, the binding of the substances to components of the system and the 
consequences thereof with regard to the volume of distribution will be 
concisely considered. 
Finally the factors mentioned above will be discussed in relation to the 
phenomenon of accumulation. 
For reasons of simplicity the mathematical models constructed will be 
mainly based upon the one-compartment model for which it is postulated 
that the amount of pollutant is completely and rapidly distributed through 
the total equilibrated volumes of distribution. This may be the case, for 
instance, for most of the substances in sewage purification plants. The 
symbols used to construct the mathematical formulations in this approach 
to environmental pharmacokinetics are listed in table 32. 
VIII, 4.1. Kinetics of elimination 
In view of the importance of biodégradation, the influence of this process on 
the kinetics of chemical pollutants in ecosystems will receive primary 
attention. 
The kinetics of biodégradation can be considered by analogy with the kinetics 
for enzymatic reactions. Substitution of biodégradation kinetics into the 
Michaelis-Menten equation (according to which the velocity of enzymatic 
transformation of the substrate depends on the concentration of the sub-
strate) gives 
dQx/dt = -Vmax Cx/(kx + Cx) (1) 
where dQ\/dt is the amount of pollutant X disappearing per unit time (initial 
velocity), CT the concentration of poUutant X, vmnT the maximal velocity of 
degradation and kx corresponds to the Michaelis constant and is numerically 
equal to the concentration of pollutant X at l^vmax. For kx » C·, that 
is when the concentration of pollutant X is far below of saturating the 
degrading system, the expression Cx/(L· + Cx) can be approximated by 
Cx/kx and consequently, the degradation process can be regarded as being 
first order. 
Once the degrading system is saturated by the pollutant ( С т » Л х ) the 
degradation will proceed at a constant rate. The process can be approximated 
by -dQx/dt = ν,ηαχ and consequently will become zero order. 
129 
In the discussion above a degrading system with constant capacity is assum-
ed. When the capacity is changing, such as for example, when the pollutant 
induces or inhibits the growth of the bacterial population involved in the 
breakdown, the kinetics of elimination will become more complex. 
Various possibilities in the kinetics of elimination will be considered in more 
detail during the following discussion. 
VIII, 4.1.1. First-order kinetics of elimination 
It is assumed that a pollutant enters an ecosystem in a single, low dose 
(Qs(o))- Further it is assumed that the concentration of the pollutant is far 
from saturating the degrading system and that the capacity of the system 
involved stays constant. This situation may be true if the breakdown is a 
metabolic process performed by higher organisms in the ecosystem. The 
same situation can be imagined when microorganisms are involved, provided 
that their number is not changing, for example in the stationary phases 1 and 
3 presented in figure 32, and also in the exponential phase 2 if a proper 
continuous dilution of the bacterial population takes place (cf. sewage purif-
ication plants). Far below saturation the degradation process can be called 
supply-limited (cf. Riggs, 1963), which means that the rate of breakdown 
is limited by the dose Qxi,,) and not by the capacity of the process itself. 
In this situation, a fixed percentage of the amount of pollutant X is destroyed 
per unit time regardless of the concentration of X. 
In the situation assumed above the number of molecules eliminated per unit 
time is directly proportional to the concentration at each moment. The 
elimination process corresponds to first-order kinetics which can be math-
ematically described as 
dQx/dt = - k^x (2) 
where ßj- is the quantity of pollutant X present in the ecosystem (mg or 
mole), ki the purification rate constant for first-order elimination (l.h.1, 
ml.min1), corresponding to that part of the system completely purified in 
one unit time, and CT the concentration of the compound (mg.!1, 
Mg.ml"1, M). 
Cr is equal to the amount of pollutant (Qx) divided by the apparent volume 
(V in 1; its significance will be discussed in section VIII, 4. 3) of the compart-
ment over which it is distributed. 
Accordingly 
dCtIC* = - (kJV)dt (3) 
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For kJV the elimination rate constant г,,ц (h-1, min-1) will be used, reii 
represents the rate at which the concentration of a pollutant A' in a compart­
ment decreases; it represents the percentual decrease of the concentration per 
unit time. 
Integration of equation (3) leads to the exponential expression 
Cx(t) = C
x
(o)e*ebt (4) 
where: Cx<t) is the concentration of pollutant X at time t, CX(U) the con­
centration of pollutant X initially present, and /v/, the elimination rate 
constant. In individual pharmacokinetics г
е
ц is substituted by r 1 . τ is the 
time constant for the elimination process. 
Accordingly equation (4) can also be written as 
Cx(t) =С
Х
(о)е~11г (4a) 
A theoretical concentration-time curve for a pollutant X, which is degraded 
in the ecosystem (E) of a sewage purification plant with the assumptions 
made above, is graphically represented in figure 33 a. According to equation 
(4), a straight line is obtained when the logarithms of the concentrations 
of the pollutant in the sewage water of the plant are plotted against time 
(figure 33b). 
The time constant (τ) determines the rate of the elimination process. 
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FIGURE 33. Theoretical concentration-time curves representing first-order kinetics 
of elimination (Df,)· a · Exponential decline in the concentration of a chemical pollu­
tant in the sewage water (SW). The decline is represented in a linear diagram accord­
ing to the scheme of a one-compartment open system, b, The logarithm of the con­
centration of the pollutant in the sewage water declines linearly with time. 
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Usually the rate of a first-order reaction is represented by the half-life time 
of the compound involved (iH)· The constant t]/2 corresponds to the 
length of time needed for the concentration to become 50% of its original 
value, τ and r
e
n are related with t]^ according to 
ty2 = 0.693 χ τ = 0.693/rw, or т = l/r,„ = 1.44 χ г ^ (5) 
It is obvious that the half-life time of a pollutant is the important parameter 
in elimination. In situations where the concentration of a pollutant can be 
measured (for example, in the water of sewage purification plants or lakes), 
and curves are found corresponding to those of figure 33, t ^ , and there­
with, τ and г,,ц can easily be calculated, dr,,) can be found as the intercept 
of the curve with the ordinate of the log concentration-tims plot. 
The discussion presented above concerns the kinetics of pollutants subjected 
to a supply-limited process of biodégradation with constant purification capa-
city. However, the parameters tl/2, τ and / л as such, do not give information 
about the mechanism of disappearance. It has to be realized that a similar 
picture can be observed when only physicochemical disintegration of the 
pollutants is involved, which also implies, first-order kinetics (cf. the decay 
of radioactive isotopes). 
A picture of first-order elimination can also be observed if the pollutants 
are not broken down. This may be the case in a sewage purification station 
when a pollutant is introduced into, transported through, and removed from 
the system with the effluent without being chemically changed. It will be 
clear that in that case the time constant represents the retention time of 
the sewage water (containing the pollutant) in the purification station. A 
sewage purification station can be considered, therefore, to operate in an 
effective way only if the retention time of the pollutants in the station is 
greater than the time constant for the purification process. 
When the pollutants in a sewage purification plant are partly subjected to 
first-order biodégradation, partly to physicochemical disintegration, and 
partly removed unchanged from the plant, the elimination rate constant found 
will be the sum of the elimination rate constants of the respective processes 
involved. 
VIII, 4. 1.2. Zero-order kinetics of elimination 
When a pollutant comes into a biodégradation system with a constant 
purification capacity in a concentration high enough to saturate this system, 
the process involved will become capacity-limited (cf. Riggs, 1963). The 
velocity of degradation will be maximal, which implies that a constant 
132 
quantity of pollutant X is destroyed per unit time. The process of elimination 
then corresponds to zero-order kinetics. It can be described by 
dQ
x
/dt = -k0OT dCzjdt = -ко/V = -/>,„ (6) 
where Q
x
 is the quantity of pollutant X present in the ecosystem (mg, ^g, 
or mole), V the apparent volume of the ecosystem (1) (cf. section VIII, 4.3), 
Cx the concentration of the compound (mg.l·1, /(g.ml"1, M) к0 the purification 
rate constant for zero-order elimination (mg.h1, moles.tr1, ^g-min1), and 
гн» the elimination rate constant for zero-order kinetics (mg.l 1.Ьг1, moles.l·1. 
h 1 , ."g.mH.mhr1). One must realize well that the dimensions of the purific­
ation and elimination rate constants are different for zero-order and first-
order kinetics. 
Integration of equation (6) and solution for Cx(t) gives 
C
x
(t) = C
x
(o) [1 - (relo/C
x
(o))t] (7) 
According to equation (7), a straight line will be obtained when the con­
centrations are plotted against time. 
When the concentration of the pollutant decreases so strongly that a level 
far below saturation of the degrading system is reached, then the capacity-
limited situation transforms into a supply-limited situation, in which an 
exponential decline (equation (4)) will be observed. 
VIII, 4.1.3. Kinetics of elimination in systems with changing capacity of 
elimination 
In this section kinetics of elimination will be considered for ecosystems of 
which the capacity to eliminate pollutants is changing during the elimination 
process (expanding or decreasing purification capacity). Processes of elimi­
nation in which microorganisms are involved may examplify this. It has 
already been discussed that in bacterial populations (cf. figure 32, phases 2 
and 4) exponential growth and death phases can be observed. As long as 
net change (i.e., the difference between births and deaths) per unit of popula­
tion and per unit of time is constant, the population will change exponen­
tially. 
It is assumed that the net rate of growth per unit of population is constant: 
dN/dt = r
e
N(t) (8) 
where N is the number of bacteria in the population, and rg the growth rate 
constant. 
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In the analogous situation when death exceeds birth 
dN/dt = - rdN(t) (8a) 
where ra is the death rate constant. 
Integration of the equations (8) and (8a) and solution for N(t) gives 
N(t) = Ν(0)€τ<>* ( 9 ) 
and Nay = N(o)e-r<it (9a) 
If it is assumed that the elimination of pollutants from ecosystems depends 
on biodégradation by bacteria, then the rate of elimination (rP/) will depend 
on the number of bacteria present. If the number of bacteria is changing 
according to equations (9) and (9a), then r,,i will correspondingly change. 
In the case of growth (an expanding purification capacity): 
rem = г
е
1(0)ет* (10) 
In the case of death (a decreasing purification capacity): 
rm) = r
eV0)e-T^ (10a) 
If one considers an elimination process which is supply-limited, then, in the 
case of exponentially expanding purification capacity, equations (3) (with for 
ki/V = rei,) and (10) have to be combined: 
аС
х
/аі = -г
еЫо)е
т
«
{
С
х
 ( И ) 
Integration of equation (11) and solution for Cx<t) gives 
CX(t) = CxMe -(»-«ι W , ) (e'o' - 1) (12) 
In the analogous situation of exponentially decreasing purification capacity 
combination of equation (3) and (10a) gives as a mathematical expression 
C*i) = CX(0)e (rebM/rd) (e-rdt . \) (12a) 
If one considers an elimination process which is capacity-limited, then, in the 
case of exponentially expanding purification capacity, equations (6) and (10) 
have to be combined: 
dC
x
/dt = - г
е
щ0)е
т<>* (13) 
Integration of equation (13) and solution for Cx(t) gives 
Cm = C
xM - (теЩо}/тя) (e'o' - 1) (14) 
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In the analogous situation of exponentially decreasing purification capacity 
equations (6) and (10a) have to be combined. The situation can be represent-
ed by the mathematical expression 
CX(t) = Ctfoj + (rcWo,/rd) (e-'*1 - 1) (14a) 
It will be evident that capacity-limited biodégradation processes (math-
ematical formulations (14) and (14a)) will become supply-limited when the 
concentration of the pollutant decreases far below the saturation level of the 
degrading system. Then, equations (12) or (12a) respectively, can be used 
for a mathematical description of the elimination process. It has to be noted, 
however, that the purification capacity of an ecosystem will preferentially 
expand at conditions of a good supply of nutrients. It can be expected, there-
fore, that in the case of an exponential growth of the degradation system 
caused by the pollutant (nutrient) itself, the kinetics of elimination will more 
probably occur according to equation (14) (a high saturating concentration of 
nutrient) rather than according to equation (12) (a low unsaturating concen-
tration of nutrient). 
Theoretical concentration-time curves calculated on the basis of equations 
(12) and (14) are graphically represented in figure 38. 
VIII, 4.2. Riversible and irreversible binding 
The amount of pollutant reversibly bound to components of an ecosystem 
can be considered to function as a depot. The substance remains available 
to processes of elimination. The amount of pollutant which is irreversibly 
bound to other substances present in an ecosystem and sequestered thus in a 
harmless form, can be considered as having been eliminated from the 
system. 
The kinetics of the binding processes involving adsorption to the material 
of the receiving systems can be described according to the adsorption iso-
therms of Freundlich or Langmuir. The kinetics of binding will not be dis-
cussed here. 
It has to be noted that binding of pollutants has a significance with regard 
to the volume of distribution and therefore ultimately to the kinetics of 
elimination. 
ПІ, 4.3. Distribution volume and fictive distribution volume 
If the dose (Qx(o)) administered to a compartment system is known, after 
determination of the initial concentration (Cx(oj) the distribution volume (F) 
can be calculated: 
V = QX(OJ/CZM (15) 
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In a sewage purification plant the distribution volume may be the volume 
of water, or the volume of water plus one or more of the other constituents 
of the purification system. As such can be mentioned pollutant-adsorbing 
solid particles or activated sludge. When the substance is uniformly distribut­
ed over all of the components of the system (a similar partition coefficient), 
the value found for V from equation (15), where C^oj is the concentration 
in the water, resembles the virtual volume of the sewage purification system. 
This will not be the case, however, if the pollutant is unequally distributed 
over the various components. Solid particles or biological material may have 
different affinities for the pollutant chemicals and variations in exchange 
rate may govern the distribution process. If excessive binding of pollutants to 
constituents of the sewage plant occurs, the concentration found in the sewage 
water will be relative low so that on the basis of equation (15) a relatively 
extensive distribution volume will be found. Therefore, it seems to be more 
adequate to introduce the term fictive or apparent distribution volume. It 
will be clear that, in the case of excessive binding of the pollutant to the 
microorganisms present, changes in the number of organisms will be 
reflected in the value found for the fictive distribution volume. 
ІП, 4.4. Kinetics of accumulation 
Accumulation of chemical pollutants in ecosystems will occur when the rate 
of introduction is higher than the rate of elimination. Considering an eco­
system as an open one-compartment system into which a pollutant is intro­
duced in a continuous flow, whereas the elimination of the pollutant from 
the system proceeds according to first-order kinetics, one can suppose that 
the amount of pollutant in that system will increase until it reaches a plateau. 
Such a plateau occurs at the time that the rate of introduction equals the 
rate of output. 
In the following mathematical descriptions of the kinetics of accumulation 
it is assumed that the main route of elimination of pollutants from an eco­
system is by means of biodégradation. The possibility of an expanding 
purification capacity will not be taken into consideration. This seems reason-
able in a first approach of the accumulation phenomenon, since a certain 
limitation in the purification capacity is required in order to produce the 
phenomenon. 
When a pollutant is introduced with a constant introduction rate (k0) into 
a compartment with a fictive volume (V/), whereas the concentration (Cr) 
of the pollutant in the system is decreased by biodégradation, the change in 
the concentration of pollutant per unit time (dCr/dt) can be described by 
dCz/dt — [k0 - VmaxCx/(kx + C,)] (1/Vf) (16) 
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where (
 тах
Сі)/(к* + CJ·) is equation (1); шях is the maximal velocity of 
degradation, and k
x
 the concentration at ^ν,,,αχ. 
When the plateau in the accumulation phenomenon is reached, dCx/dt = 0. 
The plateau concentration Cspi can be represented by 
Cxpl ^ kokx/(Vmax ~ ko) 
It has already been discussed in this chapter (section VIII, 4.1) that, 
dependent on the concentration (Cx), the kinetics of elimination will be of 
first- or zero-order. For С s « k
x
, equation (16) can be approximated to 
dC
x
/dt = (k0 - vmax Cx/kxXl/V,) (16a) 
For Cx » kj-, equation (16) can be approximated to 
dC
x
/dt = (k
a
 - VwXl/Vf) (16b) 
It can be expected that during the accumulation process at increase of Cx 
the kinetics of elimination will pass from first-order to zero-order. When 
the elimination process proceeds according to first-order kinetics, that is 
when k0 is so low (ko « ,„иг) that the concentration remains far from 
saturating the degrading system, a plateau will be reached at 
Cxpi = kokx/v
mttX 
When the process is transformed to zero-order kinetics a plateau will only be 
reached when „
ШІ
 = k„. When ko > vmax a plateau will never be reached 
and the increase in d will continue. 
It will be obvious that pollutants which can damage the degrading system 
— substances that decrease v
max
 — may prevent the occurrence of a plateau. 
The situation where a degrading system is damaged can be simplified by 
assuming the degrading system composed of a number of units (N). It is 
assumed that the velocity of degradation is proportional to the fraction of 
(N) involved. So it can be assumed that when all units (N„
m
.r) are involved 
in the degradation process, the breakdown proceeds at maximal velocity 
(ν,,,αχ). The situation where a pollutant damages Nmax can be described as 
AW = N
m
ax<o,Cx/(L + Cx) (17) 
where Nmax(o) is the initial amount of Nmax; and L the concentration of X 
where 50% of N
mn
x(„) is destroyed. 
At any concentration the remaining amount of N is (Ы„
Ш
х(о) - AN). 
Consequently 
N
m
ai(o) - Δ Ν = Nmax(o) - [N
m
ax(o)Cx/(L + Cx)] = Nmax(o)L/(L + Cx) 
(18) 
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Thus, assuming N
maT(„) = vmaj-(o) (where vmax<o) is the initial undamaged 
ν,ηαχ), in the cases where a pollutant damages vmax, the vmax in equation (16) 
can be written as (v
m
ax(
a
)L)l(L + C
x
). Therefore equation (16) can be 
written as 
<iC,/A = [ko - v
mttxMCxL/(L· + Cx)(L + Cx)] d/V,) (19) 
The differential equation (19) can be solved. However, the equation for the 
solution for Ci(t) is implicit, and gives no further insight in the kinetics of the 
process. 
Information about the course of the function Cx = f(ko, vmax, kx, L) can be 
obtained from the situation where dC
x
/dt = 0. For dC
x
/di = 0 equation 
(19) gives the quadratic equation 
Cxpl = - У
г
 (kx + L- Vmax(o)Lfko) ± ]/2 Vikx + L - тах(о)Ъ/к
а
)- - 4 kxL 
(19a) 
Real solutions (real values for which a plateau can be obtained) can be found 
for 
{k* + L - VmaxML/ktf > 4 kxL (19b) 
FIGURE 34. Kinetics of accumulation of pollutants in a one-compartment open system 
according to equation (19) at condition (19c). The pollutants (AT) are introduced at con­
stant rates. Elimination is performed by biodégradation. Arrows indicate the end of 
the introduction of the pollutants. Figures a and b represent accumulation curves for 
pollutants which are relatively nontoxic for the degrading system (relatively high value 
for L). Dotted horizontal lines indicate where the concentration is 50 per cent of the 
plateau concentration, whereas the dotted vertical lines indicate the time needed for 
reaching this value. Figures с and d represent accumulation curves for pollutants which 
are toxic for the degrading system (relatively low value for L). Family of curves a: va­
riation of the introduction rate constant (k0), whereas the other factors are kept constant. 
Note: increase in k„ increases the plateau; the time required for reaching the plateau 
remains equal; after stopping the introduction of the pollutant, the concentration rapid­
ly declines exponentially with time (equal 1%). Family of curves b: variation of the 
maximal rate of degradation (vmax(o)), whereas the other factors are kept constant. 
Note: the accumulation curve with low v
max
(0) will reach a high plateau; the time required 
for reaching the plateau is relatively long; after stopping the introduction of the pollu­
tant, the concentration declines exponentially with time (different r ^ ) . Family of curves 
c: variation of the toxicity constant (L). Note: the accumulation curve for a relatively 
nontoxic pollutant (¿ = 90) reaches a plateau; the accumulation curves for the more toxic 
pollutants surpass the plateau and the concentration increases progressively; after 
stopping the introduction of the pollutant, the highly toxic compounds (a highly dam-
aged biodégradation capacity) show persistent pollution. Family of curves d: variation 
of the introduction rate constant (kn) for toxic pollutants, whereas the other factors are 
kept constant. Note: at a critical value for kn, the plateau is surpassed and the pollution 
transits from a biologically controlled steady state into biologically uncontrolled pro-
gressive pollution. 
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Real positive solutions can be obtained for 
k0 < vmaxwL/fkx + L + 2 ykxL) (19c) 
For condition (19c) concentration-time courses were calculated according to 
equation (19) with variations for ko, vmax(o), and L. The calculations were 
performed with a computer of the General Electric Time-Sharing Service. 
Figures 34a and 34b represent the kinetics of accumulation for substances 
with low toxicity (a relatively high value for L). Figure 34a shows the effect 
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of variation of the rate of introduction (ko), whereas the other factors were 
kept constant. The family of curves shows that the plateau concentration is 
increased with the increase of ko. The time needed for reaching the plateau, 
however, remains equal. The plateau concentrations of figure 34a are far 
from saturation of the degrading system (Cx « kx). When the introduction 
of pollutant is stopped a rapid first-order decline in the concentration be­
comes apparent. The half-life times for the declining curves are equal. 
Figure 34b represents the kinetics of accumulation for pollutants with differ­
ent rates of degradation (variation of тахм), whereas the other factors are 
kept constant. The curve for the lowest vmaxt») reaches the highest plateau. 
A second important phenomenon is that the time required for reaching the 
plateau is longer in the case of a lower vmai(o). When the introduction 
of pollutant is stopped a first-order decline occurs. Since vmax(o) differs for 
the various curves, the declining curves show different half-life times. 
It seems adequate to speak of biologically controlled pollution with re­
gard to the situations depicted by the figures 34a and 34b: the accumu­
lation curves rapidly reach a plateau. With regard to a prevention of en­
vironmental pollution with chemical substances it can be concluded that 
lowering of their rate of introduction will result in a decrease in the pla­
teau concentration. An increase in their susceptibility to biodégradation has 
a more drastic effect: the plateau concentration will be decreased, and the 
plateau will be reached more rapidly. 
Figures 34c and 34d represent the kinetics of accumulation for pollutants 
which can damage the degradation capacity. In figure 34c pollutants are 
assumed with different toxicity (different values for L). The other factors 
are kept constant. It can be seen that, if L is sufficiently high, the 
accumulation curve reaches a plateau. However, with increasing toxicity 
(decrease in L) the plateau is surpassed at a critical value for L (determined 
by condition (19c)). With the increase in the concentration the damage to the 
degradation capacity will be enhanced. If it is assumed that no restoration of the 
degradation capacity occurs after stopping the introduction of pollutant, the 
remaining capacity for the various curves will require a long time for purify-
ing the system. Since Cj » k,, the declining curves show zero-order kine-
tics. When the degradation capacity is completely destroyed, persistent pollu-
tion will occur. 
Figure 34d represents the kinetics of accumulation of a toxic pollutant at 
different rates of introduction. If ko is sufficiently low, a plateau in the 
accumulation curve will be reached. If the introduction of pollutant is 
stopped, the concentration will rapidly level down. At a critical rate of intro-
duction (determined by condition (19c)), however, the plateau will be sur-
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passed. Then, the half-life time of the pollutant will be greatly prolonged because 
of further damage to the degrading system; the degree of accumulation then 
rises progressively. When the introduction of pollutant is stopped at a certain 
time the length of time required for purification of the system will depend on 
the remaining capacity for degradation. When the purification capacity is 
completely destroyed persistent pollution will result. 
concentration of pollutant (units/I) 1 
dead water 
1.6 
1.2-
0.Ö-
0.4-
2 4 6 
τ days 
contamination 
stopped 
FIGURE 35. Critical pollution level in biological self-purification. Pollutants with rela­
tively short half-life times can, in principle, be controlled by the biological self-purifica­
tion process. The longer the half-life time of a pollutant, the greater the risk that its 
concentration reaches a critical level at which the biological self-purification capacity 
is affected. The resulting prolongation of the half-life time causes an uncontrolled 
progressive pollution. Strong reduction of the purification capacity results in persistent 
pollution (Ariens, 1971). 
It seems adequate to speak of biologically uncontrolled progressive pollution 
with regard to the situations pictured in figures 34c and 34d. The main 
aspects of the kinetics of accumulation discussed above are summarized in 
figure 35. 
It can be concluded that the rate of introduction is a very critical parameter 
in environmental pollution with chemical substances that can damage the 
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biodégradation processes. If the rate of introduction is so high, that the pla-
teau in the accumulation curve is surpassed, the pollutants will accumulate 
without limit and accelerate the accumulation of other substances. 
In conclusion, it may be stated that a proper policy in the disposal of chem-
ical wastes, or in the application of, for instance, pesticides, has to be based 
on knowledge of the susceptibility of the pollutants to biodégradation, and 
on knowledge of the potential toxicity of the pollutants for the degrading 
systems involved. 
Factors which affect the processes involved in the degradation of pollutants 
will have an essential influence on the rate and the plateau of the accumula-
tion. In this respect the influence of the environmental temperature on the 
growth of bacterial populations, and ultimately on the biodégradation of 
pollutants is important. 
Long-lasting intervals in the introduction of pollutants into ecosystems can 
be important in that they will allow the system time for lowering an accumul-
ation level. This may have a practical significance with regard to certain 
environmental chemical pollution caused by factories: ecosystems exposed 
to industrial waste products will have the possibility to "discharge" during 
the periods in which the rate of contamination is reduced (weekend, holidays). 
VIII, 5. FITTING OF EXPERIMENTAL DATA BY THEORETICAL 
EQUATIONS 
The final and most important step in any approach to environmental phar-
macokinetics is the fitting of the general mathematical models to the actual 
fate of pollutants in ecosystems. 
In the foregoing discussion the fate of pollutants in sewage purification sta-
tions has repeatedly been considered as to relate the theoretical situation 
to a real-life situation. In principle it will be possible to follow experimentally 
the fate of pollutants in certain ecosystems, such as the aquatic ecosystems of 
a lake or a sewage purification station. The experimental data obtained can 
be compared with the mathematical models constructed. 
The situation in a sewage purification plant or in the water of a lake or a 
river can be imitated on a small scale in the laboratory. In the past the bio-
degradability of chemical substances has been frequently tested in this way; 
for example the biodegradability tests on detergents (Huyser, 1960; Borst-
lap and Kooijman, 1963; Fischer, 1963; see also the review of Engelbrecht 
and Banerji, 1966). 
In the present study some measurements with activated sludge from a sewage 
purification plant have been performed. 
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Experimental procedure — Activated sludge was obtained from the Sewage Works in 
Maiden (near Nijmegen). Since the samples of sludge taken at different times from the 
sewage plant might have different biodégradation activity, for every separate set of 
experiments an aliquot of sludge taken from the same sample was used. In order to 
ensure constant bioactivity the activated sludge suspension (freshly taken from the 
plant) was centrifuged in the laboratory and stored at 0 0C. For each test 5 g of this 
stock were suspended in 250 ml of a salt solution containing 3.7 χ 10-· M F e d , . бН.О, 
2.5 χ 10-» M CaCl2, 1(H M MgSO,. 7НгО, 0.15 χ 10-» M (NH4)2S04, 0.25 M KH 2 P0 4 (pH 7.2) (Borstlap and Kooijman, 1963). 
Bottles containing 250 ml sludge suspension were preincubated in a waterbath at 30 0 C 
and aerated for 15 h. From some pilot experiments phenylethylamine appeared to be 
a useful substance for a study of elimination kinetics. In the preliminary experiments 
hardly any degradation of phenylethylamine was observed in the initial stage (5-10 h) 
of its incubation with the sludge suspension. This period may be interpreted as being 
necessary for the proper bacteria to develop a population consuming measurable 
amounts of the substrate offered. In the experiments presently described the initial 
stage of low degradation could be reduced by "activation" of the sludge suspension 
by adding some phenylethylamine at the beginning of the preincubation period. After 
15 h preincubation with phenylethylamine in a concentration of 100 i^tg/ml, the sub­
strate appeared to be fully eliminated from the mixture, whereupon the sludge sus­
pension exhibited a greater bioactivity against a new supply of phenylethylamine 
For measuring the disappearance of phenylethylamine samples of 3 ml homogeneous 
sludge suspension were taken at various times during incubation. After centrifugation 
2 samples of 1 ml each were taken from the supernatant and extracted with 5 ml 
diethyl ether. Prior to the extraction each sample was alkalinized by adding 0.1 ml 
2 N NaOH, and then 1 ml of an aqueous solution of N-benzylmethylamine-HCl of 
known concentration (ranging from 0.05 - 0.5 mg/ml) was added. The JV-benzylmethyl-
amine was carried through the whole procedure as an internal standard. The ether 
extracts were removed and concentrated by evaporation. The concentration of phenyl­
ethylamine in the extracts was assayed by gas chromatography on a column packed 
with 20% Apiezon, and 5% KOH on Diatoport S 60-89 mesh. The carrier gas was 
nitrogen, and the temperature of the column 150 °C. The concentration of phenyl­
ethylamine was calculated from the chromatograms by referring the area of the peak 
found for phenylethylamine to that of the internal standard N-benzylmethylamine. A 
blank was carried through the entire procedure: 250 ml solution of phenylethylamine 
in sterilized salt solution was incubated and analysed in the same way as the mixtures 
containing the activated sludge suspension. It appeared that the concentration of phenyl­
ethylamine in this blank remained constant during the whole incubation period. 
Figure 36 represents the time course of the concentration of phenylethylamine 
in sludge suspensions incubated at different temperatures (0, 15, 30 0 C). 
In the mixtures at 0 0 C no decrease in the concentration could be observed 
over a period of 24 h. In the mixtures incubated at 30 0 C the substrate had 
completely disappeared after 8 h. The shape of the disappearance curve at 
this temperature cannot be explained on the basis of simple zero-order or 
first-order kinetics of elimination. The curve represents an elimination pro­
cess which is accelerating during the incubation; this indicates that a degrad­
ing system with an expanding purification capacity is operating. This pheno­
menon is explicable if the number of microorganisms, using phenylethyl-
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FIGURE 36. Time course of the phenylethylamine concentration in an activated 
sludge suspension at different temperatures. 
Note the acceleration of the elimination process at 30 0C. 
10 12 
time (daya) 
FIGURE 37. Time course of the concentration of surface-active compounds sus-
ceptible to biochemical oxidation. The substances were incubated in river water at 
20 CC. 1, sodium n-decylsulphate; 2, sodium p-n-decylbenzene sulphonate; 3, sodium 
di(benzyl)sulphosuccinate; 4, sodium di(/i-octyl)sulphosuccinate; 5, sodium di(2-ethyl-
hexyl)sulphosuccinate; 6, sodium di(3,5,5-trimethylhexyl)sulphosuccinate. Curves are 
drawn according to data of Hammerton (1956). 
Note the acceleration of the elimination process. 
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amine as a nutrient is increasing. This growth of the microbial population 
results in an ever-increasing consumption of substrate. The acceleration in 
the degradation of pollutants will presumably be a normally occurrmg pheno­
menon for the substances that are nutrients for the microorganisms involved. 
In this connection the data of Hammerton (1956) may be referred to (cf. 
figure 37). 
For a mathematical description of the kinetics of elimination of a substance 
under the influence of microbial growth equations (12) and (14) may be 
phenyletbylamme (Mg/rn\) 
-τ 1 1 ι r-
АО 60 60 
time(h) 
60 ao 
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F I G U R E 38 Time course of the phenylethylamine concentration in an activated 
sludge suspension at 30 " С with variation of the initial concentration (,CX(0)). Sym­
bols represent the experimental values Curves represent the time courses according 
to mathematical equations based on the assumption that a purification process with 
exponentially expanding capacity is operating, a, Curves represent time courses of 
the concentration with the assumption that the purification process remains supply-
limited at all concentrations employed Solid lines represent the curves according to 
equation (12) with r^/,^ = 1.0 χ ICH mm-1, and rg — 6 7 χ IO-3 m i n 1 . In this 
family of curves, only the curve starting at 3 4 χ IO2 «g/ml gives a good fit with the 
experimental data Doited lines represent the curves according to equation (12) with 
Грі^,,) = 3 3 x IO-5 mm- 1, and Гц = 1 2 χ IO-3 min 1 In this family of curves, only 
the curve starting at 8 5 χ IO3 .Mg/ml gives a good fit with the experimental data 
b, Curves represent time courses of the concentration with the assumption that the 
purification process remains capacity-limited at all concentrations employed. With 
equation (14) a family of curves can be obtained that fits the pattern of experimental 
data. The values r
eli)(o) ( = 0 71 ^g. ml '. mm-1), and for rg ( = 5.0 χ 10-^ min-1) were 
chosen on the basis of the experimental values in such a way that on the average a 
satisfactory fit was obtained. 
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used. It will be interesting, therefore, to investigate whether the experimental 
data found for the disappearance of phenylethylamine can be fitted by one 
of these equations. 
Figure 38 represents the results of an experiment in which equal amounts of 
suspensions of activated sludge were incubated with different amounts of 
phenylethylamine. The temperature during incubation was kept at 30 0 C. 
At various times the concentration of phenylethylamine was determined. The 
values found are represented by the symbols in figure 38a and 38b. The 
curves drawn in the figure represent the time course of the concentration 
according to the mathematical equations (12) and (14) respectively, for 
certain values of Гсіи»), rwofoj, and rg at the initial substrate concentrations 
(Сто,)) applied. 
Kinetics of elimination according to equation (12) implies a supply-limited 
process of elimination, which means that the substrate offered is far from 
saturating the degrading system. It can be expected from equation (12), 
which assumes a proportionality between Cx(t>) and Cxit), that an increase in 
the initial substrate concentration will result in a shift of the curve upwards 
along the ordinates of the concentration-time course graph. The time required 
to reduce the concentration to zero will not markedly increase with in­
creasing initial concentration, since it is assumed that the process remains 
supply-limited. 
On the contrary, when a capacity-limited process of elimination is involved, 
(equation 14), a longer time will certainly be required for complete elimina­
tion of the substrate added at higher initial concentration. An increase in 
the initial concentration will shift the concentration-time course graph both 
upwards along the ordinates and along the abscissas from left to right. 
The family of curves calculated according to equation (14) gives a better fit 
to the experimental data (figure 38b) than equation (12) does (figure 38a). 
The relatively good fit of equation (14) to the experimental data can be 
confirmed by plotting the difference between the various initial concentra­
tions and the respective concentrations measured during the incubation 
period against time. 
According to equation (14) 
CX(0) - CX(t) = (reiow/r,,) (етвг - \) 
The time course of this function with ГеЫп) = 0.71 /íg.ml^.min-1 and τ
β
 = 
5.0 χ IO"4 m i n 1 is represented by the curve in figure 39. This curve fits the 
experimental data well. 
The correspondence between the experimental data and the mathematical 
description represented by equation (14) may allow the following conclusion 
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FIGURE 39. Time course for the decrease in the phenylethylamine concentration 
(C
x
(0) - Cx(()) measured at different initial concentrations (Cx(0)). Symbols represent­
ing the experimental data correspond with the values plotted in figure 38. The curve 
drawn represents the theoretical time course according to equation (14) with ^ ( Ό ; — 
0.71 /ig. ml-1, min-1, and rg = 5.0 χ IO-
4
 min-1. 
about the elimination of phenylethylamine in the activated sludge suspen­
sions: the kinetics of elimination presumably depends upon a capacity-limited 
exponentially expanding process of purification. In view of the parallel shift 
of the curves along both the ordinates and the abscissas of figure 38b it may 
be concluded that the degrading system remains capacity-limited at decrease 
of the initial concentration of the substrate from 8.5 χ 103 to 85 ^g/ml. The 
proportionality between the initial concentrations and the extent of the 
parallel shift of the corresponding curves indicates that, within the range of 
concentrations employed, no inhibition of the growth of the bacterial popul­
ation involved occurs. 
ІП, 6. CONCLUSION 
In this study, an approach to some problems related to environmental phar­
macokinetics has been attempted. 
Insight into the fate of chemical pollutants in ecosystems will be indispensable 
for control of environmental chemical pollution. The degree of admissibility 
of chemical pollutants to ecosystems has to be based upon objective criteria. 
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Such criteria can be obtained by quantitative tracing of pollutants. Pilot 
experiments with certain model systems can give useful information. The 
use of mathematical compartment models can contribute to a clarification 
of the insight into the phenomena observed. 
Solid knowledge of the kinetics of accumulation is a primary condition for 
deliberate introduction of pollutants into nature. The present study empha-
sizes the importance of the rate of elimination. The rates of introduction and 
of elimination determine the level of the accumulation plateau. The time 
period within which an accumulation plateau is reached depends on the rate 
of elimination. Since biodégradation of pollutants is an important route for 
elimination, the factors which influence the biomass involved play a role in 
the accumulation phenomenon. In this study emphasis was put on the kinetics 
accumulation of pollutants that are toxic for the biological self-purification 
process. For such substances the accumulation curve may easily surpass the 
plateau. Thus, a steady state of biologically controlled pollution may transit 
into biologically uncontrolled progressive pollution. Finally, persistent poUu-
tion will result. 
Far-reaching conclusions concerning the equations presented in this chapter 
cannot be given until adequate experimental data are available. One of the 
more complex models (including the kinetics of an exponentially expanding 
purification process) appears to describe well the kinetics of elimination of 
a substance in a simple ecosystem under laboratory conditions. This may 
be considered as encouraging for further study. 
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S U M M A R Y 
This thesis describes biological-pharmacological studies concerning some as-
pects of chemical pollution of the biosphere. 
The first part of this thesis (chapters II — VII) concerns studies on the capa-
city of different animal species to metabolize compounds alien to them (xeno-
biotics). Biotransformation of xenobiotics is generally necessary for elimi-
nation of the compounds from the body. 
In the second part of this report (chapter VIII) an attempt is made to des-
cribe the kinetics of the fate of chemical compounds in the biosphere. Empha-
sis is placed upon the factors which determine the occurrence of various 
forms of environmental pollution, viz. biologically controlled, biologically 
uncontrolled progressive, and persistent environmental pollution. 
The above mentioned approaches are elucidated in chapter I. 
Chapter II is a survey of data from the literature concerning some general 
aspects of the biochemical conversion of xenobiotics, particularly in mam-
mals. The various types of drug-metabolizing reactions and their significance 
for the animal are discussed in this review. Further, the localisation and spe-
cificity of the enzyme systems catalyzing the reactions, and the mechanism 
of the oxidative reactions are discussed in detail. The endogenous and exo-
genous factors which can influence the capacity for metabolizing xenobio-
tics are also reviewed. An important point in the latter discussion is the en-
hanced synthesis of enzymes in animals exposed to certain xenobiotics, among 
which are DDT, phénobarbital, and 3-methylcholanthrene. Finally, the pos-
sible species differences in drug-metabolizing capacities are considered. 
Until recently, it was generally assumed that fishes and other aquatic animals 
were not provided with a drug-metabolizing ability. These animal species 
would have no need for this, since lipophilic xenobiotics would readily diffuse 
through the lipoidal membranes of gills and skin into the surrounding water. 
This argument can be invalidated, however, by referring to the consequences 
of the biotransformation of lipophilic xenobiotics into hydrophilic products. 
Such a conversion will also be in favour of aquatic animals, since the more 
water-soluble products are more restricted to the extracellular phase. In this 
way, the substances are offered in higher concentrations for excretion through 
gill, kidney and/or skin. The data in the present investigation show that tissue 
preparations from fish do possess a drug-metabolizing capacity. The enzym-
atic capacity was measured in vitro for reactions considered to be representa-
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tive for biotransformation of xenobiotics: oxidative N-dealkylation, aromatic 
hydroxylation and glucuronidation. The substrates used in these reactions were 
aminopyrine, aniline, and p-nitrophenol respectively. The animals, materials, 
and methods employed in this study are listed in chapter III. 
Among the various organs of fish, the greatest capacity for converting xeno­
biotics has been found in extracts from the liver. This agrees with the data in 
the literature for the drug-metabolizing capacities of birds and mammals, which 
are also mainly localized in the liver. The assays in this study were mainly per­
formed, therefore, with this organ. Intracellularly, the hepatic drug-metaboliz­
ing enzymes of fish are bound to the (membranes of the) endoplasmic reticulum. 
This also agrees with the data from the literature about the intracellular localiza­
tion of the enzyme systems in the mammalian and avian liver. Besides the si­
milarities in localization, further similarities were found with respect to the en­
zyme systems of the varous species: the requirements for various cofactors and 
the sensitivity of the enzyme preparations to freezing and thawing, ultrasonic 
treatment, and treatment with bile fluid, deoxycholate, carbon monoxide, 
and SKF 525A. However, clear-cut species differences were also found, for 
instance, in the stability of the enzymes, and the optimal substrate and co-
substrate concentrations. The data from the literature about the lack of a 
drug-metabolizing capacity in fish can be explained in view of the fact that 
the species differences mentioned above were left out of account in the 
enzyme assays in previous studies. In order to obtain correct comparable da­
ta for the enzymatic capacities of different animal species, the assays in this 
study were performed at adapted conditions as a standard procedure 
(chapter IV). 
Chapter V is an analysis of the oxidative ЛГ-demethylation of 4-dimethylami-
noantipyrine. It was shown that only one methyl group was split from the sub­
strate predominantly. The identification of the reaction products (4-monome-
thylaminoantipyrine and 4-aminoantipyrine) was performed by thin-layer 
chromatography and mass spectrometry. The enzymatic conversion of 4-di-
methylaminoantipyrine is generally measured in vitro with colorimetrie assays 
on the products formaldehyde and 4-aminoantipyrme. However, the colori­
metrie assays on 4-aminoantipyrine appeared not to be specific. Since 4-mo-
nomethylaminoantipyrine, the main product in the N-demethylation of 4-di-
methylaminoantipyrine, also shows a positive reaction in these assays, the re­
sults of previous studies in which the aim was to measure the formation of 4-
aminoantipyrine only, have to be interpreted with serious reservations. 
Chapter VI presents the results of the comparative study on the drug-metabo­
lizing capacity of different animal species. The differences observed for the 
enzymatic activity in the N-demethylation and for the Km-values of aminopyri-
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ne for trout, roach, and rat liver preparations in relation to the incubation tem-
perature are most probably a reflection of the different physiological conditions 
of the animals, adapted to their habitat. The trout, which lives preferentially at 
low environmental temperatures, will accordingly be cold-adapted. The wild 
roach will be adapted to the naturally occurring thermal fluctuations of its 
aquatic environment. The properties of enzymes in the homeothermic rat will 
correspond to the higher internal body temperature. As far as drug-metaboliz-
ing capacity is concerned, lower values were found for the Poikilothermie ani-
mals studied than for the homeothermic ones. An explanation of this difference 
can presumably be found in the difference in standard metabolism, which in its 
turn is related to the food intake and therefore to the degree of exposure to xeno-
biotic compounds. 
The drug-metabolizing capacity of wild fish is probably under the influence 
of enzyme-inducing xenobiotics in the chemically polluted environment. The 
difference in the drug-metabolizing capacity of the various species of Cypri-
nidae may be explained on this basis. The Leuciscus species are highly mobile 
fishes that attempt to collect a great amount of food consisting of plankton, 
plants, small aquatic animals and insects near the surface of the water. Thus 
they are presumably exposed to a great amount and variety of xenobiotics. 
The liver preparations from these fishes have a greater drug-metabolizing 
capacity than those from the white bream, bream, carp, and tench, which all 
are slow-swimming fishes, that collect their food consisting of plants, grubs, and 
worms near the bottom of the water. 
It may be asked with respect to the increased chemical water pollution, to what 
degree the species differences in drug-metabolizing capacity have played a 
role in the shifts in the fish populations. Salmonidae, which have a very low 
detoxication capacity, have almost completely disappeared from the river Waal 
(Rhine). In contrast, Cyprinidae, which have a rather high drug-metabolizing 
capacity, remain in fairly good numbers. 
That external factors have an influence on the drug-metabolizing capacity of 
fish is shown in chapter VII. The effect of exposure to insecticides and to dif-
ferences in temperature appears generally to be equal for fish and mammals. 
Trout and roach were kept in water of different temperatures (5 or 18 °C in 
standing tap water for 14 days). The drug-metabolizing capacities of the fish 
kept at high temperature appeared to be lower (about 50%) than those of the 
fish kept at low temperature. This may indicate one of the negative effects of 
thermal pollution of the surface water, viz. damage to the systems necessary 
to the animals for the elimination of chemical pollutants. 
The drug-metabolizing capacity of fish can be enhanced by exposure of the ani-
mals to certain enzyme-inducing xenobiotics (dieldrin, DDT). Roach from the 
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Waal staying in running tap water for 1 to 3 months, show a decrease in drug-
metabolizing capacity of about 50%. This decrease does not occur in animals 
living in standing tap water or in river water. Additionally, the decrease can 
be retarded by treatment of the animals with an enzyme-inducing compound 
(dieldrin). This suggests that the drug-metabolizing capacity of wild fish is de-
termined by certain chemical pollutants in the environment. These data argue 
for the hypothesis developed in this report that the seasonal varation in drug-
metabolizing capacity observed for roach and rudd (high capacity in summer 
and low in winter), is largely due to a difference in the exposure of the animals 
to enzyme-inducing compounds in the chemically polluted environment. A 
difference in the contact of the fish with its environment (a difference in mobi-
lity, in food consumption), and a difference in the concentration of enzyme-in-
ducing chemicals (e.g. insecticides and herbicides) in the water as a consequen-
ce of a different water level and of a seasonally dependent input of enzyme-
inducing substances into nature, may play a role here. 
The pharmacokinetic approach to the chemical pollution of the environment 
is worked out in chapter VIII. The procedure employed is similar to that uti-
lized in individual pharmacokinetics, where the attempt is made to describe 
the fate of xenobiotics (e.g. medicaments, poisons) in man or animal. 
Various aspects of environmental pollution are described with mathematical 
models. The rate of elimination is considered to be the most important factor. 
The main route for elimination of pollutants from ecosystems is the natural ca-
pacity of degradation, the biological self-purification capacity. Mathemati-
cal models are constructed for an expanding and a decreasing biodégrada-
tion capacity. 
An expanding biodégradation capacity may occur in the case of contaminants 
that are nutrients for the degrading system. Two theoretical models for an 
expanding biodégradation capacity are compared using the degradation of 
phenylethylamine in an activated sludge suspension from a sewage purification 
station. 
A decreasing biodégradation capacity may occur in the case of contaminants 
that are toxic for the degrading system. This case is theoretically worked out 
for a continual disposal of pollutants into ecosystems. Accumulation curves 
show that a plateau is rapidly reached for nontoxic chemicals with a short half-
life time. The level of the plateau is dependent on the rates of introduction and 
of elimination. The time required for reaching the plateau is solely dependent 
on the rate of elimination. When the input is stopped the concentration will 
rapidly decrease to zero. It seems reasonable, therefore, to speak of biologi-
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cally controlled environmental pollution with respect to the category of non-
toxic substances mentioned above. 
The most dangerous category of pollutants is that of substances that can dama-
ge the degrading system. It is shown in accumulation curves, that an ever-increa-
sing damage to the decreasing system occurs with the increase of the pollutant 
concentration. This results in a progressive prolongation of the half-life time 
of the pollutant. Toxic pollutants accumulate, therefore, progressively since 
the biodégradation (biological control) diminishes further and further with the 
increase in the pollutant concentration. It seems reasonable to speak of biolo-
gically uncontrolled progressive environmental pollution with respect to the 
category of toxic pollutants. 
When the degrading system is completely and irretrievably damaged, after 
stopping the input, the concentration will not decrease. In this situation the 
term persistent pollution may be used. 
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S A M E N V A T T I N G 
In dit proefschrift is biologisch-farmacologisch onderzoek beschreven betref-
fende enkele aspecten van de chemische verontreiniging van de biosfeer. 
Het eerste gedeelte van het proefschrift (hoofdstukken II — VII) omvat on-
derzoek naar het vermogen van verschillende diersoorten tot biotransforma-
tie van lichaamsvreemde verbindingen (xenobiotica). Biotransformatie van 
xenobiotica is als regel noodzakelijk om deze verbindingen uit het lichaam 
te elimineren. 
Het tweede gedeelte van het proefschrift (hoofdstuk VIII) geeft een farma-
cokinetische beschrijving van het lot van chemische verbindingen in de bio-
sfeer. Daarbij wordt de nadruk gelegd op factoren die bepalend zijn voor het 
optreden van verschillende vormen van chemische milieuverontreiniging, met 
name biologisch gecontroleerde, biologisch ongecontroleerde progressieve, 
en persisterende milieuverontreiniging. 
De hierboven genoemde benaderingen worden in hoofdstuk I toegelicht. 
Hoofdstuk II geeft een overzicht van literatuurgegevens betreffende algemene 
aspecten van de biochemische omzetting van xenobiotica, in het bijzonder bij 
zoogdieren. In dit overzicht worden onder meer de aard van de betreffende 
reacties en hun betekenis voor het organisme besproken. Verder wordt inge-
gaan op de localisatie en de specificiteit van de enzymsystemen betrokken bij 
de biotransformatie van xenobiotica, op het mechanisme van de oxydatieve 
reacties en op de endogene en exogene factoren die het vermogen van dieren 
om xenobiotica te metaboliseren kunnen beïnvloeden. Een belangrijk punt 
van bespreking is de verhoogde synthese van enzymen in dieren die blootge-
steld zijn aan bepaalde xenobiotica, waaronder DDT, fenobarbital en 3-methyl-
cholanthreen. Tenslotte wordt gewezen op mogelijke verschillen in het ver-
mogen van verschillende diersoorten tot het metaboliseren van xenobiotica. 
Tot voor kort werd algemeen verondersteld dat vissen en andere in het wa-
ter levende dieren niet over een vermogen om xenobiotica te metaboliseren 
beschikken. Hieraan zou bij deze diersoorten geen behoefte bestaan omdat 
lipofiele xenobiotica gemakkelijk via de lipoidale membranen in kieuwen en 
huid naar buiten zouden kunnen diffunderen. Dit argument kan echter worden 
ontkracht door verwijzing naar de gevolgen van de biotransformatie van lipo-
fiele xenobiotica tot hydrofiele producten. Een dergelijke omzetting is ook 
voor in het water levende dieren nuttig, alleen al omdat de in water beter op-
losbare producten meer tot de extracellulaire fase worden beperkt en zo in 
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hogere concentraties voor verwijdering via kieuw, nier en/of huid beschikbaar 
komen. De gegevens van het hier beschreven onderzoek aan weefselextracten 
wijzen duidelijk uit dat vissen wel over een xenobiotica-metaboliserend vermo­
gen beschikken. In vitro werd de enzymatische capaciteit gemeten voor reacties 
die representatief worden geacht voor de biotransformatie van lichaamsvreemde 
verbindingen: oxydatieve N-dealkylering, aromatische hydroxy lering en glucu-
ronidering. Bij deze reacties werden als substraten gebruikt respectievelijk ami-
nopyrine, aniline en p-nitrophenol. De in het onderzoek gebruikte dieren, mate­
rialen en methodieken zijn beschreven in hoofdstuk III. 
In aansluiting aan de gegevens uit de literatuur dat bij zoogdieren en vogels 
de enzymen die bij bovengenoemde reacties betrokken zijn, zich voornamelijk 
in de lever bevinden, werd bij vissen eveneens de hoogste enzymatische capa­
citeit in extracten uit de lever waargenomen. Derhalve werden de metingen voor­
namelijk aan dit orgaan verricht. Overeenkomstig de gegevens over de zoogdier­
en vogellever bleek dat de onderzochte enzymsystemen ook in de visselever ge­
bonden zijn aan (de membranen van) het endoplasmatische reticulum. Naast 
deze overeenkomsten voor vogels, zoogdieren en vissen werden verdere over­
eenkomsten waargenomen in de voor de reacties benodigde cofactoren en in 
de gevoeligheid van de enzympreparaten ten opzichte van invriezing en ont­
dooiing, ultrasone trillingen en behandeling met galvloeistof, deoxycholaat, 
koolmonoxyde en SKF 525A. Daarnaast werden echter toch ook duidelijke 
verschillen tussen diverse dierspecies voor de onderzochte enzymatische reac­
ties waargenomen, bijvoorbeeld wat betreft de stabiliteit van de enzymen, en 
de optimale concentraties van substraten en cosubstraten. De literatuurgege­
vens over het ontbreken van een xenobiotica-metaboliserend vermogen bij 
vissen zijn verklaarbaar op grond van het feit dat men bij de enzymtesten in 
vroegere onderzoekingen te weinig rekening heeft gehouden met bovengenoem­
de verschillen tussen de species. Teneinde in het huidige onderzoek een ver­
antwoorde vergelijking van de enzymatische capaciteiten van de verschillende 
dierspecies te realiseren werden gestandaardiseerde metingen verricht onder 
aangepaste condities (hoofdstuk IV). 
Hoofdstuk V geeft een analyse van de oxydatieve У -demethylering van 4-dime-
thylaminoantipyrine (aminopyrine). Er werd aangetoond dat in deze reactie 
voornamelijk slechts één methylgroep van het substraat wordt afgesplitst. 
Identificatie van de reactieproducten (4-monomethylaminoantipyrine en 4-
aminoantipyrine) vond plaats door middel van dunnelaag-chromatografie en 
massaspectrometrie. In het algemeen wordt bij de enzymatische omzetting van 
4-dimethylaminoantipyrine in vitro de vorming van formaldehyde en 4-ammo-
antipyrine gemeten door middel van colorimetrische bepalingen. De colori-
metrische testen op 4-aminoantipyrine bleken echter niet specifiek te zijn. 
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Omdat ook 4-monomethylaminoantipyrine, het belangrijkste product van de 
N-demethylering van 4-dimethylaminoantipyrine, reageert in deze testen, 
moet ten opzichte van de resultaten van vroegere studies, waarbij men dacht 
4-aminoantipyrine te meten, een grote reserve in acht genomen worden. 
Hoofdstuk VI omvat de resultaten van het vergelijkende onderzoek naar het 
xenobiotica-metaboliserend vermogen van verschillende diersoorten. Hoogst-
waarschijnlijk zijn de waargenomen verschillen voor de enzymatische activiteit 
in de N-demethylering en de Km-waarden van aminopyrine voor de extracten 
uit de levers van forel, blankvoorn en rat met betrekking tot de incubatietempe-
ratuur een weerspiegeling van de fysiologische aanpassing van de dieren aan hun 
habitat. De eigenschappen van de enzymen van de forel, welke bij voorkeur 
leeft in water van lage temperatuur, getuigen van een aanpassing aan deze la-
ge temperatuur, die van de in het wild levende blankvoorn aan de nogal wis-
selende temperatuur van de omgeving, terwijl die van de rat corresponderen 
met de hogere lichaamstemperatuur. Wat de capaciteiten tot het metaboli-
seren van xenobiotica betreft werden bij de onderzochte poikilotherme dieren 
lagere waarden waargenomen dan bij de homoiotherme dieren. Een verkla-
ring voor dit verschil zal vermoedelijk gezocht moeten worden in een ver-
schil in standaardmetabolisme, dat op zijn beurt gecorreleerd is met de voed-
selopname en daarmede met de mate van blootstelling aan xenobiotica. 
De capaciteit tot het metaboliseren van xenobiotica bij in het wild levende vis-
sen wordt mogelijk beïnvoed door enzym-inducerende verbindingen in het 
chemisch verontreinigde milieu. Op deze basis zouden de waargenomen ver-
schillen binnen de diverse soorten der Cyprinidae verklaard kunnen worden. 
De verschillende soorten voorn, erg beweeglijke vissen welke een grote hoe-
veelheid voedsel bestaande uit plankton, plantendelen, kleine waterdieren en 
insecten aan het wateroppervlak bemachtigen — en derhalve vermoedelijk 
blootgesteld worden aan een relatief grote hoeveelheid en variatie van xeno-
biotica — vertonen een groter vermogen tot omzetting van xenobiotica dan de 
bliek, brasem, karper en zeelt, vrij langzaam zwemmende vissoorten, welke 
hun voedsel, onder meer bestaande uit plantendelen en wormen, dieper in het 
water verzamelen. 
Men kan zich afvragen in hoeverre de toegenomen chemische waterveront-
reiniging heeft bijgedragen tot speciesverschillen wat betreft het vermogen 
om xenobiotica te metaboliseren en zodoende tot verschuivingen in de vispo-
pulatics. Salmonidae, welke over een zeer geringe detoxificatiecapaciteit be-
schikken, komen vrijwel niet meer voor in de Waal, terwijl Cyprinidae, welke 
een vrij hoge capaciteit hebben, zich betrekkelijk goed weten te handhaven. 
Dat externe factoren een invloed hebben op de capaciteit van vissen om li-
chaamsvreemde verbindingen te metaboliseren, is aangetoond in hoofdstuk 
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VII. Het effect van blootstelling aan insecticiden en aan tcmperatuursverschil-
len blijkt bij vissen in grote lijnen gelijk te zijn aan dat bij zoogdieren. 
Na een verblijf van forellen en blankvoorns in water van verschillende tem-
peratuur (14 dagen bij 5 of 18 0C in stilstaand kraanwater) bleken de metabole 
capaciteiten van de vissen gehouden bij hoge temperatuur veel lager (onge-
veer 50%) te zijn dan die van de vissen gehouden bij lage temperatuur. Dit 
wijst op een van de gevaren die een thermische verontreiniging van het op-
pervlaktewater kan inhouden, namelijk beschadiging van juist die systemen 
die vissen gebruiken bij de eliminatie van lichaamsvreemde verbindingen. 
Het vermogen van vissen om xenobiotica te metaboliseren kan worden ver-
hoogd door blootstelling van de dieren aan bepaalde enzym-inducerende stof-
fen (dieldrin, DDT). Blankvoorns uit de Waal vertonen na een verblijf van 1 
tot 3 maanden in stromend kraanwater een daling van omzettingscapaciteit tot 
ongeveer 50%. Deze daling treedt niet op wanneer de dieren worden gehou-
den in stilstaand kraanwater of rivierwater. Zij kan bovendien worden gean-
tagoneerd door de dieren in stromend kraanwater te belasten met een enzym-
inducerende verbinding (dieldrin). Dit wijst erop dat het xenobiotica-metaboli-
serende vermogen van in het wild levende vissen beïnvloed kan worden door 
bepaalde chemische contaminanten in het milieu. Deze gegevens pleiten sterk 
voor de in dit proefschrift uitgewerkte hypothese dat de waargenomen seizoens-
variatie in het vermogen om xenobiotica te metaboliseren bij blank- en ruis-
voorn (hoge waarden gedurende de zomer, lage gedurende de winter) in be-
langrijke mate veroorzaakt wordt door een verschil in blootstelling van de 
dieren aan enzym-inducerende verbindingen in het chemisch verontreinigde 
milieu. Factoren, die vermoedelijk hierbij een rol spelen zijn: een verschillend 
contact van het dier met zijn milieu (verschil in beweegijkheid, in voedselop-
name), en een verschillende concentratie van enzym-inducerende verbindin-
gen (bijvoorbeeld insecticiden en herbiciden) in het water als gevolg van ver-
schillende waterstand en een seizoensafhankelijke introductie van inducerende 
verbindingen in de natuur. 
De farmacokinetische benadering van de chemische milieuverontreiniging is 
uitgewerkt in hoofdstuk VIII. De gevolgde werkwijze vertoont een grote over-
eenkomst met die toegepast in de individuele farmacokinetiek, waarmede men 
het lot van xenobiotica (bijvoorbeeld geneesmiddelen, vergiften) in de mens 
of in het proefdier tracht te beschrijven. 
Een aantal aspecten van de milieuverontreiniging is beschreven met behulp 
van mathematische modellen. In deze modellen wordt de eliminatiesnelheid als 
de belangrijkste factor beschouwd. De snelheid van eliminatie van chemische 
verbindingen in ecosystemen wordt voornamelijk bepaald door de natuurlijke 
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capaciteit tot degradatie, het biologisch zelfreinigend vermogen. Mathema-
tische modellen zijn geconstrueerd voor een toenemende, respectievelijk afne-
mende biodegradatiecapaciteit. 
Een toenemende biodegradatiecapaciteit is denkbaar in het geval dat de con-
taminanten voedingsstoffen voor het afbrekende systeem zijn. Een tweetal mo-
dellen die deze situatie beschrijven, is experimenteel getoetst aan de hand van 
de afbraak van phenylcthylamine in een suspensie van actief slib uit een riool-
waterzuiveringsinstallatie. 
Een afnemende biodegradatiecapaciteit is denkbaar in het geval dat de conta-
minanten voor het afbrekende systeem toxisch zijn. Dit geval is theoretisch uit-
gewerkt voor situaties waarbij continue lozing van chemische verbindingen in 
ecosystemen plaatsvindt. In cumulatie-curven is te zien dat vrij snel een pla-
teau bereikt wordt in geval van continue lozing van verbindingen met geringe 
toxiciteit en korte halfwaarde-tijd. De hoogte van het plateau is afhankelijk 
van de snelheden van introductie en eliminatie. De tijd waarin het plateau 
wordt bereikt is alleen afhankelijk van de snelheid van eliminatie. Als de aan-
voer van de stof wordt gestopt, zal de concentratie weer snel tot de nulwaarde 
dalen. Het lijkt daarom adequaat ten opzichte van de hier bedoelde categorie 
van stoffen te spreken van biologisch gecontroleerde milieuverontreiniging. 
Toxische stoffen die het degradatiesysteem kunnen beschadigen, vormen de 
gevaarlijkste categorie van verbindingen in de milieuvervuiling. In cumulatie-
curven wordt weergegeven dat bij toenemende concentratie een steeds sterke-
re beschadiging van het biodcgradatiesysteem optreedt. Als gevolg hiervan 
wordt de halfwaarde-tijd van de stof progressief verlengd. Toxische verbindin-
gen cumuleren derhalve progressief doordat de biodegradatie (biologische 
controle) met het toenemen van de concentratie steeds geringer wordt. Het 
lijkt daarom adequaat met betrekking tot de hier bedoelde categorie van to-
xische verbindingen te spreken van biologisch ongecontroleerde progressieve 
milieuverontreiniging. 
Wanneer het biodcgradatiesysteem volledig en onherstelbaar wordt bescha-
digd, zal bij beëindiging van de aanvoer van stof de concentratie niet afnemen. 
Er kan dan worden gesproken van persisterende milieuverontreiniging. 
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